data_2kco_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kco _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 78' ' ' ILE . 25.8 m . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.218 0.532 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HZ3' ' HB3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.544 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.544 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HB3' HG23 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 94' ' ' GLY . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HG3' HD23 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.756 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.756 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.7 m120 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t . . . . . 0 CA--C 1.558 1.275 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.426 HD22 ' HB1' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.559 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HZ1' ' HB3' ' A' ' 75' ' ' LYS . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 101' ' ' LYS . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.417 ' O ' HD11 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD22 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.3 m120 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.559 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt . . . . . 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.575 HG21 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HD3' HG23 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' HZ1' ' A' ' 77' ' ' LYS . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.575 ' HB ' HG21 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.502 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HB1' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 78' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.546 HD23 ' HB1' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' HG22 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.4 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.441 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 . . . . . 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HB3' HG21 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.452 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG3' HD22 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.553 ' HB2' HG11 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.22 0.057 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 41' ' ' ASP . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.077 0.465 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB2' HD11 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 102' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HB3' HG23 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.525 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' HD11 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.602 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.476 HD11 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.768 0.318 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.557 0.694 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.637 ' HZ2' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 HG21 ' HB1' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HG2' HD13 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.513 HD13 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.41 ' HG1' HG23 ' A' ' 124' ' ' VAL . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 17.5 m120 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.43 HG11 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.779 -0.153 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.493 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.631 HD21 ' HB2' ' A' ' 90' ' ' LEU . 5.6 p-10 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' HD21 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.631 ' HB2' HD21 ' A' ' 87' ' ' ASN . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 78' ' ' ILE . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.529 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD22 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HG2' HD13 ' A' ' 44' ' ' ILE . 2.3 ppt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.455 HG21 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 120.857 0.36 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.503 HG12 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HZ3' ' HB3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' HG21 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.538 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD22 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.503 ' HG ' HG12 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.454 HD12 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 121.094 0.473 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.546 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.504 ' HB2' HD22 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.513 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' HG3' HD23 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.54 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.67 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.546 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 78' ' ' ILE . 14.5 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HB3' HG21 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.547 HD11 HG23 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG3' HD23 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' HD13 ' A' ' 126' ' ' LEU . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.618 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.618 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.471 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt . . . . . 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 . . . . . 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.438 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m . . . . . 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HG2' HG22 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 102' ' ' ILE . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.506 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' H ' HG21 ' A' ' 97' ' ' ILE . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.409 HG21 ' H ' ' A' ' 86' ' ' ALA . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.441 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG3' HD23 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HB3' HG13 ' A' ' 121' ' ' ILE . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.444 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 . . . . . 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.541 HG21 HD13 ' A' ' 78' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.553 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.553 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.401 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 102' ' ' ILE . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.453 HG21 HG21 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.9 OUTLIER -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.453 HG21 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.465 HG23 HD13 ' A' ' 78' ' ' ILE . 3.6 m . . . . . 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' HG22 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.552 HD23 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' HG21 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' HD23 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.491 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.533 HG22 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 0.2 OUTLIER -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG22 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.52 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD22 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.56 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.56 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.59 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.412 HD12 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.498 ' HB ' HG23 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG3' HD22 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.696 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.527 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.433 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.244 0.802 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.582 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HZ1' ' HB3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.519 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.505 HD13 HD11 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.546 HG21 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' HG3' HD22 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.505 HD11 HD13 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.582 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.466 0.174 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' HG23 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HB3' HG22 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HG2' HG23 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.464 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.495 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.502 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 121' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.51 HG23 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.968 0.413 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HB3' HG21 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HB3' HG23 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.42 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HB3' HG23 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.635 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HG2' HD21 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.537 ' HG3' HD22 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.558 ' HG2' HG21 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' HB3' HG13 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.8 OUTLIER -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.5 HD22 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.46 -72.63 0.11 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -157.29 141.17 16.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.423 0.689 . . . . 0.0 110.2 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -158.27 138.13 12.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.793 0.837 . . . . 0.0 109.051 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -75.09 130.26 38.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.004 0.522 . . . . 0.0 109.923 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.2 168.37 54.6 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.323 -0.709 . . . . 0.0 113.257 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.93 96.85 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.278 2.652 . . . . 0.0 112.603 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.44 123.63 23.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.659 0.784 . . . . 0.0 109.399 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -121.66 131.2 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 109.588 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.22 157.41 24.92 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 109.58 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 99.94 12.83 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.99 89.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.3 p -95.93 96.12 8.7 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.244 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.33 31.05 4.56 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.38 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.87 40.53 2.98 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 123.087 0.375 . . . . 0.0 112.939 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.32 78.45 9.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HZ1' ' HB2' ' A' ' 17' ' ' LYS . 4.7 ttmp? -140.96 116.34 10.07 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.347 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.59 150.7 19.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.13 179.77 7.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.341 0.656 . . . . 0.0 109.796 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -108.85 160.08 16.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -91.13 134.17 34.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.85 140.28 29.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.011 0.925 . . . . 0.0 111.586 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 -166.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.535 1.134 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -75.82 147.67 38.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.865 0.466 . . . . 0.0 110.035 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -103.35 -77.81 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.846 0.458 . . . . 0.0 109.8 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.29 37.93 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.378 0.671 . . . . 0.0 110.608 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.73 148.59 24.31 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.798 0.839 . . . . 0.0 112.154 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.21 118.34 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.9 -103.58 0.48 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 123.461 0.475 . . . . 0.0 112.673 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.07 139.18 42.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.646 0.778 . . . . 0.0 110.675 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.62 157.58 28.4 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.687 2.258 . . . . 0.0 111.202 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.68 159.88 38.45 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.286 1.991 . . . . 0.0 112.449 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.8 p -67.26 163.95 19.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.446 0.698 . . . . 0.0 110.602 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -103.21 167.83 9.57 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 110.874 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.5 p -75.73 162.34 28.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.801 0.84 . . . . 0.0 110.142 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 p -82.86 -96.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.995 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -170.68 -173.94 1.49 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.698 0.799 . . . . 0.0 110.655 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -140.04 20.25 2.46 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.91 0.884 . . . . 0.0 110.114 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.01 -49.85 75.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.73 0.812 . . . . 0.0 111.766 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 -74.1 -35.97 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.402 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 13.4 t -86.93 15.84 5.52 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.65 0.78 . . . . 0.0 111.906 -174.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -56.8 148.12 21.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.445 0.698 . . . . 0.0 111.512 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.5 168.76 54.8 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.314 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.51 -148.61 4.0 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 122.711 0.196 . . . . 0.0 112.831 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -125.63 146.76 49.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.428 0.691 . . . . 0.0 109.973 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -66.94 147.71 52.88 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.023 0.929 . . . . 0.0 110.299 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 54' ' ' LYS . 11.2 mmpt? -92.25 176.58 6.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.181 0.592 . . . . 0.0 111.619 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -86.33 160.92 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.435 0.694 . . . . 0.0 110.977 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -114.71 153.74 29.71 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.164 0.986 . . . . 0.0 110.162 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.61 141.92 42.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -111.7 165.29 12.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.54 0.736 . . . . 0.0 110.464 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.5 106.47 12.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.738 0.815 . . . . 0.0 109.252 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.3 p -78.23 143.71 36.88 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.698 0.399 . . . . 0.0 110.007 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.519 HG21 HD12 ' A' ' 78' ' ' ILE . 25.8 m -64.51 115.62 5.34 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 123.734 0.646 . . . . 0.0 110.2 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HB3' ' HZ3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.471 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.544 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 130' ' ' SER . 4.2 mp -80.63 -4.08 52.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 10.8 mmpt? 67.15 18.82 10.43 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.694 1.597 . . . . 0.0 111.63 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -171.74 167.43 6.42 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 124.847 1.259 . . . . 0.0 108.779 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 105.9 10.84 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.491 ' HB3' HD21 ' A' ' 126' ' ' LEU . 78.1 p -65.4 116.72 7.0 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.038 0.535 . . . . 0.0 110.128 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.04 114.84 3.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.564 0.746 . . . . 0.0 110.514 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -89.75 91.1 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.502 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.36 143.35 9.09 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.197 0.31 . . . . 0.0 112.487 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.9 143.69 27.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.611 1.164 . . . . 0.0 108.672 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -132.26 117.12 17.78 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.207 0.603 . . . . 0.0 110.023 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -70.73 112.78 7.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.87 158.07 53.11 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.011 -0.883 . . . . 0.0 113.067 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.57 138.7 71.75 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.21 2.607 . . . . 0.0 112.639 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.53 -173.08 2.22 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.218 1.007 . . . . 0.0 110.439 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -75.83 85.35 2.8 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -71.6 134.98 46.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.197 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -75.86 107.17 7.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.883 0.873 . . . . 0.0 111.88 -165.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -85.54 163.01 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.66 0.784 . . . . 0.0 111.16 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -160.36 172.26 17.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.656 0.782 . . . . 0.0 109.955 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.76 122.26 1.02 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.64 149.68 47.01 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 117.026 0.413 . . . . 0.0 113.005 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -153.59 75.83 1.06 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' HZ1' ' HB2' ' A' ' 17' ' ' LYS . 4.7 ttmp? -80.13 145.48 32.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.801 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.94 -141.19 4.06 Favored Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.443 0.464 . . . . 0.0 112.849 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HZ2' ' HB3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -150.64 167.04 28.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 109.979 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -77.78 124.17 27.63 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.9 tpt85 -71.8 91.24 1.14 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.182 0.515 . . . . 0.0 110.268 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -101.32 141.86 33.57 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 164.06 32.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.685 1.194 . . . . 0.0 108.864 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -125.07 112.38 16.45 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.94 -177.81 4.45 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.193 0.997 . . . . 0.0 109.971 175.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -75.86 130.57 38.74 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.7 137.47 45.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.665 0.386 . . . . 0.0 110.178 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.2 mt -67.19 134.64 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 122.965 0.506 . . . . 0.0 109.658 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.29 82.1 0.34 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -68.43 160.05 78.01 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.323 0.649 . . . . 0.0 110.764 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.44 105.9 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 122.807 2.338 . . . . 0.0 111.697 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.46 -10.55 12.09 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.791 2.328 . . . . 0.0 112.832 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -154.43 157.42 38.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.04 0.936 . . . . 0.0 109.574 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.87 158.65 42.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.028 0.931 . . . . 0.0 109.765 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 t -106.19 160.26 15.47 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.538 0.735 . . . . 0.0 111.15 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 p -95.74 175.31 6.57 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.575 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 p -113.09 4.31 16.56 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.805 0.842 . . . . 0.0 112.141 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.18 82.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 0.0 111.503 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -34.84 78.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.7 m -65.51 -32.33 73.88 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.852 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.45 105.27 1.43 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.874 0.869 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.5 -156.21 31.59 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.531 0.519 . . . . 0.0 111.833 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.41 -18.76 0.05 OUTLIER Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.871 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -79.95 132.14 35.98 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.073 0.937 . . . . 0.0 110.732 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.53 157.11 32.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.305 0.642 . . . . 0.0 110.411 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HZ1' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.27 147.23 30.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.537 0.735 . . . . 0.0 109.252 177.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.41 144.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.662 0.385 . . . . 0.0 110.825 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -74.78 140.32 43.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.61 116.25 15.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.84 171.32 15.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.36 98.53 7.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.667 0.387 . . . . 0.0 110.67 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.1 m -69.16 150.38 47.57 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m -58.91 124.4 19.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HB3' HG21 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.544 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HB3' HG23 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 94' ' ' GLY . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HG3' HD23 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.756 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.756 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.7 m120 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.05 50.63 1.85 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -70.61 88.15 0.69 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.151 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -166.86 162.36 15.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.144 0.978 . . . . 0.0 109.566 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.98 116.57 14.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.5 p -72.69 86.95 1.23 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.147 0.579 . . . . 0.0 109.63 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -74.69 101.63 4.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.602 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -75.69 -44.5 41.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.162 0.985 . . . . 0.0 111.55 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 CA--C 1.553 1.064 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.28 -178.841 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.34 118.92 8.94 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.254 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -73.22 101.67 3.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.294 0.637 . . . . 0.0 110.043 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -64.77 117.79 8.02 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -65.86 -46.29 78.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.734 0.814 . . . . 0.0 111.702 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.87 165.14 12.25 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.189 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.85 106.31 1.65 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.819 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.77 127.07 29.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.613 0.765 . . . . 0.0 111.369 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -86.43 138.57 31.67 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.812 0.845 . . . . 0.0 109.988 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.47 138.6 34.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.485 . . . . 0.0 110.374 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -82.02 145.16 30.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.803 0.841 . . . . 0.0 110.243 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.32 162.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -58.4 148.37 28.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.148 0.579 . . . . 0.0 111.208 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.54 -27.16 71.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.974 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.1 -116.44 2.19 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.41 164.15 15.05 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.141 0.977 . . . . 0.0 108.708 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -162.02 115.66 1.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.74 133.45 6.4 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -87.42 168.92 12.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.603 0.761 . . . . 0.0 111.383 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -68.56 163.96 22.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.001 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -103.7 177.51 4.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.833 0.853 . . . . 0.0 109.461 174.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -125.34 160.67 28.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.246 0.618 . . . . 0.0 110.731 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -94.2 -168.85 1.94 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.161 0.984 . . . . 0.0 109.509 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.15 159.36 21.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.466 0.707 . . . . 0.0 110.256 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -74.04 151.15 40.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -89.01 169.18 11.74 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.6 0.76 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.39 157.59 44.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.822 0.449 . . . . 0.0 111.17 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -79.14 144.45 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.966 0.906 . . . . 0.0 109.865 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.13 -100.91 0.29 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -135.16 149.16 69.34 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.952 0.901 . . . . 0.0 109.802 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.24 149.1 90.91 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.987 2.458 . . . . 0.0 112.965 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.01 -165.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.844 3.029 . . . . 0.0 113.528 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.4 p -52.45 133.07 35.52 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 112.043 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -70.53 172.09 9.09 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.946 0.899 . . . . 0.0 112.282 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.6 p -91.88 127.69 37.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.44 0.696 . . . . 0.0 109.612 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.4 p -80.76 159.08 25.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.166 0.587 . . . . 0.0 110.905 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.75 160.63 22.53 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.68 0.792 . . . . 0.0 112.146 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -90.23 16.73 8.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.735 0.814 . . . . 0.0 112.823 -173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.33 61.63 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -65.02 -39.66 93.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 t -86.51 -21.7 26.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.135 0.574 . . . . 0.0 111.915 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.07 92.8 4.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 109.407 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.65 -116.03 2.81 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.763 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.26 120.31 1.04 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -81.29 127.0 32.24 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 117.135 0.467 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.64 156.49 25.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.7 0.8 . . . . 0.0 111.163 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.51 121.9 33.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.334 0.654 . . . . 0.0 109.667 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.6 t -72.36 132.84 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.759 0.424 . . . . 0.0 109.933 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.46 117.8 34.95 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.946 0.898 . . . . 0.0 109.391 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.9 tp -74.74 140.35 44.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.231 1.013 . . . . 0.0 111.781 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.21 133.28 38.94 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.872 0.869 . . . . 0.0 109.952 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -79.78 140.63 36.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.684 0.794 . . . . 0.0 109.812 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -68.68 158.22 34.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.878 0.871 . . . . 0.0 112.123 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t -51.67 147.14 6.84 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.064 1.346 . . . . 0.0 113.016 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.426 HD22 ' HB1' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.559 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HZ1' ' HB3' ' A' ' 75' ' ' LYS . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 101' ' ' LYS . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.417 ' O ' HD11 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD22 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.3 m120 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.559 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt -82.97 13.49 3.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -66.74 85.71 0.12 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.984 0.914 . . . . 0.0 109.92 171.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -155.66 153.75 30.51 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.945 0.898 . . . . 0.0 108.9 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -76.26 105.26 7.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.451 0.643 . . . . 0.0 109.613 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -62.34 -30.3 71.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 0.0 111.074 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -101.68 112.63 25.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.739 0.816 . . . . 0.0 109.447 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -166.64 99.12 0.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.65 0.78 . . . . 0.0 109.782 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 C--O 1.257 1.457 0 C-N-CA 124.662 1.185 . . . . 0.0 108.342 176.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.5 177.17 41.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -85.61 124.14 31.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.813 0.445 . . . . 0.0 110.21 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -152.1 -179.02 7.14 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.198 0.999 . . . . 0.0 109.739 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -159.07 149.05 19.14 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 0.0 110.18 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.07 -141.26 4.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.838 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.04 101.23 0.48 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.721 2.281 . . . . 0.0 111.688 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.42 123.91 19.96 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.182 0.593 . . . . 0.0 110.623 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -125.74 127.92 46.95 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -121.85 136.13 54.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.122 0.969 . . . . 0.0 109.713 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.96 153.31 44.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.235 0.614 . . . . 0.0 110.605 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.57 173.16 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.774 0.83 . . . . 0.0 110.565 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 98.0 m -132.69 120.08 21.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 109.196 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.24 93.71 0.42 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.16 158.93 51.78 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -132.98 111.73 11.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.33 0.565 . . . . 0.0 109.52 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HB2' ' HZ2' ' A' ' 17' ' ' LYS . 4.4 ttmp? -150.0 127.73 11.7 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.646 1.178 . . . . 0.0 108.434 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.5 -165.29 20.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.601 0.563 . . . . 0.0 112.956 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.6 176.7 8.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.959 0.504 . . . . 0.0 109.996 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -124.44 157.88 34.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.413 0.685 . . . . 0.0 110.135 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -100.58 -175.41 2.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.512 0.725 . . . . 0.0 109.788 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -131.9 160.49 35.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.627 0.771 . . . . 0.0 110.423 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -73.16 81.65 1.3 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -67.68 135.13 52.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.195 0.998 . . . . 0.0 110.812 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -87.1 114.81 24.03 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.602 0.761 . . . . 0.0 110.282 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.04 -175.25 4.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.0 109.49 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.74 118.35 10.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.963 0.505 . . . . 0.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mm -63.73 114.18 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.263 1.025 . . . . 0.0 111.489 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 -132.64 2.7 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.8 132.87 38.98 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.27 118.47 4.95 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.265 1.977 . . . . 0.0 111.253 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.88 101.19 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.93 2.42 . . . . 0.0 112.103 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -111.21 92.44 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.642 0.777 . . . . 0.0 109.551 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -82.6 130.96 35.21 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.847 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 t -79.76 132.03 36.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.813 0.445 . . . . 0.0 109.87 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -92.05 -72.4 0.59 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.957 0.503 . . . . 0.0 110.576 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.08 171.73 18.77 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.233 0.539 . . . . 0.0 112.066 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 t -124.07 19.0 9.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.667 1.187 . . . . 0.0 108.548 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -23.17 66.65 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.932 0.893 . . . . 0.0 111.994 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -68.05 -38.72 82.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -81.01 -10.46 59.7 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.357 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.05 -60.32 2.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.151 0.581 . . . . 0.0 109.732 172.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.05 60.43 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.698 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.83 -145.78 40.57 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.944 0.438 . . . . 0.0 112.796 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -97.69 134.08 41.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.545 0.738 . . . . 0.0 109.223 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -106.95 134.92 49.37 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.134 0.974 . . . . 0.0 110.343 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 60.04 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.695 1.598 . . . . 0.0 112.691 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.39 137.03 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.127 0.571 . . . . 0.0 110.329 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -91.29 149.01 21.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.496 0.719 . . . . 0.0 109.467 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.04 136.84 45.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.535 0.734 . . . . 0.0 109.873 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -61.95 1.46 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.954 0.501 . . . . 0.0 110.86 -176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -154.52 157.18 37.95 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.997 0.519 . . . . 0.0 110.561 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -117.03 141.39 48.31 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.359 0.664 . . . . 0.0 110.979 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.575 HG21 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m -127.4 89.73 3.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HD3' HG23 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' HZ1' ' A' ' 77' ' ' LYS . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.575 ' HB ' HG21 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.502 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HB1' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 78' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.546 HD23 ' HB1' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.94 94.1 2.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -71.52 86.29 0.87 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.863 0.84 . . . . 0.0 108.821 167.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -117.16 161.47 19.4 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.795 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.61 85.23 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -73.13 151.29 41.64 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.626 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.46 120.98 15.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.94 92.29 1.8 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 C--O 1.249 1.064 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.387 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.67 86.09 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.874 -0.403 . . . . 0.0 114.089 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.69 96.54 3.57 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -67.47 -15.82 63.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.192 0.997 . . . . 0.0 113.179 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 79.45 -21.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.964 1.306 . . . . 0.0 113.287 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.19 80.21 0.35 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.73 -9.23 11.09 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.833 2.355 . . . . 0.0 113.526 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -115.42 145.3 42.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.036 0.934 . . . . 0.0 110.651 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.58 138.81 20.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.684 1.194 . . . . 0.0 108.283 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.04 134.59 37.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.068 0.461 . . . . 0.0 111.202 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.57 156.69 19.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.017 0.927 . . . . 0.0 109.243 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.82 121.06 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.134 0.492 . . . . 0.0 110.22 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.8 m -144.88 121.14 10.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.816 0.846 . . . . 0.0 108.898 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.5 162.74 49.55 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.338 0.398 . . . . 0.0 112.18 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.94 -148.35 5.81 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -162.86 157.26 21.07 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -167.07 133.68 2.31 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.88 130.49 5.5 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.593 ' HZ1' ' HB3' ' A' ' 19' ' ' LYS . 2.7 mmmp? -86.25 108.73 18.52 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.547 0.739 . . . . 0.0 110.203 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -88.74 127.85 35.61 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.63 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 143.82 42.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.966 0.906 . . . . 0.0 109.751 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -128.51 123.87 34.64 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.211 0.604 . . . . 0.0 110.013 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -94.86 149.0 21.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.765 0.826 . . . . 0.0 109.724 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -97.99 165.58 11.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.197 0.599 . . . . 0.0 110.383 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.51 159.22 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.781 0.832 . . . . 0.0 110.001 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -121.63 172.02 8.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.246 0.618 . . . . 0.0 110.187 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.36 140.02 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 0.0 110.348 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.27 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.86 42.5 0.91 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.42 127.1 59.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.757 . . . . 0.0 109.809 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -85.68 111.97 1.25 Allowed 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.449 2.099 . . . . 0.0 112.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.73 102.53 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.938 2.425 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.3 m -81.45 90.02 6.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.463 0.705 . . . . 0.0 109.901 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.17 141.21 50.71 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.223 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 p -86.75 140.4 29.78 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.4 p -71.45 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.869 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -177.51 157.2 1.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.589 0.755 . . . . 0.0 111.378 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.7 m -126.4 9.2 7.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 109.923 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.99 75.4 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.719 0.807 . . . . 0.0 112.224 -174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -70.56 -25.48 63.11 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -74.39 -2.48 25.51 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.55 156.2 35.28 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 166.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.96 -153.34 5.94 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.2 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.08 134.15 2.66 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.3 151.83 23.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.437 0.695 . . . . 0.0 110.909 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.34 164.36 18.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.667 0.787 . . . . 0.0 110.723 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HZ2' ' HB3' ' A' ' 54' ' ' LYS . 8.0 mtpm? -76.5 164.67 25.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.948 0.899 . . . . 0.0 112.2 -175.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -116.24 132.07 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.904 0.882 . . . . 0.0 110.019 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.67 134.21 50.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.962 0.905 . . . . 0.0 110.028 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.92 128.3 4.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.759 0.824 . . . . 0.0 110.097 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -95.13 100.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.701 0.8 . . . . 0.0 109.988 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -73.07 101.47 3.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -70.05 122.15 18.84 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.075 0.55 . . . . 0.0 111.172 -170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m -78.78 118.71 21.1 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HD2' HG22 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.424 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.401 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.4 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' H ' ' HD3' ' A' ' 127' ' ' LYS . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.441 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.19 25.4 10.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.582 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 29.7 ttpp -70.09 92.9 0.77 Allowed 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.263 0.625 . . . . 0.0 109.556 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -72.74 81.46 1.14 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.414 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.99 78.94 8.14 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 122.158 0.98 . . . . 0.0 110.199 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.0 p -72.46 128.63 36.18 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.394 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.02 84.8 0.52 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.634 0.774 . . . . 0.0 109.687 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -159.14 81.4 0.77 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.249 1.053 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.169 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -163.59 32.99 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.19 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -117.26 134.12 55.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.685 0.794 . . . . 0.0 109.153 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -119.74 107.56 13.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.533 0.733 . . . . 0.0 109.34 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -154.56 158.93 40.53 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.787 0.835 . . . . 0.0 110.181 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.0 136.73 8.89 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.771 -1.016 . . . . 0.0 110.798 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.57 131.03 30.04 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.892 2.395 . . . . 0.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.02 147.55 48.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.706 0.802 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -87.19 143.86 27.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.654 0.381 . . . . 0.0 110.552 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -110.65 157.96 19.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.581 0.753 . . . . 0.0 109.459 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -65.96 122.25 16.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.22 0.608 . . . . 0.0 111.191 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.6 mm -80.43 126.66 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.624 0.77 . . . . 0.0 110.252 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -136.97 106.63 6.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 109.071 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.77 -173.11 49.7 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 112.458 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.23 152.42 41.71 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 123.379 0.105 . . . . 0.0 113.254 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.7 tp -116.65 35.31 4.63 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.39 127.68 33.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.717 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.61 -93.39 0.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 -171.26 3.66 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.579 0.751 . . . . 0.0 109.5 -173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -81.36 124.36 29.32 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -77.22 -70.44 0.47 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.23 0.538 . . . . 0.0 111.615 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -104.2 160.36 14.94 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.629 -162.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.57 -170.04 1.7 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 107.779 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -94.71 97.16 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -63.81 -32.78 74.4 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.65 1.18 . . . . 0.0 112.667 -161.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -147.26 51.54 1.07 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 110.453 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.05 123.59 18.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.489 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mt -121.58 96.05 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.27 44.44 1.11 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.29 130.67 61.49 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.015 0.926 . . . . 0.0 109.572 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.22 112.91 3.66 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.49 2.127 . . . . 0.0 110.86 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.15 166.27 30.16 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.436 2.09 . . . . 0.0 111.333 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.4 p -66.15 96.05 0.31 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -64.06 116.75 6.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.218 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -73.33 154.92 39.9 Favored 'General case' 0 C--O 1.247 0.949 0 O-C-N 123.768 0.668 . . . . 0.0 110.019 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -63.7 132.71 51.89 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 pp -67.59 -173.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.866 0.466 . . . . 0.0 110.858 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 42' ' ' ILE . 22.7 m -81.51 18.47 1.18 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -166.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.08 -57.57 11.6 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.482 0.713 . . . . 0.0 112.398 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 38' ' ' SER . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 -67.31 -51.28 54.44 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -61.67 -35.33 77.67 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -164.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -84.68 151.1 24.67 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.0 87.07 0.63 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.26 148.31 45.57 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.694 0.291 . . . . 0.0 113.703 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 143.74 30.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.67 0.788 . . . . 0.0 110.306 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.254 0.622 . . . . 0.0 109.754 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -73.64 166.55 23.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -84.43 137.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.709 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -84.95 144.08 28.56 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.93 161.71 20.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.557 0.743 . . . . 0.0 109.803 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.99 -68.94 0.73 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.284 0.634 . . . . 0.0 109.88 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -174.34 165.28 3.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.998 0.919 . . . . 0.0 110.15 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 155.29 18.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.531 0.732 . . . . 0.0 109.108 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t -71.42 129.98 40.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HB3' HG21 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.452 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG3' HD22 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.553 ' HB2' HG11 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.29 10.26 3.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 89.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.153 0.981 . . . . 0.0 109.689 168.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -89.38 147.9 23.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.213 1.005 . . . . 0.0 109.955 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -74.18 83.89 1.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.087 0.946 . . . . 0.0 109.183 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.3 p -100.83 29.7 4.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.704 0.802 . . . . 0.0 110.759 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.96 -39.98 95.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.46 0.704 . . . . 0.0 109.599 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -87.98 78.19 8.29 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.139 170.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.432 0.693 . . . . 0.0 109.998 178.292 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.05 174.51 47.64 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.746 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -131.25 154.01 48.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 110.042 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.59 90.51 8.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.501 0.72 . . . . 0.0 109.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.87 120.2 27.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.12 137.58 2.25 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.572 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.1 109.31 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.253 2.635 . . . . 0.0 112.758 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -133.05 96.68 3.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.099 0.96 . . . . 0.0 109.828 -172.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 64.87 7.14 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.808 1.243 . . . . 0.0 113.947 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -83.01 116.18 22.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.63 150.5 28.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.766 . . . . 0.0 110.613 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.5 pt -79.51 147.56 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.423 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -133.46 126.53 31.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.428 0.691 . . . . 0.0 109.41 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.4 -136.34 3.06 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.5 57.68 3.45 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.973 0.387 . . . . 0.0 112.715 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.57 -30.94 47.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.134 0.573 . . . . 0.0 109.506 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.04 118.71 31.05 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.17 45.72 1.27 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 123.076 0.235 . . . . 0.0 113.075 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -81.55 106.14 13.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -107.58 136.7 46.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.49 0.716 . . . . 0.0 110.497 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -70.26 142.91 52.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.552 1.141 . . . . 0.0 110.966 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.12 132.81 48.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -107.92 159.04 16.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.33 0.652 . . . . 0.0 110.582 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -81.4 -1.69 46.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.405 0.682 . . . . 0.0 111.848 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.15 113.05 3.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.352 0.661 . . . . 0.0 110.214 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -82.22 71.97 9.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.694 0.797 . . . . 0.0 109.27 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -72.64 101.0 2.93 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.906 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -82.32 87.67 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.501 0.72 . . . . 0.0 109.681 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.78 -20.67 49.89 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.157 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -76.85 129.18 79.67 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.372 0.669 . . . . 0.0 110.203 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.92 160.52 45.8 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.945 2.43 . . . . 0.0 111.358 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.79 84.28 0.41 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.591 2.194 . . . . 0.0 112.07 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 p -94.43 155.1 17.12 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.309 1.044 . . . . 0.0 110.295 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.27 94.4 0.37 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.62 0.768 . . . . 0.0 110.501 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 m -97.51 116.54 29.92 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.8 p -98.74 173.66 6.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.223 0.609 . . . . 0.0 111.003 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD22 ' HG3' ' A' ' 40' ' ' GLU . 5.4 tt -70.61 94.99 1.04 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.959 0.904 . . . . 0.0 109.508 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -103.42 14.22 31.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.165 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.5 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.171 0.588 . . . . 0.0 110.887 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HG3' HD22 ' A' ' 37' ' ' LEU . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 41' ' ' ASP . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HG3' ' N ' ' A' ' 48' ' ' THR . 6.2 ptt180 -68.67 -35.88 77.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.7 t -75.82 -26.92 57.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.403 0.281 . . . . 0.0 111.241 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 tp -78.25 -55.18 5.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.879 0.472 . . . . 0.0 110.708 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.44 -15.49 60.18 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.712 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.11 80.79 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.24 166.02 14.06 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 110.656 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -89.56 114.39 25.94 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.7 105.98 3.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.69 147.84 4.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.223 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -95.07 102.49 14.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -92.1 167.03 12.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.44 0.696 . . . . 0.0 111.031 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.12 149.37 37.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.011 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -65.51 101.4 0.59 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -64.23 158.88 22.04 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.96 0.904 . . . . 0.0 111.77 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m -59.17 128.48 37.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.727 0.811 . . . . 0.0 110.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB2' HD11 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 102' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HB3' HG23 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.525 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.476 ' HG ' HD11 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.602 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.476 HD11 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp -81.58 14.8 2.38 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HE3' HD13 ' A' ' 125' ' ' LEU . 26.0 ttpp -76.85 7.81 4.38 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.404 1.482 . . . . 0.0 110.881 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.713 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 8.1 p30 -79.52 -17.36 54.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.155 0.582 . . . . 0.0 110.753 166.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.75 140.67 58.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 109.884 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.3 p -65.17 87.97 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.461 0.704 . . . . 0.0 110.389 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -75.1 104.29 5.61 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 86.02 7.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.249 1.043 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.97 19.18 6.54 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.623 0.577 . . . . 0.0 112.783 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -80.79 112.69 18.4 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -140.46 139.45 35.19 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.937 0.895 . . . . 0.0 109.416 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -119.8 137.24 54.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.359 0.664 . . . . 0.0 110.491 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.82 -164.47 36.7 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.53 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.08 159.74 33.63 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.386 2.057 . . . . 0.0 111.894 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.25 128.78 36.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.045 0.538 . . . . 0.0 109.713 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -70.35 132.58 45.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -125.34 116.8 22.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 0.0 109.386 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 143.57 40.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.991 0.516 . . . . 0.0 110.635 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -85.64 113.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.682 0.793 . . . . 0.0 109.694 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.3 m -82.98 119.17 24.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.07 -135.94 4.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 116.72 -0.218 . . . . 0.0 112.758 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.37 -172.4 13.6 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.7 tp -166.98 137.98 3.19 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -146.66 118.71 8.23 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.681 0.792 . . . . 0.0 108.889 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.46 153.14 50.32 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -76.72 166.56 23.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -71.75 135.78 46.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.159 0.584 . . . . 0.0 111.331 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.65 82.47 8.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.156 0.983 . . . . 0.0 109.322 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 67.64 132.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.246 1.418 . . . . 0.0 111.463 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.29 158.69 15.47 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.316 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.87 151.9 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.632 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -87.36 118.01 26.52 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -71.66 148.64 46.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.459 0.704 . . . . 0.0 111.481 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -69.43 150.76 46.89 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.612 0.765 . . . . 0.0 110.801 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.42 88.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.618 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.13 -5.88 63.58 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.464 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.94 114.67 59.43 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.45 120.16 3.94 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 111.974 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.95 128.31 13.04 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.74 2.293 . . . . 0.0 112.031 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -78.51 154.78 30.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.471 0.708 . . . . 0.0 110.617 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -70.42 149.09 47.62 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.0 p -75.21 157.6 34.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.785 0.834 . . . . 0.0 112.017 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.7 m -79.19 137.02 37.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.131 0.973 . . . . 0.0 110.802 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.508 HD22 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -128.71 -178.64 4.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.485 0.714 . . . . 0.0 111.321 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -127.83 37.95 4.11 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.891 0.877 . . . . 0.0 110.701 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' H ' HD22 ' A' ' 37' ' ' LEU . . . -65.69 -22.44 66.62 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.076 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -65.5 -37.63 87.35 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.495 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.5 t -61.99 -20.06 63.49 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.95 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.6 84.82 2.65 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.28 71.96 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.93 -33.05 77.02 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -124.23 122.65 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.398 0.679 . . . . 0.0 110.949 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -108.25 151.76 25.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.414 1.085 . . . . 0.0 109.102 169.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -74.49 88.68 2.13 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.99 126.35 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.604 0.761 . . . . 0.0 110.009 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -81.34 132.9 35.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.179 0.592 . . . . 0.0 109.8 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.4 149.89 36.85 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -100.68 171.23 7.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.751 0.821 . . . . 0.0 110.692 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' HB3' ' HA3' ' A' ' 119' ' ' GLY . 51.2 m-85 -65.51 98.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.912 0.485 . . . . 0.0 109.843 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 t -65.66 131.72 47.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.518 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m -67.85 94.79 0.48 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.493 0.717 . . . . 0.0 109.623 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.637 ' HZ2' ' HB3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 HG21 ' HB1' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HG2' HD13 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.513 HD13 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.41 ' HG1' HG23 ' A' ' 124' ' ' VAL . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 59' ' ' TYR . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 17.5 m120 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.43 HG11 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.92 44.26 1.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -150.97 98.85 2.64 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.17 0.988 . . . . 0.0 109.254 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -129.24 155.99 44.69 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.52 56.52 3.65 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.112 0.965 . . . . 0.0 109.476 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.3 p -74.49 98.98 3.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.991 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -93.84 -164.1 1.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.653 1.181 . . . . 0.0 109.988 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.55 83.75 1.53 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.453 0.701 . . . . 0.0 109.38 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.555 1.151 0 C-N-CA 123.697 0.799 . . . . 0.0 109.572 178.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.5 -135.3 4.88 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.848 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 64.11 20.96 12.41 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.518 1.127 . . . . 0.0 111.981 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -88.25 110.56 20.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 0.0 109.45 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.65 142.75 33.65 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.005 0.522 . . . . 0.0 109.694 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.03 146.15 44.22 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.763 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.99 137.65 41.77 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.876 2.384 . . . . 0.0 112.47 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.33 154.61 41.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.844 0.858 . . . . 0.0 111.613 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -86.85 128.84 35.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.571 0.748 . . . . 0.0 109.283 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.52 115.96 29.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -93.9 139.24 31.14 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.978 0.511 . . . . 0.0 110.703 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.1 mt -78.15 129.98 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.688 0.795 . . . . 0.0 109.265 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.2 t -143.52 161.01 39.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.187 0.595 . . . . 0.0 110.507 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 166.54 36.79 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.543 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.65 -156.21 32.39 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 122.717 0.199 . . . . 0.0 112.884 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 tp -173.29 85.3 0.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.71 120.93 21.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.41 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.98 123.76 7.26 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.699 0.624 . . . . 0.0 111.841 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -111.22 155.95 22.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -134.58 146.47 49.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.06 143.14 28.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.82 -165.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.231 0.612 . . . . 0.0 110.613 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 158.9 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.739 0.415 . . . . 0.0 110.859 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -81.23 134.64 35.64 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.334 1.054 . . . . 0.0 110.258 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.09 170.21 15.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.592 0.757 . . . . 0.0 111.249 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -71.94 171.46 11.75 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.829 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 162.47 21.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.524 1.13 . . . . 0.0 109.094 171.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.4 mt -116.45 134.36 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.171 0.588 . . . . 0.0 109.848 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.91 -158.24 34.16 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.41 0.444 . . . . 0.0 112.574 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.81 141.71 39.57 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 123.864 0.866 . . . . 0.0 110.432 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.04 163.66 20.19 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.224 2.616 . . . . 0.0 112.566 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.06 146.77 71.92 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.66 2.24 . . . . 0.0 112.01 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -113.83 -66.83 1.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 111.931 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -73.96 118.81 17.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.451 0.7 . . . . 0.0 111.191 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.7 m -143.94 105.78 4.33 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.24 1.016 . . . . 0.0 108.861 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 p -77.61 -179.92 6.17 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.637 0.775 . . . . 0.0 111.284 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.52 161.56 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.497 0.719 . . . . 0.0 109.736 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.5 m -121.74 31.93 6.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.259 0.624 . . . . 0.0 110.184 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.07 -51.92 67.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.08 0.552 . . . . 0.0 111.389 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 -66.89 -35.39 79.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -69.56 -8.92 51.47 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.28 159.65 33.07 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.558 0.343 . . . . 0.0 110.349 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -147.62 -74.58 0.02 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.2 163.38 12.44 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -81.87 137.46 35.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.86 0.864 . . . . 0.0 109.508 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.99 123.87 33.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.547 0.739 . . . . 0.0 109.407 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 143.33 54.47 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.524 0.33 . . . . 0.0 110.213 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.21 169.24 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.717 0.807 . . . . 0.0 111.766 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -79.46 152.68 30.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.367 0.667 . . . . 0.0 111.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.54 163.17 26.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.286 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.02 168.44 14.91 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.049 0.54 . . . . 0.0 109.848 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.3 138.89 31.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.515 0.726 . . . . 0.0 109.363 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -68.61 126.43 29.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.883 0.473 . . . . 0.0 110.324 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m -64.85 114.2 4.34 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.493 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.631 HD21 ' HB2' ' A' ' 90' ' ' LEU . 5.6 p-10 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HG2' HD21 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.631 ' HB2' HD21 ' A' ' 87' ' ' ASN . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 78' ' ' ILE . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.529 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD22 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.528 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.61 -37.44 87.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 58.37 -81.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.414 1.486 . . . . 0.0 110.631 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.62 100.27 1.81 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 122.28 46.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.5 t -59.66 145.2 45.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.049 0.939 . . . . 0.0 110.057 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.84 102.58 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.887 0.875 . . . . 0.0 110.527 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -143.65 146.1 32.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.853 1.261 . . . . 0.0 109.365 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.111 0.965 . . . . 0.0 108.992 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.66 -174.4 35.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.295 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -63.07 122.35 15.86 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 0.0 110.662 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -77.47 70.14 3.82 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.521 0.677 . . . . 0.0 109.458 173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -92.0 111.58 23.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.644 0.778 . . . . 0.0 109.241 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.81 73.64 0.38 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.49 170.04 19.0 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.404 2.069 . . . . 0.0 111.534 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.08 91.56 3.68 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.308 0.643 . . . . 0.0 110.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.34 81.98 1.04 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -80.14 149.38 30.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.223 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 163.87 27.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.416 0.686 . . . . 0.0 110.016 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.74 149.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.216 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 p -111.81 118.75 36.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.688 0.395 . . . . 0.0 110.089 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.43 140.16 8.34 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.79 73.62 0.11 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.1 tp -122.09 99.04 6.22 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -147.7 124.34 11.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.091 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.28 129.29 1.39 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -118.92 168.6 10.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.494 0.718 . . . . 0.0 110.458 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -139.18 155.81 47.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.735 1.214 . . . . 0.0 108.652 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -102.41 141.35 35.38 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.42 97.89 9.76 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.843 0.457 . . . . 0.0 109.865 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 129.78 40.74 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -145.97 99.37 3.25 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.616 0.766 . . . . 0.0 110.506 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -94.5 103.1 15.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.22 1.008 . . . . 0.0 109.84 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -78.7 158.78 28.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.209 1.003 . . . . 0.0 110.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -117.26 156.42 27.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.339 1.056 . . . . 0.0 109.574 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.9 mt -97.56 137.57 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.663 0.785 . . . . 0.0 109.904 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.61 167.85 52.12 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.275 0.36 . . . . 0.0 112.456 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.46 135.44 75.58 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 122.786 0.434 . . . . 0.0 110.391 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.57 143.15 86.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.884 2.389 . . . . 0.0 111.713 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.8 161.73 44.17 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.62 2.213 . . . . 0.0 111.887 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -62.91 123.85 19.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.125 0.57 . . . . 0.0 110.529 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -66.77 155.92 36.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.521 0.728 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 m -113.77 126.99 55.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.601 0.76 . . . . 0.0 109.603 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.5 p -89.13 173.72 8.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.799 0.439 . . . . 0.0 110.739 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.63 162.44 10.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.42 1.088 . . . . 0.0 112.956 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -118.9 30.59 7.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.426 1.09 . . . . 0.0 110.036 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.04 65.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.73 0.812 . . . . 0.0 112.78 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' HG2' HD13 ' A' ' 44' ' ' ILE . 2.3 ppt_? -67.38 -24.48 65.69 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -52.52 -34.79 51.37 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.526 1.13 . . . . 0.0 112.402 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.05 103.31 0.59 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.018 0.527 . . . . 0.0 110.658 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.4 -131.69 3.07 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.58 74.6 0.3 Allowed Glycine 0 C--N 1.351 1.407 0 O-C-N 123.994 0.467 . . . . 0.0 113.515 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -79.79 122.4 26.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -76.81 135.37 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 110.835 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -81.94 114.31 20.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.5 103.66 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.85 153.9 20.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.508 0.723 . . . . 0.0 110.25 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.2 176.48 8.55 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.81 0.844 . . . . 0.0 110.275 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.6 164.81 15.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.699 0.8 . . . . 0.0 109.593 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -51.82 128.73 24.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.145 0.978 . . . . 0.0 112.204 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -81.34 141.24 34.21 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 110.424 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.455 HG21 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m -72.35 103.13 3.33 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.449 1.1 . . . . 0.0 110.48 -176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 HG12 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' HG2' HD22 ' A' ' 128' ' ' ASN . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HZ3' ' HB3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' HG21 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.538 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD22 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.503 ' HG ' HG12 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.454 HD12 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp -75.92 -27.32 57.58 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.628 ' HB2' ' HZ1' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -62.82 95.59 0.08 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.936 0.894 . . . . 0.0 111.189 177.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.453 HD22 ' HG2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -121.86 166.0 15.04 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.25 96.11 0.1 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.32 0.581 . . . . 0.0 109.438 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.7 p -66.39 116.64 7.62 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.332 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -59.69 118.12 5.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.291 1.036 . . . . 0.0 110.551 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -93.71 -10.93 32.72 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.747 0.819 . . . . 0.0 112.061 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.87 0.868 . . . . 0.0 108.933 179.468 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.14 121.15 0.55 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.83 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.99 85.88 2.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.704 0.802 . . . . 0.0 109.262 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.67 -178.65 4.45 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.803 0.841 . . . . 0.0 109.582 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.86 163.91 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.156 0.582 . . . . 0.0 110.32 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 68.47 0.34 Allowed Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.657 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.03 134.79 8.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.604 2.203 . . . . 0.0 111.633 174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -111.81 135.67 52.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.476 0.711 . . . . 0.0 109.533 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -133.48 135.2 44.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.6 0.76 . . . . 0.0 109.849 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.88 116.83 22.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.01 0.924 . . . . 0.0 108.646 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -74.7 136.32 41.84 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.1 mm -76.1 75.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 123.912 0.758 . . . . 0.0 109.226 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -104.7 50.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.65 -163.87 29.38 Favored Glycine 0 C--O 1.242 0.647 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.235 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.38 35.53 92.18 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 112.118 -0.393 . . . . 0.0 112.118 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.27 -4.97 28.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.303 1.041 . . . . 0.0 110.765 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.21 94.51 1.17 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.418 0.687 . . . . 0.0 109.354 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.54 103.5 0.19 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 145.72 55.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.363 0.665 . . . . 0.0 110.945 -174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -169.26 153.77 5.54 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.97 91.4 2.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.05 126.24 28.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.309 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.42 -177.64 6.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.499 0.72 . . . . 0.0 111.106 -171.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -83.92 93.77 8.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.148 0.579 . . . . 0.0 109.484 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -83.42 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 109.485 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -178.94 151.19 0.51 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.019 1.328 . . . . 0.0 109.609 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -96.32 132.02 42.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.244 0.617 . . . . 0.0 109.459 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.1 91.99 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.54 20.71 2.04 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.554 -0.581 . . . . 0.0 114.208 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -87.81 111.8 44.67 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 117.437 0.618 . . . . 0.0 109.351 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -88.71 134.12 2.7 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.43 134.66 36.67 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.49 2.127 . . . . 0.0 111.074 170.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 t -85.09 -177.92 6.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.275 0.63 . . . . 0.0 111.12 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -59.45 124.45 20.08 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.959 0.904 . . . . 0.0 110.096 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -113.25 145.58 40.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.799 . . . . 0.0 110.247 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.7 p -78.12 169.01 18.97 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.819 0.848 . . . . 0.0 110.762 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.75 177.51 7.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.876 0.871 . . . . 0.0 111.844 -175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.7 p -123.26 39.86 3.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.253 1.021 . . . . 0.0 109.588 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -15.26 63.22 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.207 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -69.45 -39.0 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 t -78.36 -21.24 49.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tt -76.6 89.47 3.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.03 43.51 0.07 OUTLIER Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.541 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.55 90.22 0.13 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.45 124.99 28.98 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.085 0.554 . . . . 0.0 110.596 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -67.29 111.58 4.08 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.196 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -63.31 120.07 10.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.841 0.856 . . . . 0.0 110.279 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.38 160.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.837 0.855 . . . . 0.0 112.035 -176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -107.17 137.05 45.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.584 0.753 . . . . 0.0 110.627 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.5 104.38 13.1 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -106.95 106.03 16.36 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -70.23 110.66 5.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.8 p -77.66 157.97 29.93 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.054 0.542 . . . . 0.0 111.373 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -58.93 146.34 38.14 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.069 0.947 . . . . 0.0 111.952 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.546 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.504 ' HB2' HD22 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.513 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' HG3' HD23 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.54 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.67 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.546 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt -92.96 44.65 1.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -78.63 85.48 4.67 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.343 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -173.8 166.97 4.45 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.621 1.168 . . . . 0.0 108.709 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -127.19 107.06 9.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.9 p -119.32 60.0 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 108.924 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.45 125.95 25.61 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.885 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -161.0 122.76 3.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 108.818 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.84 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.02 117.05 2.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -71.26 88.74 0.85 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.911 0.484 . . . . 0.0 109.852 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.02 96.12 0.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.665 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 11.4 pt20 -87.01 165.33 15.91 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.219 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.01 80.94 0.36 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' ' HG3' ' A' ' 5' ' ' GLN . 96.2 Cg_endo -77.61 98.89 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.553 2.169 . . . . 0.0 111.189 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.36 109.93 5.01 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.208 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -70.65 153.91 42.38 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -115.6 118.15 32.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -54.91 107.04 0.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.269 0.627 . . . . 0.0 110.296 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.4 mt -70.38 112.01 4.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 t -66.49 121.2 14.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.37 151.57 36.61 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.726 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 141.92 36.79 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.164 -0.375 . . . . 0.0 112.164 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.94 109.08 18.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -152.54 106.59 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.1 152.78 47.48 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.649 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -82.73 116.28 22.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.513 0.725 . . . . 0.0 110.144 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -72.48 124.72 25.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -84.07 86.94 7.13 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -70.6 152.95 43.36 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.35 -172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 151.75 39.79 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.312 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HB3' ' HD1' ' A' ' 26' ' ' TYR . 10.4 mpt_? -82.47 129.63 34.94 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.557 ' HZ1' ' HB3' ' A' ' 25' ' ' LYS . 3.6 mmmp? -84.15 36.87 0.59 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.778 0.831 . . . . 0.0 111.64 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HD1' ' HB3' ' A' ' 24' ' ' ARG . 13.3 m-85 -93.96 97.44 10.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -67.51 108.91 3.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.767 0.427 . . . . 0.0 110.22 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.4 mt -57.75 131.25 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.312 1.045 . . . . 0.0 110.516 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 42.29 2.25 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -168.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.36 124.73 88.89 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.195 0.998 . . . . 0.0 110.697 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.38 157.0 5.47 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.127 2.551 . . . . 0.0 113.063 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.63 102.96 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.853 2.369 . . . . 0.0 110.455 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.9 p -86.16 -62.2 1.57 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.213 0.605 . . . . 0.0 111.237 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.16 125.73 54.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.708 0.803 . . . . 0.0 109.64 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -74.85 91.28 2.43 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.118 0.961 . . . . 0.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -79.67 -37.42 35.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.348 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 38' ' ' SER . 1.4 pp -62.87 -31.58 72.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.275 0.63 . . . . 0.0 111.676 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' N ' HD12 ' A' ' 37' ' ' LEU . 34.2 m 56.55 24.5 8.78 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.628 1.171 . . . . 0.0 112.935 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -56.82 -55.89 28.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.699 0.799 . . . . 0.0 112.03 -173.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 -64.81 -36.26 83.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -70.78 -11.81 61.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.754 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.86 79.44 2.12 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.69 122.54 5.84 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.03 86.42 0.13 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.972 0.386 . . . . 0.0 112.233 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -81.53 123.06 28.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.087 0.555 . . . . 0.0 109.642 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -69.3 143.75 53.73 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -133.72 84.02 2.09 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.924 0.89 . . . . 0.0 108.756 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.43 144.2 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.96 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 122.65 39.19 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.74 133.39 51.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.738 0.815 . . . . 0.0 108.875 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.63 124.05 26.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.524 0.73 . . . . 0.0 110.394 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.13 96.39 4.91 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 p -125.48 95.98 4.65 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.334 1.054 . . . . 0.0 109.351 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.547 HG23 HD11 ' A' ' 78' ' ' ILE . 14.5 m -95.38 120.57 35.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 173.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.54 ' HB3' HG21 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.547 HD11 HG23 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG3' HD23 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' HD13 ' A' ' 126' ' ' LEU . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.618 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.618 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.471 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt -72.81 -46.34 53.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm 72.11 -0.98 3.04 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.831 1.252 . . . . 0.0 112.504 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -93.43 171.94 8.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.447 0.699 . . . . 0.0 110.074 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -96.12 91.64 6.03 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -76.56 85.31 3.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 110.598 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.15 86.98 4.27 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -111.31 130.04 55.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.253 1.249 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.157 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.42 163.59 31.39 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.687 -0.233 . . . . 0.0 112.539 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -124.64 108.76 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.341 0.656 . . . . 0.0 110.082 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -72.99 90.25 1.48 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.589 0.756 . . . . 0.0 109.228 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.96 133.69 9.11 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.4 -152.11 22.8 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.49 -0.616 . . . . 0.0 111.833 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.84 -21.86 24.27 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.893 2.395 . . . . 0.0 112.409 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.27 138.1 43.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.564 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 75.35 -16.28 0.6 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.07 1.748 . . . . 0.0 112.462 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -85.18 119.73 25.89 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.189 0.596 . . . . 0.0 110.017 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.19 155.71 27.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.881 0.872 . . . . 0.0 110.198 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 pt -72.17 95.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 110.048 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -76.9 -5.3 47.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.051 0.94 . . . . 0.0 112.173 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.13 120.92 19.92 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.408 0.443 . . . . 0.0 112.472 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.05 91.31 1.72 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.36 88.26 1.55 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.635 0.774 . . . . 0.0 109.111 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -162.3 74.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.8 76.28 1.72 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.688 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.06 97.32 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.877 0.471 . . . . 0.0 110.429 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -65.44 97.79 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.087 0.955 . . . . 0.0 109.602 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -75.56 -177.16 3.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 111.646 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.8 102.51 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.445 1.098 . . . . 0.0 112.028 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -128.39 130.63 47.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.028 0.931 . . . . 0.0 108.71 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -74.08 -15.13 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.479 0.487 . . . . 0.0 111.888 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -67.51 99.49 0.76 Allowed 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.663 0.385 . . . . 0.0 110.448 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -97.21 108.6 21.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.04 103.55 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.211 0.605 . . . . 0.0 109.93 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.08 99.57 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.454 0.701 . . . . 0.0 110.316 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.62 15.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 168.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -106.95 130.21 23.21 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.541 1.136 . . . . 0.0 109.368 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.0 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.314 2.676 . . . . 0.0 110.791 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.2 103.5 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 121.497 1.465 . . . . 0.0 109.901 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -58.05 120.3 8.33 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.315 1.01 . . . . 0.0 111.931 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -86.97 18.2 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.704 1.202 . . . . 0.0 111.875 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -72.54 98.56 2.33 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 p -77.26 -168.35 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.255 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.52 97.99 0.16 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.15 0.58 . . . . 0.0 110.023 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -115.13 13.13 16.76 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.501 1.12 . . . . 0.0 109.703 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.22 81.8 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.697 0.799 . . . . 0.0 111.576 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -64.16 -32.34 73.87 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -94.51 -25.28 16.92 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.685 0.394 . . . . 0.0 111.846 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.02 -51.99 40.73 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.922 0.489 . . . . 0.0 109.995 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.37 -9.75 81.24 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.354 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.96 83.39 0.6 Allowed Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.428 0.537 . . . . 0.0 113.194 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -128.84 146.25 50.98 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -65.45 104.61 1.01 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 97.06 0.16 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.47 160.25 3.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 O-C-N 124.016 0.822 . . . . 0.0 110.818 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -71.21 111.61 6.69 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.51 124.07 18.37 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.019 0.824 . . . . 0.0 110.811 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -70.34 129.76 40.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.42 95.09 0.59 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -74.66 159.49 32.02 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.803 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.438 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m -55.52 129.63 39.63 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HG2' HG22 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 102' ' ' ILE . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.506 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' H ' HG21 ' A' ' 97' ' ' ILE . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.409 HG21 ' H ' ' A' ' 86' ' ' ALA . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.441 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG3' HD23 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HB3' HG13 ' A' ' 121' ' ' ILE . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.444 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp -78.36 6.26 8.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 83.49 0.3 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.998 0.904 . . . . 0.0 108.868 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 9.1 p30 178.11 -28.74 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.553 1.941 . . . . 0.0 108.31 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -70.82 160.93 31.84 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.422 1.089 . . . . 0.0 110.594 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 p -56.69 95.17 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.079 0.952 . . . . 0.0 111.212 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -144.52 108.58 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.141 0.976 . . . . 0.0 108.594 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.48 73.25 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.249 1.033 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.08 64.58 4.25 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.438 -0.346 . . . . 0.0 113.119 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.5 137.78 54.71 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.805 0.842 . . . . 0.0 109.377 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.76 154.55 18.16 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.971 0.908 . . . . 0.0 110.063 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.45 152.9 26.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.575 0.75 . . . . 0.0 110.264 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.64 34.95 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.258 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.53 147.7 28.71 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.391 2.06 . . . . 0.0 111.721 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.5 -179.15 4.66 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.03 104.11 1.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -67.42 124.57 23.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.436 0.636 . . . . 0.0 110.468 -176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -83.16 104.07 13.06 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.55 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.32 116.42 38.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.781 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.0 p -97.79 165.98 11.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.435 0.694 . . . . 0.0 110.136 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.55 -65.21 3.49 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.459 0.474 . . . . 0.0 112.892 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.68 -164.86 22.39 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 123.729 0.311 . . . . 0.0 112.667 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.76 -24.91 18.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 111.615 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HB2' ' HZ3' ' A' ' 17' ' ' LYS . 5.0 ttmp? -69.45 106.67 3.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 110.638 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.81 -149.53 17.91 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.631 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.6 94.0 2.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -70.64 126.13 28.76 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.509 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -100.31 148.01 25.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.045 0.938 . . . . 0.0 110.076 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.31 165.02 15.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.304 0.642 . . . . 0.0 111.361 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -130.0 179.53 5.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.063 0.945 . . . . 0.0 108.703 171.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.01 131.63 22.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.787 0.435 . . . . 0.0 110.067 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -78.34 121.78 24.91 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.486 0.714 . . . . 0.0 109.973 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -78.81 105.13 9.91 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.59 175.22 5.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.66 136.2 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.31 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.09 -175.55 32.96 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.495 0.497 . . . . 0.0 112.937 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.17 138.54 64.66 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.236 0.614 . . . . 0.0 110.544 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.29 136.79 41.43 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.682 2.255 . . . . 0.0 111.71 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.3 169.17 12.79 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 123.008 2.472 . . . . 0.0 112.834 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.8 p -75.3 151.37 38.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.09 164.59 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.183 0.593 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.5 p -75.67 137.46 40.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.558 0.743 . . . . 0.0 111.657 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.7 p -91.44 155.14 18.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 110.454 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.73 161.01 21.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.044 0.537 . . . . 0.0 110.992 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -126.42 15.4 7.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.255 1.022 . . . . 0.0 112.684 -170.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -68.48 -42.93 77.97 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 t -80.69 -5.12 56.56 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.727 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.78 -19.88 15.16 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.578 0.751 . . . . 0.0 110.589 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.6 144.5 40.53 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.62 119.65 0.8 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -90.97 157.14 17.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.414 0.686 . . . . 0.0 111.145 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -102.95 109.52 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.931 0.892 . . . . 0.0 108.62 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -78.94 120.65 23.84 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.89 136.71 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.629 0.371 . . . . 0.0 110.534 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -78.15 143.12 37.53 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.091 0.556 . . . . 0.0 110.077 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.44 141.08 50.27 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -70.39 175.37 4.77 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.744 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -69.14 143.84 54.01 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.502 HG21 ' HD2' ' A' ' 77' ' ' LYS . 7.6 m -76.78 155.2 33.31 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.541 HG21 HD13 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -64.53 128.93 37.9 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.037 0.535 . . . . 0.0 109.94 178.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' HD2' HG21 ' A' ' 60' ' ' THR . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.401 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.553 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.553 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.492 ' HA3' HG22 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.401 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.685 ' HB3' ' HG2' ' A' ' 127' ' ' LYS . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD12 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.453 HG21 HG21 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.9 OUTLIER -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.453 HG21 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.537 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt -74.0 -31.81 63.12 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.685 ' HG2' ' HB3' ' A' ' 108' ' ' LEU . 30.9 mmmt -73.46 95.43 2.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.486 167.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -149.43 165.96 30.52 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.556 0.742 . . . . 0.0 109.971 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.85 127.42 54.02 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -128.01 144.59 51.11 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 109.41 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.29 105.27 2.48 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.669 0.788 . . . . 0.0 110.696 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -146.65 149.85 34.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.16 0.984 . . . . 0.0 109.208 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 123.901 0.88 . . . . 0.0 111.048 -176.765 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.988 0.423 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.77 161.57 11.67 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.535 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -80.55 99.12 7.92 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -69.5 107.18 3.26 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.381 0.672 . . . . 0.0 109.69 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -142.01 137.83 31.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.443 0.697 . . . . 0.0 110.533 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . -167.36 42.73 0.25 Allowed Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.128 -1.373 . . . . 0.0 114.588 165.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 6' ' ' GLY . 56.2 Cg_endo -93.74 114.2 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.764 0 CA-C-N 121.384 2.592 . . . . 0.0 111.212 173.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.17 139.07 58.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.33 112.62 1.81 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.456 0.702 . . . . 0.0 109.396 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -58.56 120.77 9.46 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.272 0.983 . . . . 0.0 110.948 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.36 132.75 43.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.699 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 tt -126.24 142.34 43.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.316 1.046 . . . . 0.0 108.6 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.4 m -71.26 125.46 27.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.191 0.597 . . . . 0.0 110.48 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.06 169.4 46.08 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.366 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 80.73 0.59 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.06 74.73 3.63 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.734 0.813 . . . . 0.0 109.734 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -164.13 129.13 2.81 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.403 -172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.64 -141.73 11.82 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -164.39 152.37 12.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.342 0.657 . . . . 0.0 110.106 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -82.61 97.64 8.6 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.305 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -77.19 113.7 15.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.892 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.55 149.84 49.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.827 0.451 . . . . 0.0 110.518 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -95.53 169.76 9.82 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.444 0.697 . . . . 0.0 110.156 -173.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -80.03 96.88 6.59 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.83 169.67 17.6 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.372 0.669 . . . . 0.0 110.745 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.92 152.34 51.66 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.59 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 154.2 23.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.056 0.542 . . . . 0.0 109.944 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -106.25 118.54 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.98 169.88 50.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.826 0.704 . . . . 0.0 112.945 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.18 148.47 45.15 Favored Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 123.402 0.681 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 152.1 81.86 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.629 2.219 . . . . 0.0 111.703 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.23 147.43 95.02 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.57 2.18 . . . . 0.0 112.157 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 t -69.15 104.99 2.32 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.655 0.741 . . . . 0.0 110.414 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -72.82 -66.48 0.66 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.225 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -131.4 154.82 48.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.877 0.871 . . . . 0.0 110.226 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 p -76.5 136.58 39.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 39' ' ' ALA . 4.0 pp -72.51 154.51 40.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.905 0.482 . . . . 0.0 112.024 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.2 p -104.0 11.04 35.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.548 0.739 . . . . 0.0 111.726 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -69.87 -20.41 63.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.344 0.658 . . . . 0.0 111.923 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 -75.04 -36.11 61.87 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -82.6 -42.36 18.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -168.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.89 148.05 50.79 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.536 0.607 . . . . 0.0 110.406 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.73 86.11 0.16 Allowed Glycine 0 C--N 1.343 0.919 0 O-C-N 123.583 0.552 . . . . 0.0 112.865 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.93 52.64 1.93 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.46 105.77 11.01 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.334 0.654 . . . . 0.0 109.37 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -68.67 122.42 18.49 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.119 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -58.82 142.03 51.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.244 0.618 . . . . 0.0 111.343 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.13 168.26 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.045 0.538 . . . . 0.0 111.394 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -74.38 118.78 17.73 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.28 149.71 49.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.165 0.586 . . . . 0.0 110.402 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.68 122.02 26.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 110.677 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.04 119.57 38.91 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.815 1.246 . . . . 0.0 107.854 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -74.55 143.6 44.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.965 0.506 . . . . 0.0 110.719 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.465 HG23 HD13 ' A' ' 78' ' ' ILE . 3.6 m -76.33 117.14 17.7 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' HG22 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.552 HD23 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' HG21 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.552 ' HG3' HD23 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.491 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.16 -50.88 68.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 46.2 23.02 0.17 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 126.03 1.732 . . . . 0.0 114.565 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -127.47 94.78 4.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.02 112.56 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.266 0.979 . . . . 0.0 109.884 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -105.55 97.24 7.1 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -69.91 161.53 29.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.256 0.622 . . . . 0.0 110.842 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -88.67 -13.29 40.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.918 0.487 . . . . 0.0 111.811 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.203 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.8 63.36 0.01 OUTLIER Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -75.1 86.96 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.308 0.575 . . . . 0.0 109.812 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -84.31 111.33 19.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -56.71 147.97 21.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.004 0.922 . . . . 0.0 111.564 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 111.49 3.76 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.89 -0.95 . . . . 0.0 111.837 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.06 129.15 14.8 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.442 2.095 . . . . 0.0 111.11 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.97 83.94 2.24 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -110.68 133.86 52.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.89 0.876 . . . . 0.0 109.622 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -154.03 135.55 14.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.748 0.819 . . . . 0.0 109.25 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -88.57 97.87 11.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.487 0.715 . . . . 0.0 109.274 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 tt -69.53 118.33 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 t -75.65 153.31 37.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 0.0 110.926 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.48 -125.42 0.14 Allowed Glycine 0 C--N 1.352 1.465 0 O-C-N 123.464 0.477 . . . . 0.0 112.978 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.36 159.69 32.62 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.991 0.396 . . . . 0.0 112.424 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.9 tp -161.12 127.28 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -145.3 144.6 30.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.56 0.744 . . . . 0.0 110.323 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.21 173.88 52.11 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.171 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -139.08 134.81 33.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.113 0.565 . . . . 0.0 110.251 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -91.88 151.98 20.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -87.49 -176.19 5.5 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -71.64 169.13 16.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.143 0.977 . . . . 0.0 111.155 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.02 157.26 21.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -113.77 94.05 4.66 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.4 0.68 . . . . 0.0 110.405 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -91.92 126.59 37.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.654 0.782 . . . . 0.0 109.652 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -84.47 151.19 24.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.453 0.701 . . . . 0.0 109.734 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.34 143.95 44.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.075 0.55 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.65 134.42 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.12 -136.56 0.8 Allowed Glycine 0 CA--C 1.537 1.407 0 O-C-N 123.497 0.498 . . . . 0.0 113.573 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.4 142.61 46.93 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.702 0.801 . . . . 0.0 111.196 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -72.48 172.98 13.96 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.174 2.583 . . . . 0.0 112.589 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.69 178.01 0.81 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.908 2.405 . . . . 0.0 113.244 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.1 p -72.81 169.69 16.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.385 0.674 . . . . 0.0 112.279 -175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -69.52 170.01 11.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.206 1.002 . . . . 0.0 112.269 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 p -75.15 161.27 29.53 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.177 0.991 . . . . 0.0 112.597 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.2 p -87.17 172.68 9.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.724 0.81 . . . . 0.0 110.828 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.08 170.89 9.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.667 0.787 . . . . 0.0 110.962 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.4 m -127.16 39.78 3.84 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.183 0.993 . . . . 0.0 109.464 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 -26.76 64.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.446 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -67.8 -29.18 68.29 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -39.87 77.57 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.502 171.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.77 124.9 24.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.153 0.581 . . . . 0.0 110.803 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.73 -103.02 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 74.79 1.27 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -121.19 107.37 12.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.833 0.853 . . . . 0.0 109.685 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -73.34 152.67 40.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.432 0.293 . . . . 0.0 110.334 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -83.13 164.38 20.27 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.375 0.67 . . . . 0.0 111.444 -174.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -67.37 156.57 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.788 0.835 . . . . 0.0 111.989 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.26 132.88 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.042 0.537 . . . . 0.0 110.305 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.4 174.96 10.97 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.57 0.7 . . . . 0.0 111.665 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.93 175.13 10.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.614 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -121.37 162.92 19.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.356 1.062 . . . . 0.0 109.759 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -97.76 146.48 25.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.324 0.649 . . . . 0.0 110.232 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.533 HG22 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t -67.96 141.66 56.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 0.2 OUTLIER -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.59 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG22 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD22 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.52 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD22 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.56 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.56 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.59 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.412 HD12 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt -75.11 -27.49 59.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp 68.09 -66.93 0.21 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 126.637 1.975 . . . . 0.0 111.582 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -51.59 128.96 24.65 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.133 1.373 . . . . 0.0 111.276 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -62.51 138.34 58.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 110.42 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.8 t -66.77 87.51 0.13 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 110.163 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.05 89.96 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.918 0.887 . . . . 0.0 109.537 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -157.34 -44.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.815 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.456 0.703 . . . . 0.0 110.115 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.67 -94.97 0.62 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 78.67 -41.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.604 1.562 . . . . 0.0 112.746 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -72.83 162.04 29.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.416 0.687 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -77.39 177.89 7.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.384 0.673 . . . . 0.0 111.687 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 -143.31 14.32 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.23 -173.63 1.92 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.046 2.498 . . . . 0.0 111.521 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.81 143.19 57.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.758 0.423 . . . . 0.0 109.979 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -57.42 111.31 1.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.718 0.807 . . . . 0.0 110.399 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -61.34 116.28 4.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.208 0.603 . . . . 0.0 111.054 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -85.1 98.25 10.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.016 0.926 . . . . 0.0 109.566 -168.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.13 135.31 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.991 0.916 . . . . 0.0 109.958 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -85.64 168.57 14.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.807 0.843 . . . . 0.0 110.474 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -135.21 -33.01 0.28 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 116.551 -0.295 . . . . 0.0 112.575 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 138.86 21.51 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.932 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.01 147.76 21.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 108.1 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -167.52 146.07 4.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.61 0.364 . . . . 0.0 110.656 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.91 148.27 19.76 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -90.6 124.17 34.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.684 0.794 . . . . 0.0 110.53 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -98.84 121.01 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -82.17 164.45 21.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.79 173.38 12.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 112.293 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 138.38 31.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.75 0.82 . . . . 0.0 110.114 -171.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -91.37 141.2 29.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.536 0.735 . . . . 0.0 110.562 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.12 160.67 24.36 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -120.07 109.58 15.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.469 0.708 . . . . 0.0 109.305 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.34 109.24 3.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.384 0.673 . . . . 0.0 109.903 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.41 117.21 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.173 0.989 . . . . 0.0 108.927 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.84 69.15 0.18 Allowed Glycine 0 C--N 1.343 0.953 0 O-C-N 123.366 0.416 . . . . 0.0 112.875 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -102.83 114.18 65.43 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.99 132.33 9.45 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.87 2.38 . . . . 0.0 112.787 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.98 112.1 3.21 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.583 2.189 . . . . 0.0 111.283 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.7 p -67.67 146.5 53.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.605 0.762 . . . . 0.0 111.96 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -88.42 129.03 35.52 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.991 0.916 . . . . 0.0 110.506 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 m -77.68 120.53 22.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.767 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.4 p -75.52 -89.27 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.251 0.62 . . . . 0.0 111.399 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.9 172.3 5.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.001 0.92 . . . . 0.0 110.995 -175.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 p -126.08 37.94 4.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.269 1.028 . . . . 0.0 108.26 169.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.493 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -65.71 -41.71 91.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.696 -175.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -66.44 -38.2 86.85 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -80.52 -2.65 47.0 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.431 0.692 . . . . 0.0 112.717 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.55 137.54 57.99 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.52 78.93 0.57 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.565 0.541 . . . . 0.0 113.822 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.95 -4.16 61.69 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.142 0.401 . . . . 0.0 112.614 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.02 150.77 28.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.821 0.848 . . . . 0.0 110.164 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.54 157.29 15.96 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.779 0.831 . . . . 0.0 109.734 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -94.55 175.04 6.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.422 0.689 . . . . 0.0 110.722 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.16 136.89 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.852 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -76.58 154.41 34.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.941 0.896 . . . . 0.0 110.951 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.4 126.1 24.9 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.993 0.917 . . . . 0.0 111.9 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -68.16 130.91 44.35 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.244 1.018 . . . . 0.0 110.635 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -74.38 111.17 9.3 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.821 0.849 . . . . 0.0 110.345 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.7 m -80.25 134.47 36.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -69.69 142.49 53.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.975 0.51 . . . . 0.0 110.069 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.498 ' HB ' HG23 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.535 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' H ' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.549 ' HG3' HD22 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HB1' HD21 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.696 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.527 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt -82.11 -24.62 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.89 109.53 2.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -126.26 140.73 52.3 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.599 0.76 . . . . 0.0 109.398 -168.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -93.58 -15.42 25.43 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.835 0.854 . . . . 0.0 111.378 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 t 64.46 173.08 0.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.905 1.282 . . . . 0.0 111.092 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -158.8 102.11 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.875 -0.516 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -94.81 -52.33 4.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.258 1.529 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.827 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.81 86.09 1.07 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -58.85 114.62 2.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.096 0.958 . . . . 0.0 111.192 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -61.04 117.54 5.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.491 1.116 . . . . 0.0 109.615 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -53.63 -52.76 58.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.608 1.163 . . . . 0.0 112.546 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.15 141.9 3.42 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.273 -0.737 . . . . 0.0 112.282 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.61 140.65 21.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.78 2.32 . . . . 0.0 112.039 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.82 142.06 46.15 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.164 0.585 . . . . 0.0 110.399 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -94.12 142.5 27.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.882 0.873 . . . . 0.0 109.932 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.9 144.23 54.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 0.0 110.292 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.1 136.3 34.51 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.653 0.781 . . . . 0.0 110.576 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 tt -141.32 150.44 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.104 0.962 . . . . 0.0 108.865 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -74.79 161.97 29.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.078 0.551 . . . . 0.0 111.792 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.32 -32.52 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.08 75.04 2.39 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.037 0.351 . . . . 0.0 112.846 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.55 144.93 24.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 108.384 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -168.77 125.25 0.97 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.292 0.637 . . . . 0.0 109.457 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.84 137.82 14.38 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -95.98 157.96 15.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.759 0.824 . . . . 0.0 110.466 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -76.14 160.89 29.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.554 0.742 . . . . 0.0 111.048 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -102.3 172.04 7.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.656 0.782 . . . . 0.0 110.991 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.6 142.49 29.92 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.796 0.839 . . . . 0.0 110.807 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -90.99 141.26 29.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.69 0.796 . . . . 0.0 109.774 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -67.06 116.39 7.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.871 0.869 . . . . 0.0 110.943 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.7 124.04 25.24 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.439 0.695 . . . . 0.0 109.917 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -75.54 154.46 36.81 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.537 0.735 . . . . 0.0 110.286 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.71 166.52 23.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.314 0.646 . . . . 0.0 111.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.0 136.42 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.074 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.64 -162.32 27.16 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.292 0.37 . . . . 0.0 112.782 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.26 130.84 27.46 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.015 0.526 . . . . 0.0 109.7 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.4 168.02 23.54 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.978 2.452 . . . . 0.0 112.008 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -49.65 145.62 17.0 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.299 2.666 . . . . 0.0 113.123 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.6 p -76.22 -83.15 0.07 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.68 168.67 26.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.81 0.444 . . . . 0.0 111.594 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 p -107.6 158.61 17.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.838 1.255 . . . . 0.0 109.927 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.0 p -69.32 147.1 51.59 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.823 0.449 . . . . 0.0 111.417 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -65.15 169.86 5.13 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.115 0.966 . . . . 0.0 112.029 175.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -101.39 27.65 6.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.374 0.67 . . . . 0.0 111.909 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -71.75 -44.67 63.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.62 0.368 . . . . 0.0 111.615 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.433 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 44' ' ' ILE . 13.1 t -82.0 -19.19 41.02 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.518 0.327 . . . . 0.0 110.451 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.65 117.62 7.09 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -71.58 0.76 Allowed Glycine 0 C--N 1.342 0.916 0 O-C-N 124.242 0.964 . . . . 0.0 114.7 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.1 4.73 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -80.51 155.94 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.465 0.706 . . . . 0.0 111.719 -174.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.5 151.13 30.94 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.681 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 2.9 mptp? -84.27 122.39 28.82 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.566 0.747 . . . . 0.0 109.621 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.38 135.24 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.439 0.696 . . . . 0.0 109.911 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 120.42 38.99 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.106 0.963 . . . . 0.0 109.055 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.18 146.91 43.04 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.68 0.792 . . . . 0.0 109.694 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.34 158.43 26.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.179 0.591 . . . . 0.0 111.603 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -67.35 146.62 53.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.39 0.676 . . . . 0.0 111.392 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -63.95 137.02 57.82 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 110.632 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t -67.86 135.0 51.84 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.543 0.527 . . . . 0.0 109.595 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.439 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.582 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HZ1' ' HB3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.519 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.505 HD13 HD11 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.448 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.546 HG21 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.491 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' HG3' HD22 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.546 ' HG2' HG21 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.505 HD11 HD13 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.582 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt -86.17 29.64 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 125' ' ' LEU . 56.1 mtpt -57.06 -26.81 60.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 110.717 169.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -63.51 111.9 2.54 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.88 154.03 39.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -69.83 -35.48 74.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.396 0.678 . . . . 0.0 111.271 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -149.12 149.17 30.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.217 0.607 . . . . 0.0 110.716 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -156.56 108.63 2.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.769 0.827 . . . . 0.0 109.863 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.678 1.191 . . . . 0.0 108.413 177.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.99 126.42 1.15 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.509 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.29 175.76 5.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.208 1.003 . . . . 0.0 108.919 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -119.32 138.09 53.27 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.02 0.528 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -150.07 178.01 9.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.732 0.813 . . . . 0.0 110.116 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.66 -111.59 0.5 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-O 118.895 -0.947 . . . . 0.0 112.177 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.22 122.58 11.34 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.358 2.706 . . . . 0.0 113.429 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -115.21 -175.03 2.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.042 0.937 . . . . 0.0 109.292 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.41 82.66 2.08 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -130.25 116.66 18.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.404 1.082 . . . . 0.0 108.272 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -100.16 114.23 27.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.491 0.716 . . . . 0.0 109.988 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.84 132.94 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.327 0.651 . . . . 0.0 109.451 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -156.88 101.2 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.334 1.054 . . . . 0.0 108.558 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.5 -30.48 27.2 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.016 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.48 -163.88 37.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.09 -45.96 7.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.771 0.828 . . . . 0.0 109.59 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.3 tptm 61.8 103.43 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 111.1 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.36 139.8 11.24 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.445 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -114.21 100.41 8.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.111 0.964 . . . . 0.0 108.417 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -68.94 106.59 2.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.519 0.728 . . . . 0.0 111.323 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -78.05 98.26 5.69 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 -169.55 2.64 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.162 0.585 . . . . 0.0 109.892 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -130.77 154.41 48.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 0.0 110.439 -174.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -114.07 136.94 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 109.195 173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HB2' ' HZ3' ' A' ' 25' ' ' LYS . 9.6 mtmp? -76.4 144.74 39.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.94 0.496 . . . . 0.0 109.996 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -80.51 165.29 22.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.42 0.688 . . . . 0.0 111.319 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.46 147.96 26.81 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.433 0.693 . . . . 0.0 111.156 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.58 147.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.794 0.837 . . . . 0.0 109.974 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.3 179.78 14.5 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -99.09 151.47 37.4 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 123.904 0.882 . . . . 0.0 111.209 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.27 140.3 76.5 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.248 2.632 . . . . 0.0 113.191 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.45 174.17 13.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.968 2.445 . . . . 0.0 113.392 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -86.46 148.77 25.4 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 0.0 110.545 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.42 158.28 20.26 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.529 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.2 p -80.98 159.17 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.219 0.608 . . . . 0.0 112.109 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -97.76 178.98 4.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.952 0.901 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.35 152.21 50.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.961 0.504 . . . . 0.0 111.159 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -119.78 21.34 12.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.251 1.02 . . . . 0.0 110.463 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -61.43 -34.34 75.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.256 0.623 . . . . 0.0 111.088 176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' HG21 ' A' ' 48' ' ' THR . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.517 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 -54.59 -61.2 2.46 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 45' ' ' LYS . 11.4 t -71.97 -6.16 40.05 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.978 -165.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 tp -73.0 111.83 8.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.28 -157.71 26.03 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.766 -0.197 . . . . 0.0 113.09 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.23 -170.7 12.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.078 0.37 . . . . 0.0 112.408 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -109.4 171.77 7.24 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.834 0.854 . . . . 0.0 110.842 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -89.98 164.41 14.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.173 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -114.51 157.58 22.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.267 0.627 . . . . 0.0 109.351 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.94 137.67 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.042 0.537 . . . . 0.0 111.246 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 140.26 30.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.046 0.938 . . . . 0.0 108.634 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.78 147.42 26.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.449 0.699 . . . . 0.0 110.399 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -100.1 -178.35 3.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.411 0.684 . . . . 0.0 110.782 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -104.84 175.68 5.41 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.277 1.031 . . . . 0.0 110.057 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -136.73 151.92 49.77 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.8 m -115.33 100.6 8.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.707 1.203 . . . . 0.0 108.343 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' HG23 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HB3' HG22 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HG2' HG23 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.464 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.495 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 129' ' ' GLU . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.495 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 121' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.51 HG23 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.499 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.36 -35.51 79.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 71.03 -61.88 0.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.428 1.491 . . . . 0.0 110.535 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.524 ' H ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -114.77 133.79 55.64 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 163.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -110.11 142.87 41.01 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 m -80.54 68.1 6.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.267 0.627 . . . . 0.0 109.544 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.94 110.4 11.53 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -77.07 99.26 5.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 123.543 0.737 . . . . 0.0 109.169 176.391 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.82 6.55 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 62.61 23.02 13.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.232 1.013 . . . . 0.0 112.165 -178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -97.98 108.3 20.98 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.804 0.842 . . . . 0.0 109.528 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -88.36 152.57 21.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.201 1.001 . . . . 0.0 110.765 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.48 149.75 19.44 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.253 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.87 132.41 15.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.802 2.334 . . . . 0.0 112.581 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.52 125.02 26.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.771 0.429 . . . . 0.0 109.959 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -75.37 130.88 39.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.1 0.56 . . . . 0.0 109.978 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.8 119.0 23.8 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.123 0.569 . . . . 0.0 110.172 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.7 124.79 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.883 0.873 . . . . 0.0 110.2 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 t -122.72 164.89 17.46 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.138 0.975 . . . . 0.0 109.764 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.9 146.32 11.64 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.75 -160.9 36.03 Favored Glycine 0 C--N 1.343 0.945 0 O-C-N 123.674 0.279 . . . . 0.0 112.439 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 tp -173.12 90.87 0.09 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -84.48 103.11 13.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.438 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.52 117.07 4.33 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.93 174.28 8.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.5 0.72 . . . . 0.0 110.307 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -138.64 161.22 37.68 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.81 0.844 . . . . 0.0 109.634 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -132.01 148.04 52.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.984 0.914 . . . . 0.0 109.561 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.0 169.09 18.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.177 0.591 . . . . 0.0 110.294 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 157.26 43.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.783 0.833 . . . . 0.0 109.399 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.23 114.58 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.113 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -76.38 164.05 26.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.735 0.814 . . . . 0.0 110.974 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -58.55 153.88 15.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.542 1.137 . . . . 0.0 113.448 -173.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.91 161.27 39.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.478 1.111 . . . . 0.0 109.078 170.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.94 146.75 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.2 0.6 . . . . 0.0 109.912 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.28 -145.52 5.43 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.325 0.391 . . . . 0.0 112.794 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -120.26 139.85 29.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.465 0.706 . . . . 0.0 110.467 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.02 163.44 33.1 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.984 2.456 . . . . 0.0 111.962 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -50.74 139.27 40.06 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.352 2.701 . . . . 0.0 113.169 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 p -86.53 -90.46 0.11 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.206 0.602 . . . . 0.0 112.291 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.21 159.64 37.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.472 0.709 . . . . 0.0 110.335 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.8 m -150.03 123.94 9.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 108.966 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.5 p -72.73 -179.72 3.23 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.617 0.767 . . . . 0.0 111.864 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 163.55 23.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.177 0.991 . . . . 0.0 109.834 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.5 m -125.71 20.25 7.84 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.105 0.562 . . . . 0.0 110.757 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.37 -42.58 87.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.734 0.814 . . . . 0.0 110.854 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -67.43 -37.33 82.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -82.6 -1.6 51.34 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 45' ' ' LYS . 4.4 mm? -111.71 121.55 45.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.32 -81.68 1.49 Allowed Glycine 0 C--N 1.353 1.495 0 O-C-N 123.388 0.43 . . . . 0.0 112.415 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.54 179.32 42.68 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -88.98 141.43 28.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.197 0.599 . . . . 0.0 110.446 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.43 117.46 34.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.065 0.946 . . . . 0.0 108.584 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 168.29 20.3 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -82.39 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.235 0.614 . . . . 0.0 110.911 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -90.27 153.7 20.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.543 0.737 . . . . 0.0 111.35 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.91 167.82 1.48 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.011 1.325 . . . . 0.0 113.333 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -86.83 160.01 18.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.226 -175.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.62 128.74 35.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.497 0.719 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.2 p -78.97 122.14 25.79 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.399 0.679 . . . . 0.0 110.54 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 m -69.9 123.45 21.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.644 0.778 . . . . 0.0 109.922 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HB3' HG21 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.455 ' HB3' HG23 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HB3' HG23 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.635 HD21 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HG2' HD21 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD21 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' HG3' HD22 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.558 ' HG2' HG21 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' HB3' HG13 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.8 OUTLIER -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.5 HD22 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 58.32 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.895 1.372 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -73.06 112.79 9.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.556 0.742 . . . . 0.0 109.067 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.89 153.17 46.96 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -55.03 123.09 12.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.912 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -71.57 87.3 0.91 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.683 0.754 . . . . 0.0 109.079 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -87.04 78.31 8.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.847 1.259 . . . . 0.0 110.103 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.43 1.092 . . . . 0.0 108.679 179.5 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.553 HG22 HD12 ' A' ' 78' ' ' ILE . 25.8 m . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.218 0.532 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 t30 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.555 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HB3' HG22 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 111' ' ' VAL . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HG3' HD21 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.599 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 21.4 m-80 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.637 HG21 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t . . . . . 0 CA--C 1.558 1.275 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 87' ' ' ASN . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD21 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.448 HD13 HD11 ' A' ' 78' ' ' ILE . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 63.0 m-20 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.617 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt . . . . . 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 16.2 ptt180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.56 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.475 HD21 ' HB1' ' A' ' 73' ' ' ALA . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' HG22 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.66 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HA ' HG23 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HD2' HG21 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG21 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 . . . . . 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.46 HD21 ' HB1' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.403 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.477 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.475 ' HG3' HD21 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.22 0.057 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 44' ' ' ILE . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.077 0.465 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 121' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.454 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.61 ' HB3' HG22 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 90' ' ' LEU . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.489 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.768 0.318 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.557 0.694 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 82' ' ' LEU . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 37.4 m-80 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.424 HG13 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.779 -0.153 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 ' HG2' ' A' ' 89' ' ' GLU . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 103' ' ' ARG . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 120' ' ' VAL . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 118' ' ' ASP . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.585 HD12 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG2' HD12 ' A' ' 44' ' ' ILE . 2.3 ppt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 120.857 0.36 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' CG1' ' A' ' 120' ' ' VAL . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.569 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG3' HD21 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.407 ' CG1' ' HB2' ' A' ' 64' ' ' ASN . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.464 HD13 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 121.094 0.473 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 75' ' ' LYS . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 64' ' ' ASN . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' HD22 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.564 HD22 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 121' ' ' ILE . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 111' ' ' VAL . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.556 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 100' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.693 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.627 HG22 HD12 ' A' ' 78' ' ' ILE . 14.5 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 t30 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.627 HD12 HG22 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.551 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt . . . . . 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 . . . . . 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m . . . . . 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 97' ' ' ILE . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 85' ' ' PRO . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG3' HD21 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HG ' HD13 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 . . . . . 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.663 HG22 HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.539 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.573 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 102' ' ' ILE . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 3.2 m-20 -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.573 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 HD12 ' A' ' 78' ' ' ILE . 3.6 m . . . . . 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 HG22 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 103' ' ' ARG . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.3 t-20 -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.667 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 103' ' ' ARG . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.494 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.477 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HG3' HD21 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.667 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.491 ' HB ' HG22 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.574 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.2 t30 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 HD13 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HG3' HD21 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.627 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.627 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.463 HD11 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.244 0.802 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' HG21 ' A' ' 62' ' ' THR . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 87' ' ' ASN . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HG3' HD21 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HG2' HG23 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.691 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.466 0.174 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 78' ' ' ILE . 90.8 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB3' HG23 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.456 ' HB2' HD12 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG3' HD21 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 102' ' ' ILE . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 124' ' ' VAL . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HG3' HG23 ' A' ' 95' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.968 0.413 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 78' ' ' ILE . 14.0 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 61' ' ' THR . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HB3' HG22 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.674 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.674 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG3' HD21 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' HB3' HG12 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 121' ' ' ILE . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 2.8 m-20 -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.46 -72.63 0.11 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -157.29 141.17 16.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.423 0.689 . . . . 0.0 110.2 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -158.27 138.13 12.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.793 0.837 . . . . 0.0 109.051 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -75.09 130.26 38.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.004 0.522 . . . . 0.0 109.923 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.2 168.37 54.6 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.323 -0.709 . . . . 0.0 113.257 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.93 96.85 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.278 2.652 . . . . 0.0 112.603 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.44 123.63 23.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.659 0.784 . . . . 0.0 109.399 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -121.66 131.2 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 109.588 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.22 157.41 24.92 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 109.58 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 99.94 12.83 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.99 89.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.3 p -95.93 96.12 8.7 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.244 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.33 31.05 4.56 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.38 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.87 40.53 2.98 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 123.087 0.375 . . . . 0.0 112.939 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.32 78.45 9.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -140.96 116.34 10.07 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.347 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.59 150.7 19.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.13 179.77 7.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.341 0.656 . . . . 0.0 109.796 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -108.85 160.08 16.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -91.13 134.17 34.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.85 140.28 29.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.011 0.925 . . . . 0.0 111.586 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 -166.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.535 1.134 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -75.82 147.67 38.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.865 0.466 . . . . 0.0 110.035 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -103.35 -77.81 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.846 0.458 . . . . 0.0 109.8 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.29 37.93 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.378 0.671 . . . . 0.0 110.608 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.73 148.59 24.31 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.798 0.839 . . . . 0.0 112.154 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.21 118.34 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.9 -103.58 0.48 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 123.461 0.475 . . . . 0.0 112.673 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.07 139.18 42.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.646 0.778 . . . . 0.0 110.675 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.62 157.58 28.4 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.687 2.258 . . . . 0.0 111.202 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.68 159.88 38.45 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.286 1.991 . . . . 0.0 112.449 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.8 p -67.26 163.95 19.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.446 0.698 . . . . 0.0 110.602 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -103.21 167.83 9.57 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 110.874 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.5 p -75.73 162.34 28.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.801 0.84 . . . . 0.0 110.142 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 p -82.86 -96.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.995 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 39' ' ' ALA . 2.4 pp -170.68 -173.94 1.49 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.698 0.799 . . . . 0.0 110.655 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -140.04 20.25 2.46 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.91 0.884 . . . . 0.0 110.114 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.406 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -61.01 -49.85 75.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.73 0.812 . . . . 0.0 111.766 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 -74.1 -35.97 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 13.4 t -86.93 15.84 5.52 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.65 0.78 . . . . 0.0 111.906 -174.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -56.8 148.12 21.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.445 0.698 . . . . 0.0 111.512 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.5 168.76 54.8 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.314 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.51 -148.61 4.0 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 122.711 0.196 . . . . 0.0 112.831 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -125.63 146.76 49.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.428 0.691 . . . . 0.0 109.973 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -66.94 147.71 52.88 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.023 0.929 . . . . 0.0 110.299 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 54' ' ' LYS . 11.2 mmpt? -92.25 176.58 6.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.181 0.592 . . . . 0.0 111.619 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -86.33 160.92 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.435 0.694 . . . . 0.0 110.977 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -114.71 153.74 29.71 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.164 0.986 . . . . 0.0 110.162 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.61 141.92 42.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -111.7 165.29 12.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.54 0.736 . . . . 0.0 110.464 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.5 106.47 12.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.738 0.815 . . . . 0.0 109.252 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.3 p -78.23 143.71 36.88 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.698 0.399 . . . . 0.0 110.007 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.553 HG22 HD12 ' A' ' 78' ' ' ILE . 25.8 m -64.51 115.62 5.34 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 123.734 0.646 . . . . 0.0 110.2 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 t30 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 121' ' ' ILE . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 130' ' ' SER . 4.2 mp -80.63 -4.08 52.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 127' ' ' LYS . 10.8 mmpt? 67.15 18.82 10.43 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.694 1.597 . . . . 0.0 111.63 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -171.74 167.43 6.42 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 124.847 1.259 . . . . 0.0 108.779 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 105.9 10.84 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.508 ' HB3' HD22 ' A' ' 126' ' ' LEU . 78.1 p -65.4 116.72 7.0 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.038 0.535 . . . . 0.0 110.128 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.04 114.84 3.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.564 0.746 . . . . 0.0 110.514 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -89.75 91.1 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.502 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.36 143.35 9.09 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.197 0.31 . . . . 0.0 112.487 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.9 143.69 27.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.611 1.164 . . . . 0.0 108.672 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -132.26 117.12 17.78 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.207 0.603 . . . . 0.0 110.023 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -70.73 112.78 7.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.87 158.07 53.11 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.011 -0.883 . . . . 0.0 113.067 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.57 138.7 71.75 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.21 2.607 . . . . 0.0 112.639 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.53 -173.08 2.22 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.218 1.007 . . . . 0.0 110.439 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -75.83 85.35 2.8 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -71.6 134.98 46.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.197 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -75.86 107.17 7.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.883 0.873 . . . . 0.0 111.88 -165.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -85.54 163.01 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.66 0.784 . . . . 0.0 111.16 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -160.36 172.26 17.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.656 0.782 . . . . 0.0 109.955 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.76 122.26 1.02 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.64 149.68 47.01 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 117.026 0.413 . . . . 0.0 113.005 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -153.59 75.83 1.06 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -80.13 145.48 32.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.801 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.94 -141.19 4.06 Favored Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.443 0.464 . . . . 0.0 112.849 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.64 167.04 28.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 109.979 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -77.78 124.17 27.63 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.9 tpt85 -71.8 91.24 1.14 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.182 0.515 . . . . 0.0 110.268 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -101.32 141.86 33.57 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 164.06 32.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.685 1.194 . . . . 0.0 108.864 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -125.07 112.38 16.45 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.94 -177.81 4.45 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.193 0.997 . . . . 0.0 109.971 175.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -75.86 130.57 38.74 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.7 137.47 45.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.665 0.386 . . . . 0.0 110.178 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.2 mt -67.19 134.64 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 122.965 0.506 . . . . 0.0 109.658 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.29 82.1 0.34 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -68.43 160.05 78.01 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.323 0.649 . . . . 0.0 110.764 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.44 105.9 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 122.807 2.338 . . . . 0.0 111.697 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.46 -10.55 12.09 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.791 2.328 . . . . 0.0 112.832 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -154.43 157.42 38.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.04 0.936 . . . . 0.0 109.574 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.87 158.65 42.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.028 0.931 . . . . 0.0 109.765 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 t -106.19 160.26 15.47 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.538 0.735 . . . . 0.0 111.15 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 p -95.74 175.31 6.57 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.575 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 p -113.09 4.31 16.56 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.805 0.842 . . . . 0.0 112.141 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.18 82.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 0.0 111.503 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -66.65 -34.84 78.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 25.7 m -65.51 -32.33 73.88 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.852 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.45 105.27 1.43 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.874 0.869 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.5 -156.21 31.59 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.531 0.519 . . . . 0.0 111.833 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.41 -18.76 0.05 OUTLIER Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.871 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -79.95 132.14 35.98 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.073 0.937 . . . . 0.0 110.732 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.53 157.11 32.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.305 0.642 . . . . 0.0 110.411 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.27 147.23 30.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.537 0.735 . . . . 0.0 109.252 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.41 144.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.662 0.385 . . . . 0.0 110.825 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -74.78 140.32 43.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.61 116.25 15.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.84 171.32 15.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.36 98.53 7.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.667 0.387 . . . . 0.0 110.67 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.1 m -69.16 150.38 47.57 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m -58.91 124.4 19.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.555 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HB3' HG22 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 111' ' ' VAL . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HG3' HD21 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.599 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 21.4 m-80 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.05 50.63 1.85 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -70.61 88.15 0.69 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.151 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -166.86 162.36 15.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.144 0.978 . . . . 0.0 109.566 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.98 116.57 14.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.5 p -72.69 86.95 1.23 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.147 0.579 . . . . 0.0 109.63 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -74.69 101.63 4.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.602 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -75.69 -44.5 41.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.162 0.985 . . . . 0.0 111.55 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 CA--C 1.553 1.064 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.28 -178.841 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.34 118.92 8.94 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.254 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -73.22 101.67 3.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.294 0.637 . . . . 0.0 110.043 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -64.77 117.79 8.02 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -65.86 -46.29 78.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.734 0.814 . . . . 0.0 111.702 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.87 165.14 12.25 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.189 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.85 106.31 1.65 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.819 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.77 127.07 29.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.613 0.765 . . . . 0.0 111.369 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -86.43 138.57 31.67 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.812 0.845 . . . . 0.0 109.988 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.47 138.6 34.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.485 . . . . 0.0 110.374 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -82.02 145.16 30.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.803 0.841 . . . . 0.0 110.243 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.32 162.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -58.4 148.37 28.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.148 0.579 . . . . 0.0 111.208 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.54 -27.16 71.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.974 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.1 -116.44 2.19 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.41 164.15 15.05 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.141 0.977 . . . . 0.0 108.708 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -162.02 115.66 1.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.74 133.45 6.4 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -87.42 168.92 12.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.603 0.761 . . . . 0.0 111.383 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -68.56 163.96 22.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.001 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -103.7 177.51 4.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.833 0.853 . . . . 0.0 109.461 174.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -125.34 160.67 28.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.246 0.618 . . . . 0.0 110.731 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -94.2 -168.85 1.94 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.161 0.984 . . . . 0.0 109.509 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.15 159.36 21.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.466 0.707 . . . . 0.0 110.256 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -74.04 151.15 40.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -89.01 169.18 11.74 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.6 0.76 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.39 157.59 44.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.822 0.449 . . . . 0.0 111.17 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -79.14 144.45 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.966 0.906 . . . . 0.0 109.865 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.13 -100.91 0.29 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -135.16 149.16 69.34 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.952 0.901 . . . . 0.0 109.802 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 31.3 Cg_exo -61.24 149.1 90.91 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.987 2.458 . . . . 0.0 112.965 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 31' ' ' PRO . 19.5 Cg_exo -67.01 -165.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.844 3.029 . . . . 0.0 113.528 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.4 p -52.45 133.07 35.52 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 112.043 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -70.53 172.09 9.09 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.946 0.899 . . . . 0.0 112.282 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.6 p -91.88 127.69 37.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.44 0.696 . . . . 0.0 109.612 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.4 p -80.76 159.08 25.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.166 0.587 . . . . 0.0 110.905 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.75 160.63 22.53 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.68 0.792 . . . . 0.0 112.146 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -90.23 16.73 8.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.735 0.814 . . . . 0.0 112.823 -173.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.33 61.63 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -65.02 -39.66 93.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 t -86.51 -21.7 26.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.135 0.574 . . . . 0.0 111.915 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.07 92.8 4.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 109.407 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.65 -116.03 2.81 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.763 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.26 120.31 1.04 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -81.29 127.0 32.24 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 117.135 0.467 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.64 156.49 25.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.7 0.8 . . . . 0.0 111.163 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.51 121.9 33.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.334 0.654 . . . . 0.0 109.667 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.6 t -72.36 132.84 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.759 0.424 . . . . 0.0 109.933 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.46 117.8 34.95 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.946 0.898 . . . . 0.0 109.391 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.9 tp -74.74 140.35 44.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.231 1.013 . . . . 0.0 111.781 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.21 133.28 38.94 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.872 0.869 . . . . 0.0 109.952 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -79.78 140.63 36.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.684 0.794 . . . . 0.0 109.812 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -68.68 158.22 34.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.878 0.871 . . . . 0.0 112.123 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.637 HG21 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t -51.67 147.14 6.84 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.064 1.346 . . . . 0.0 113.016 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 87' ' ' ASN . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD21 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.448 HD13 HD11 ' A' ' 78' ' ' ILE . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 63.0 m-20 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.617 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt -82.97 13.49 3.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HD3' HD13 ' A' ' 125' ' ' LEU . 50.1 mtpt -66.74 85.71 0.12 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.984 0.914 . . . . 0.0 109.92 171.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -155.66 153.75 30.51 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.945 0.898 . . . . 0.0 108.9 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -76.26 105.26 7.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.451 0.643 . . . . 0.0 109.613 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -62.34 -30.3 71.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 0.0 111.074 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -101.68 112.63 25.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.739 0.816 . . . . 0.0 109.447 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -166.64 99.12 0.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.65 0.78 . . . . 0.0 109.782 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 C--O 1.257 1.457 0 C-N-CA 124.662 1.185 . . . . 0.0 108.342 176.613 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.5 177.17 41.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -85.61 124.14 31.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.813 0.445 . . . . 0.0 110.21 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -152.1 -179.02 7.14 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.198 0.999 . . . . 0.0 109.739 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -159.07 149.05 19.14 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 0.0 110.18 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.07 -141.26 4.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.838 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.04 101.23 0.48 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.721 2.281 . . . . 0.0 111.688 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.42 123.91 19.96 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.182 0.593 . . . . 0.0 110.623 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -125.74 127.92 46.95 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -121.85 136.13 54.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.122 0.969 . . . . 0.0 109.713 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.96 153.31 44.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.235 0.614 . . . . 0.0 110.605 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.57 173.16 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.774 0.83 . . . . 0.0 110.565 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 98.0 m -132.69 120.08 21.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 109.196 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.24 93.71 0.42 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.16 158.93 51.78 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -132.98 111.73 11.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.33 0.565 . . . . 0.0 109.52 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -150.0 127.73 11.7 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.646 1.178 . . . . 0.0 108.434 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.5 -165.29 20.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.601 0.563 . . . . 0.0 112.956 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.6 176.7 8.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.959 0.504 . . . . 0.0 109.996 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -124.44 157.88 34.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.413 0.685 . . . . 0.0 110.135 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -100.58 -175.41 2.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.512 0.725 . . . . 0.0 109.788 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -131.9 160.49 35.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.627 0.771 . . . . 0.0 110.423 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -73.16 81.65 1.3 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -67.68 135.13 52.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.195 0.998 . . . . 0.0 110.812 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -87.1 114.81 24.03 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.602 0.761 . . . . 0.0 110.282 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.04 -175.25 4.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.0 109.49 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.74 118.35 10.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.963 0.505 . . . . 0.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mm -63.73 114.18 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.263 1.025 . . . . 0.0 111.489 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 -132.64 2.7 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.8 132.87 38.98 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.27 118.47 4.95 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.265 1.977 . . . . 0.0 111.253 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.88 101.19 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.93 2.42 . . . . 0.0 112.103 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -111.21 92.44 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.642 0.777 . . . . 0.0 109.551 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -82.6 130.96 35.21 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.847 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 t -79.76 132.03 36.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.813 0.445 . . . . 0.0 109.87 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -92.05 -72.4 0.59 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.957 0.503 . . . . 0.0 110.576 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.08 171.73 18.77 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.233 0.539 . . . . 0.0 112.066 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 t -124.07 19.0 9.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.667 1.187 . . . . 0.0 108.548 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -65.78 -23.17 66.65 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.932 0.893 . . . . 0.0 111.994 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 16.2 ptt180 -68.05 -38.72 82.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -81.01 -10.46 59.7 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.357 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.05 -60.32 2.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.151 0.581 . . . . 0.0 109.732 172.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.05 60.43 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.698 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.83 -145.78 40.57 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.944 0.438 . . . . 0.0 112.796 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -97.69 134.08 41.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.545 0.738 . . . . 0.0 109.223 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -106.95 134.92 49.37 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.134 0.974 . . . . 0.0 110.343 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 60.04 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.695 1.598 . . . . 0.0 112.691 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.39 137.03 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.127 0.571 . . . . 0.0 110.329 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -91.29 149.01 21.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.496 0.719 . . . . 0.0 109.467 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.04 136.84 45.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.535 0.734 . . . . 0.0 109.873 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -61.95 1.46 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.954 0.501 . . . . 0.0 110.86 -176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -154.52 157.18 37.95 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.997 0.519 . . . . 0.0 110.561 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -117.03 141.39 48.31 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.359 0.664 . . . . 0.0 110.979 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m -127.4 89.73 3.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.56 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.475 HD21 ' HB1' ' A' ' 73' ' ' ALA . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' HG22 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.66 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HA ' HG23 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.94 94.1 2.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -71.52 86.29 0.87 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.863 0.84 . . . . 0.0 108.821 167.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -117.16 161.47 19.4 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.795 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.61 85.23 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -73.13 151.29 41.64 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.626 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.46 120.98 15.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.94 92.29 1.8 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 C--O 1.249 1.064 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.387 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.67 86.09 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.874 -0.403 . . . . 0.0 114.089 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.69 96.54 3.57 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -67.47 -15.82 63.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.192 0.997 . . . . 0.0 113.179 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 79.45 -21.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.964 1.306 . . . . 0.0 113.287 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.19 80.21 0.35 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.73 -9.23 11.09 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.833 2.355 . . . . 0.0 113.526 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -115.42 145.3 42.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.036 0.934 . . . . 0.0 110.651 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.58 138.81 20.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.684 1.194 . . . . 0.0 108.283 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.04 134.59 37.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.068 0.461 . . . . 0.0 111.202 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.57 156.69 19.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.017 0.927 . . . . 0.0 109.243 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.82 121.06 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.134 0.492 . . . . 0.0 110.22 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.8 m -144.88 121.14 10.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.816 0.846 . . . . 0.0 108.898 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.5 162.74 49.55 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.338 0.398 . . . . 0.0 112.18 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.94 -148.35 5.81 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -162.86 157.26 21.07 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -167.07 133.68 2.31 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.88 130.49 5.5 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -86.25 108.73 18.52 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.547 0.739 . . . . 0.0 110.203 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -88.74 127.85 35.61 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.63 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 143.82 42.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.966 0.906 . . . . 0.0 109.751 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -128.51 123.87 34.64 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.211 0.604 . . . . 0.0 110.013 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -94.86 149.0 21.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.765 0.826 . . . . 0.0 109.724 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -97.99 165.58 11.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.197 0.599 . . . . 0.0 110.383 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.51 159.22 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.781 0.832 . . . . 0.0 110.001 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -121.63 172.02 8.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.246 0.618 . . . . 0.0 110.187 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.36 140.02 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 0.0 110.348 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.27 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.86 42.5 0.91 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.42 127.1 59.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.757 . . . . 0.0 109.809 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -85.68 111.97 1.25 Allowed 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.449 2.099 . . . . 0.0 112.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.73 102.53 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.938 2.425 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.3 m -81.45 90.02 6.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.463 0.705 . . . . 0.0 109.901 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.17 141.21 50.71 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.223 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 p -86.75 140.4 29.78 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.4 p -71.45 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.869 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -177.51 157.2 1.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.589 0.755 . . . . 0.0 111.378 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.7 m -126.4 9.2 7.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 109.923 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.99 75.4 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.719 0.807 . . . . 0.0 112.224 -174.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -70.56 -25.48 63.11 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -74.39 -2.48 25.51 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.55 156.2 35.28 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 166.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.96 -153.34 5.94 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.2 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.08 134.15 2.66 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.3 151.83 23.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.437 0.695 . . . . 0.0 110.909 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.34 164.36 18.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.667 0.787 . . . . 0.0 110.723 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -76.5 164.67 25.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.948 0.899 . . . . 0.0 112.2 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -116.24 132.07 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.904 0.882 . . . . 0.0 110.019 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -126.67 134.21 50.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.962 0.905 . . . . 0.0 110.028 178.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.92 128.3 4.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.759 0.824 . . . . 0.0 110.097 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -95.13 100.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.701 0.8 . . . . 0.0 109.988 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -73.07 101.47 3.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -70.05 122.15 18.84 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.075 0.55 . . . . 0.0 111.172 -170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m -78.78 118.71 21.1 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HD2' HG21 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.643 ' H ' ' HD3' ' A' ' 127' ' ' LYS . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG21 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.19 25.4 10.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 29.7 ttpp -70.09 92.9 0.77 Allowed 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.263 0.625 . . . . 0.0 109.556 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -72.74 81.46 1.14 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.414 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.99 78.94 8.14 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 122.158 0.98 . . . . 0.0 110.199 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.0 p -72.46 128.63 36.18 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.394 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.02 84.8 0.52 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.634 0.774 . . . . 0.0 109.687 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -159.14 81.4 0.77 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.249 1.053 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.169 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -163.59 32.99 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.19 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -117.26 134.12 55.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.685 0.794 . . . . 0.0 109.153 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -119.74 107.56 13.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.533 0.733 . . . . 0.0 109.34 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -154.56 158.93 40.53 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.787 0.835 . . . . 0.0 110.181 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.0 136.73 8.89 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.771 -1.016 . . . . 0.0 110.798 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.57 131.03 30.04 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.892 2.395 . . . . 0.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.02 147.55 48.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.706 0.802 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -87.19 143.86 27.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.654 0.381 . . . . 0.0 110.552 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -110.65 157.96 19.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.581 0.753 . . . . 0.0 109.459 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -65.96 122.25 16.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.22 0.608 . . . . 0.0 111.191 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.6 mm -80.43 126.66 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.624 0.77 . . . . 0.0 110.252 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -136.97 106.63 6.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 109.071 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.77 -173.11 49.7 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 112.458 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.23 152.42 41.71 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 123.379 0.105 . . . . 0.0 113.254 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.7 tp -116.65 35.31 4.63 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.39 127.68 33.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.717 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.61 -93.39 0.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 -171.26 3.66 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.579 0.751 . . . . 0.0 109.5 -173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -81.36 124.36 29.32 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -77.22 -70.44 0.47 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.23 0.538 . . . . 0.0 111.615 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -104.2 160.36 14.94 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.629 -162.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.57 -170.04 1.7 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 107.779 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -94.71 97.16 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -63.81 -32.78 74.4 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.65 1.18 . . . . 0.0 112.667 -161.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -147.26 51.54 1.07 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 110.453 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.05 123.59 18.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.489 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mt -121.58 96.05 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.27 44.44 1.11 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.29 130.67 61.49 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.015 0.926 . . . . 0.0 109.572 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.22 112.91 3.66 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.49 2.127 . . . . 0.0 110.86 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.15 166.27 30.16 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.436 2.09 . . . . 0.0 111.333 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.4 p -66.15 96.05 0.31 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -64.06 116.75 6.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.218 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -73.33 154.92 39.9 Favored 'General case' 0 C--O 1.247 0.949 0 O-C-N 123.768 0.668 . . . . 0.0 110.019 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -63.7 132.71 51.89 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 pp -67.59 -173.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.866 0.466 . . . . 0.0 110.858 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 42' ' ' ILE . 22.7 m -81.51 18.47 1.18 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -166.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.08 -57.57 11.6 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.482 0.713 . . . . 0.0 112.398 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' SER . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 -67.31 -51.28 54.44 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 45' ' ' LYS . 10.0 t -61.67 -35.33 77.67 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -164.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -84.68 151.1 24.67 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.0 87.07 0.63 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.26 148.31 45.57 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.694 0.291 . . . . 0.0 113.703 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 143.74 30.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.67 0.788 . . . . 0.0 110.306 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.254 0.622 . . . . 0.0 109.754 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -73.64 166.55 23.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -84.43 137.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.709 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -84.95 144.08 28.56 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.93 161.71 20.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.557 0.743 . . . . 0.0 109.803 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.99 -68.94 0.73 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.284 0.634 . . . . 0.0 109.88 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -174.34 165.28 3.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.998 0.919 . . . . 0.0 110.15 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 155.29 18.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.531 0.732 . . . . 0.0 109.108 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t -71.42 129.98 40.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.46 HD21 ' HB1' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.403 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.477 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.475 ' HG3' HD21 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.29 10.26 3.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 89.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.153 0.981 . . . . 0.0 109.689 168.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -89.38 147.9 23.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.213 1.005 . . . . 0.0 109.955 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -74.18 83.89 1.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.087 0.946 . . . . 0.0 109.183 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.3 p -100.83 29.7 4.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.704 0.802 . . . . 0.0 110.759 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.96 -39.98 95.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.46 0.704 . . . . 0.0 109.599 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -87.98 78.19 8.29 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.139 170.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.432 0.693 . . . . 0.0 109.998 178.292 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.05 174.51 47.64 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.746 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -131.25 154.01 48.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 110.042 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.59 90.51 8.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.501 0.72 . . . . 0.0 109.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.87 120.2 27.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.12 137.58 2.25 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.572 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.1 109.31 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.253 2.635 . . . . 0.0 112.758 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -133.05 96.68 3.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.099 0.96 . . . . 0.0 109.828 -172.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 64.87 7.14 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.808 1.243 . . . . 0.0 113.947 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -83.01 116.18 22.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.63 150.5 28.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.766 . . . . 0.0 110.613 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.5 pt -79.51 147.56 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.423 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -133.46 126.53 31.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.428 0.691 . . . . 0.0 109.41 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.4 -136.34 3.06 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.5 57.68 3.45 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.973 0.387 . . . . 0.0 112.715 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.57 -30.94 47.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.134 0.573 . . . . 0.0 109.506 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.04 118.71 31.05 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.17 45.72 1.27 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 123.076 0.235 . . . . 0.0 113.075 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -81.55 106.14 13.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -107.58 136.7 46.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.49 0.716 . . . . 0.0 110.497 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -70.26 142.91 52.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.552 1.141 . . . . 0.0 110.966 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.12 132.81 48.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -107.92 159.04 16.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.33 0.652 . . . . 0.0 110.582 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -81.4 -1.69 46.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.405 0.682 . . . . 0.0 111.848 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.15 113.05 3.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.352 0.661 . . . . 0.0 110.214 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -82.22 71.97 9.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.694 0.797 . . . . 0.0 109.27 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -72.64 101.0 2.93 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.906 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -82.32 87.67 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.501 0.72 . . . . 0.0 109.681 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.78 -20.67 49.89 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.157 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -76.85 129.18 79.67 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.372 0.669 . . . . 0.0 110.203 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.92 160.52 45.8 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.945 2.43 . . . . 0.0 111.358 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.79 84.28 0.41 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.591 2.194 . . . . 0.0 112.07 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 p -94.43 155.1 17.12 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.309 1.044 . . . . 0.0 110.295 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.27 94.4 0.37 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.62 0.768 . . . . 0.0 110.501 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 m -97.51 116.54 29.92 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.8 p -98.74 173.66 6.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.223 0.609 . . . . 0.0 111.003 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD22 ' HG3' ' A' ' 40' ' ' GLU . 5.4 tt -70.61 94.99 1.04 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.959 0.904 . . . . 0.0 109.508 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -103.42 14.22 31.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.165 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.5 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.171 0.588 . . . . 0.0 110.887 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' A' ' 37' ' ' LEU . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 44' ' ' ILE . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 48' ' ' THR . 6.2 ptt180 -68.67 -35.88 77.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.7 t -75.82 -26.92 57.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.403 0.281 . . . . 0.0 111.241 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 tp -78.25 -55.18 5.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.879 0.472 . . . . 0.0 110.708 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.44 -15.49 60.18 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.712 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.11 80.79 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.24 166.02 14.06 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 110.656 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -89.56 114.39 25.94 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.7 105.98 3.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.69 147.84 4.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.223 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -95.07 102.49 14.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -92.1 167.03 12.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.44 0.696 . . . . 0.0 111.031 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.12 149.37 37.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.011 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -65.51 101.4 0.59 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -64.23 158.88 22.04 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.96 0.904 . . . . 0.0 111.77 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m -59.17 128.48 37.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.727 0.811 . . . . 0.0 110.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 121' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.454 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.61 ' HB3' HG22 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 90' ' ' LEU . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.489 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp -81.58 14.8 2.38 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 125' ' ' LEU . 26.0 ttpp -76.85 7.81 4.38 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.404 1.482 . . . . 0.0 110.881 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.713 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 8.1 p30 -79.52 -17.36 54.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.155 0.582 . . . . 0.0 110.753 166.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.75 140.67 58.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 109.884 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.3 p -65.17 87.97 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.461 0.704 . . . . 0.0 110.389 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -75.1 104.29 5.61 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 86.02 7.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.249 1.043 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.062 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.97 19.18 6.54 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.623 0.577 . . . . 0.0 112.783 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -80.79 112.69 18.4 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -140.46 139.45 35.19 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.937 0.895 . . . . 0.0 109.416 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -119.8 137.24 54.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.359 0.664 . . . . 0.0 110.491 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.82 -164.47 36.7 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.53 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.08 159.74 33.63 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.386 2.057 . . . . 0.0 111.894 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.25 128.78 36.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.045 0.538 . . . . 0.0 109.713 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -70.35 132.58 45.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -125.34 116.8 22.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 0.0 109.386 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 143.57 40.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.991 0.516 . . . . 0.0 110.635 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -85.64 113.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.682 0.793 . . . . 0.0 109.694 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.3 m -82.98 119.17 24.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.07 -135.94 4.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 116.72 -0.218 . . . . 0.0 112.758 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.37 -172.4 13.6 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.7 tp -166.98 137.98 3.19 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -146.66 118.71 8.23 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.681 0.792 . . . . 0.0 108.889 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.46 153.14 50.32 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -76.72 166.56 23.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -71.75 135.78 46.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.159 0.584 . . . . 0.0 111.331 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.65 82.47 8.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.156 0.983 . . . . 0.0 109.322 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 67.64 132.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.246 1.418 . . . . 0.0 111.463 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.29 158.69 15.47 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.316 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.87 151.9 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.632 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -87.36 118.01 26.52 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -71.66 148.64 46.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.459 0.704 . . . . 0.0 111.481 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -69.43 150.76 46.89 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.612 0.765 . . . . 0.0 110.801 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.42 88.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.618 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.13 -5.88 63.58 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.464 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -86.94 114.67 59.43 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.45 120.16 3.94 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 111.974 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.95 128.31 13.04 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.74 2.293 . . . . 0.0 112.031 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -78.51 154.78 30.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.471 0.708 . . . . 0.0 110.617 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -70.42 149.09 47.62 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.0 p -75.21 157.6 34.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.785 0.834 . . . . 0.0 112.017 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.7 m -79.19 137.02 37.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.131 0.973 . . . . 0.0 110.802 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -128.71 -178.64 4.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.485 0.714 . . . . 0.0 111.321 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -127.83 37.95 4.11 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.891 0.877 . . . . 0.0 110.701 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -65.69 -22.44 66.62 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.076 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -65.5 -37.63 87.35 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.5 t -61.99 -20.06 63.49 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.95 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.6 84.82 2.65 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.28 71.96 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.93 -33.05 77.02 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -124.23 122.65 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.398 0.679 . . . . 0.0 110.949 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -108.25 151.76 25.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.414 1.085 . . . . 0.0 109.102 169.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -74.49 88.68 2.13 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.99 126.35 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.604 0.761 . . . . 0.0 110.009 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -81.34 132.9 35.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.179 0.592 . . . . 0.0 109.8 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.4 149.89 36.85 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -100.68 171.23 7.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.751 0.821 . . . . 0.0 110.692 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 119' ' ' GLY . 51.2 m-85 -65.51 98.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.912 0.485 . . . . 0.0 109.843 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 t -65.66 131.72 47.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.518 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m -67.85 94.79 0.48 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.493 0.717 . . . . 0.0 109.623 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 82' ' ' LEU . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 59' ' ' TYR . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 37.4 m-80 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.424 HG13 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.92 44.26 1.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -150.97 98.85 2.64 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.17 0.988 . . . . 0.0 109.254 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -129.24 155.99 44.69 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.52 56.52 3.65 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.112 0.965 . . . . 0.0 109.476 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.3 p -74.49 98.98 3.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.991 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -93.84 -164.1 1.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.653 1.181 . . . . 0.0 109.988 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.55 83.75 1.53 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.453 0.701 . . . . 0.0 109.38 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.555 1.151 0 C-N-CA 123.697 0.799 . . . . 0.0 109.572 178.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.5 -135.3 4.88 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.848 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 64.11 20.96 12.41 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.518 1.127 . . . . 0.0 111.981 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -88.25 110.56 20.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 0.0 109.45 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.65 142.75 33.65 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.005 0.522 . . . . 0.0 109.694 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.03 146.15 44.22 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.763 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.99 137.65 41.77 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.876 2.384 . . . . 0.0 112.47 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.33 154.61 41.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.844 0.858 . . . . 0.0 111.613 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -86.85 128.84 35.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.571 0.748 . . . . 0.0 109.283 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.52 115.96 29.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -93.9 139.24 31.14 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.978 0.511 . . . . 0.0 110.703 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.1 mt -78.15 129.98 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.688 0.795 . . . . 0.0 109.265 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.2 t -143.52 161.01 39.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.187 0.595 . . . . 0.0 110.507 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 166.54 36.79 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.543 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.65 -156.21 32.39 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 122.717 0.199 . . . . 0.0 112.884 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 tp -173.29 85.3 0.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.71 120.93 21.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.41 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.98 123.76 7.26 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.699 0.624 . . . . 0.0 111.841 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -111.22 155.95 22.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -134.58 146.47 49.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.06 143.14 28.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.82 -165.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.231 0.612 . . . . 0.0 110.613 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 158.9 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.739 0.415 . . . . 0.0 110.859 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -81.23 134.64 35.64 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.334 1.054 . . . . 0.0 110.258 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.09 170.21 15.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.592 0.757 . . . . 0.0 111.249 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -71.94 171.46 11.75 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.829 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 162.47 21.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.524 1.13 . . . . 0.0 109.094 171.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.4 mt -116.45 134.36 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.171 0.588 . . . . 0.0 109.848 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.91 -158.24 34.16 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.41 0.444 . . . . 0.0 112.574 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.81 141.71 39.57 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 123.864 0.866 . . . . 0.0 110.432 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.04 163.66 20.19 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.224 2.616 . . . . 0.0 112.566 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.06 146.77 71.92 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.66 2.24 . . . . 0.0 112.01 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -113.83 -66.83 1.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 111.931 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -73.96 118.81 17.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.451 0.7 . . . . 0.0 111.191 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.7 m -143.94 105.78 4.33 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.24 1.016 . . . . 0.0 108.861 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 p -77.61 -179.92 6.17 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.637 0.775 . . . . 0.0 111.284 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.52 161.56 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.497 0.719 . . . . 0.0 109.736 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 42' ' ' ILE . 40.5 m -121.74 31.93 6.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.259 0.624 . . . . 0.0 110.184 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.07 -51.92 67.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.08 0.552 . . . . 0.0 111.389 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 38' ' ' SER . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 -66.89 -35.39 79.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -69.56 -8.92 51.47 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.28 159.65 33.07 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.558 0.343 . . . . 0.0 110.349 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -147.62 -74.58 0.02 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.2 163.38 12.44 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -81.87 137.46 35.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.86 0.864 . . . . 0.0 109.508 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.99 123.87 33.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.547 0.739 . . . . 0.0 109.407 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -68.93 143.33 54.47 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.524 0.33 . . . . 0.0 110.213 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.21 169.24 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.717 0.807 . . . . 0.0 111.766 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -79.46 152.68 30.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.367 0.667 . . . . 0.0 111.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.54 163.17 26.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.286 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.02 168.44 14.91 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.049 0.54 . . . . 0.0 109.848 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.3 138.89 31.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.515 0.726 . . . . 0.0 109.363 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -68.61 126.43 29.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.883 0.473 . . . . 0.0 110.324 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m -64.85 114.2 4.34 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 ' HG2' ' A' ' 89' ' ' GLU . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 103' ' ' ARG . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 120' ' ' VAL . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 118' ' ' ASP . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.61 -37.44 87.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 58.37 -81.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.414 1.486 . . . . 0.0 110.631 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.62 100.27 1.81 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 122.28 46.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.5 t -59.66 145.2 45.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.049 0.939 . . . . 0.0 110.057 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.84 102.58 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.887 0.875 . . . . 0.0 110.527 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -143.65 146.1 32.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.853 1.261 . . . . 0.0 109.365 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.111 0.965 . . . . 0.0 108.992 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.66 -174.4 35.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.295 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -63.07 122.35 15.86 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 0.0 110.662 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -77.47 70.14 3.82 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.521 0.677 . . . . 0.0 109.458 173.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -92.0 111.58 23.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.644 0.778 . . . . 0.0 109.241 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.81 73.64 0.38 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.49 170.04 19.0 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.404 2.069 . . . . 0.0 111.534 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.08 91.56 3.68 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.308 0.643 . . . . 0.0 110.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.34 81.98 1.04 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -80.14 149.38 30.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.223 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 163.87 27.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.416 0.686 . . . . 0.0 110.016 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.74 149.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.216 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 p -111.81 118.75 36.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.688 0.395 . . . . 0.0 110.089 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.43 140.16 8.34 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.79 73.62 0.11 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.1 tp -122.09 99.04 6.22 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -147.7 124.34 11.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.091 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.28 129.29 1.39 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -118.92 168.6 10.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.494 0.718 . . . . 0.0 110.458 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -139.18 155.81 47.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.735 1.214 . . . . 0.0 108.652 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -102.41 141.35 35.38 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.42 97.89 9.76 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.843 0.457 . . . . 0.0 109.865 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 129.78 40.74 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -145.97 99.37 3.25 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.616 0.766 . . . . 0.0 110.506 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -94.5 103.1 15.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.22 1.008 . . . . 0.0 109.84 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -78.7 158.78 28.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.209 1.003 . . . . 0.0 110.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -117.26 156.42 27.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.339 1.056 . . . . 0.0 109.574 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.9 mt -97.56 137.57 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.663 0.785 . . . . 0.0 109.904 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.61 167.85 52.12 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.275 0.36 . . . . 0.0 112.456 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.46 135.44 75.58 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 122.786 0.434 . . . . 0.0 110.391 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.57 143.15 86.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.884 2.389 . . . . 0.0 111.713 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.8 161.73 44.17 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.62 2.213 . . . . 0.0 111.887 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -62.91 123.85 19.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.125 0.57 . . . . 0.0 110.529 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -66.77 155.92 36.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.521 0.728 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 m -113.77 126.99 55.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.601 0.76 . . . . 0.0 109.603 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.5 p -89.13 173.72 8.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.799 0.439 . . . . 0.0 110.739 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.63 162.44 10.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.42 1.088 . . . . 0.0 112.956 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -118.9 30.59 7.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.426 1.09 . . . . 0.0 110.036 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.04 65.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.73 0.812 . . . . 0.0 112.78 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.585 HD12 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG2' HD12 ' A' ' 44' ' ' ILE . 2.3 ppt_? -67.38 -24.48 65.69 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -52.52 -34.79 51.37 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.526 1.13 . . . . 0.0 112.402 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.05 103.31 0.59 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.018 0.527 . . . . 0.0 110.658 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.4 -131.69 3.07 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.58 74.6 0.3 Allowed Glycine 0 C--N 1.351 1.407 0 O-C-N 123.994 0.467 . . . . 0.0 113.515 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -79.79 122.4 26.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -76.81 135.37 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 110.835 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -81.94 114.31 20.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.5 103.66 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.85 153.9 20.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.508 0.723 . . . . 0.0 110.25 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -134.2 176.48 8.55 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.81 0.844 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.6 164.81 15.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.699 0.8 . . . . 0.0 109.593 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -51.82 128.73 24.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.145 0.978 . . . . 0.0 112.204 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -81.34 141.24 34.21 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 110.424 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m -72.35 103.13 3.33 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.449 1.1 . . . . 0.0 110.48 -176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' CG1' ' A' ' 120' ' ' VAL . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG3' HD21 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.407 ' CG1' ' HB2' ' A' ' 64' ' ' ASN . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.464 HD13 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp -75.92 -27.32 57.58 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 95.59 0.08 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.936 0.894 . . . . 0.0 111.189 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.86 166.0 15.04 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.25 96.11 0.1 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.32 0.581 . . . . 0.0 109.438 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.7 p -66.39 116.64 7.62 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.332 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -59.69 118.12 5.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.291 1.036 . . . . 0.0 110.551 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -93.71 -10.93 32.72 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.747 0.819 . . . . 0.0 112.061 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.87 0.868 . . . . 0.0 108.933 179.468 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.14 121.15 0.55 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.83 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.99 85.88 2.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.704 0.802 . . . . 0.0 109.262 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.67 -178.65 4.45 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.803 0.841 . . . . 0.0 109.582 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.86 163.91 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.156 0.582 . . . . 0.0 110.32 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 68.47 0.34 Allowed Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.657 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.03 134.79 8.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.604 2.203 . . . . 0.0 111.633 174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -111.81 135.67 52.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.476 0.711 . . . . 0.0 109.533 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -133.48 135.2 44.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.6 0.76 . . . . 0.0 109.849 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.88 116.83 22.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.01 0.924 . . . . 0.0 108.646 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -74.7 136.32 41.84 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.1 mm -76.1 75.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 123.912 0.758 . . . . 0.0 109.226 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -104.7 50.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.65 -163.87 29.38 Favored Glycine 0 C--O 1.242 0.647 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.235 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.38 35.53 92.18 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 112.118 -0.393 . . . . 0.0 112.118 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.27 -4.97 28.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.303 1.041 . . . . 0.0 110.765 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.21 94.51 1.17 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.418 0.687 . . . . 0.0 109.354 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.54 103.5 0.19 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 145.72 55.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.363 0.665 . . . . 0.0 110.945 -174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -169.26 153.77 5.54 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.97 91.4 2.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.05 126.24 28.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.309 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.42 -177.64 6.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.499 0.72 . . . . 0.0 111.106 -171.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -83.92 93.77 8.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.148 0.579 . . . . 0.0 109.484 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -83.42 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 109.485 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -178.94 151.19 0.51 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.019 1.328 . . . . 0.0 109.609 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -96.32 132.02 42.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.244 0.617 . . . . 0.0 109.459 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.1 91.99 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.54 20.71 2.04 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.554 -0.581 . . . . 0.0 114.208 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -87.81 111.8 44.67 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 117.437 0.618 . . . . 0.0 109.351 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -88.71 134.12 2.7 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.43 134.66 36.67 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.49 2.127 . . . . 0.0 111.074 170.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 t -85.09 -177.92 6.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.275 0.63 . . . . 0.0 111.12 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -59.45 124.45 20.08 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.959 0.904 . . . . 0.0 110.096 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -113.25 145.58 40.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.799 . . . . 0.0 110.247 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.7 p -78.12 169.01 18.97 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.819 0.848 . . . . 0.0 110.762 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -129.75 177.51 7.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.876 0.871 . . . . 0.0 111.844 -175.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.7 p -123.26 39.86 3.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.253 1.021 . . . . 0.0 109.588 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.438 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -69.5 -15.26 63.22 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.207 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -69.45 -39.0 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 t -78.36 -21.24 49.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tt -76.6 89.47 3.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.03 43.51 0.07 OUTLIER Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.541 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.55 90.22 0.13 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.45 124.99 28.98 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.085 0.554 . . . . 0.0 110.596 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -67.29 111.58 4.08 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.196 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -63.31 120.07 10.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.841 0.856 . . . . 0.0 110.279 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.38 160.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.837 0.855 . . . . 0.0 112.035 -176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -107.17 137.05 45.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.584 0.753 . . . . 0.0 110.627 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.5 104.38 13.1 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -106.95 106.03 16.36 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -70.23 110.66 5.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.8 p -77.66 157.97 29.93 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.054 0.542 . . . . 0.0 111.373 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -58.93 146.34 38.14 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.069 0.947 . . . . 0.0 111.952 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 75' ' ' LYS . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 64' ' ' ASN . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' HD22 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.564 HD22 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 121' ' ' ILE . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 111' ' ' VAL . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.556 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 100' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.693 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt -92.96 44.65 1.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -78.63 85.48 4.67 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.343 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -173.8 166.97 4.45 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.621 1.168 . . . . 0.0 108.709 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -127.19 107.06 9.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.9 p -119.32 60.0 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 108.924 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.45 125.95 25.61 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.885 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -161.0 122.76 3.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 108.818 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.84 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.02 117.05 2.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -71.26 88.74 0.85 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.911 0.484 . . . . 0.0 109.852 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.02 96.12 0.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.665 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 11.4 pt20 -87.01 165.33 15.91 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.219 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.01 80.94 0.36 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HG3' ' A' ' 5' ' ' GLN . 96.2 Cg_endo -77.61 98.89 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.553 2.169 . . . . 0.0 111.189 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.36 109.93 5.01 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.208 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -70.65 153.91 42.38 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -115.6 118.15 32.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -54.91 107.04 0.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.269 0.627 . . . . 0.0 110.296 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.4 mt -70.38 112.01 4.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 t -66.49 121.2 14.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.37 151.57 36.61 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.726 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 141.92 36.79 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.164 -0.375 . . . . 0.0 112.164 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.94 109.08 18.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -152.54 106.59 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.1 152.78 47.48 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.649 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 1.2 tpmt? -82.73 116.28 22.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.513 0.725 . . . . 0.0 110.144 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -72.48 124.72 25.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -84.07 86.94 7.13 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -70.6 152.95 43.36 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.35 -172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 151.75 39.79 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.312 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB3' ' HD1' ' A' ' 26' ' ' TYR . 10.4 mpt_? -82.47 129.63 34.94 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -84.15 36.87 0.59 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.778 0.831 . . . . 0.0 111.64 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 24' ' ' ARG . 13.3 m-85 -93.96 97.44 10.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -67.51 108.91 3.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.767 0.427 . . . . 0.0 110.22 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.4 mt -57.75 131.25 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.312 1.045 . . . . 0.0 110.516 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 42.29 2.25 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -168.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.36 124.73 88.89 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.195 0.998 . . . . 0.0 110.697 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.38 157.0 5.47 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.127 2.551 . . . . 0.0 113.063 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.63 102.96 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.853 2.369 . . . . 0.0 110.455 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.9 p -86.16 -62.2 1.57 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.213 0.605 . . . . 0.0 111.237 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.16 125.73 54.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.708 0.803 . . . . 0.0 109.64 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -74.85 91.28 2.43 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.118 0.961 . . . . 0.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -79.67 -37.42 35.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.348 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 38' ' ' SER . 1.4 pp -62.87 -31.58 72.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.275 0.63 . . . . 0.0 111.676 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' N ' HD12 ' A' ' 37' ' ' LEU . 34.2 m 56.55 24.5 8.78 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.628 1.171 . . . . 0.0 112.935 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -56.82 -55.89 28.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.699 0.799 . . . . 0.0 112.03 -173.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 -64.81 -36.26 83.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -70.78 -11.81 61.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.754 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.86 79.44 2.12 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.69 122.54 5.84 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.03 86.42 0.13 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.972 0.386 . . . . 0.0 112.233 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -81.53 123.06 28.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.087 0.555 . . . . 0.0 109.642 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -69.3 143.75 53.73 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -133.72 84.02 2.09 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.924 0.89 . . . . 0.0 108.756 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.43 144.2 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.96 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 122.65 39.19 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.74 133.39 51.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.738 0.815 . . . . 0.0 108.875 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.63 124.05 26.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.524 0.73 . . . . 0.0 110.394 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.13 96.39 4.91 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 p -125.48 95.98 4.65 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.334 1.054 . . . . 0.0 109.351 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.627 HG22 HD12 ' A' ' 78' ' ' ILE . 14.5 m -95.38 120.57 35.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 t30 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.627 HD12 HG22 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.551 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt -72.81 -46.34 53.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm 72.11 -0.98 3.04 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.831 1.252 . . . . 0.0 112.504 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -93.43 171.94 8.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.447 0.699 . . . . 0.0 110.074 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -96.12 91.64 6.03 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -76.56 85.31 3.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 110.598 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.15 86.98 4.27 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -111.31 130.04 55.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.253 1.249 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.157 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.42 163.59 31.39 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.687 -0.233 . . . . 0.0 112.539 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -124.64 108.76 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.341 0.656 . . . . 0.0 110.082 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -72.99 90.25 1.48 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.589 0.756 . . . . 0.0 109.228 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.96 133.69 9.11 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.4 -152.11 22.8 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.49 -0.616 . . . . 0.0 111.833 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.84 -21.86 24.27 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.893 2.395 . . . . 0.0 112.409 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.27 138.1 43.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.564 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 75.35 -16.28 0.6 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.07 1.748 . . . . 0.0 112.462 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -85.18 119.73 25.89 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.189 0.596 . . . . 0.0 110.017 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.19 155.71 27.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.881 0.872 . . . . 0.0 110.198 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 pt -72.17 95.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 110.048 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -76.9 -5.3 47.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.051 0.94 . . . . 0.0 112.173 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.13 120.92 19.92 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.408 0.443 . . . . 0.0 112.472 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.05 91.31 1.72 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.36 88.26 1.55 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.635 0.774 . . . . 0.0 109.111 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -162.3 74.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.8 76.28 1.72 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.688 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.06 97.32 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.877 0.471 . . . . 0.0 110.429 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -65.44 97.79 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.087 0.955 . . . . 0.0 109.602 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -75.56 -177.16 3.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 111.646 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.8 102.51 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.445 1.098 . . . . 0.0 112.028 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -128.39 130.63 47.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.028 0.931 . . . . 0.0 108.71 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -74.08 -15.13 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.479 0.487 . . . . 0.0 111.888 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -67.51 99.49 0.76 Allowed 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.663 0.385 . . . . 0.0 110.448 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -97.21 108.6 21.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.04 103.55 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.211 0.605 . . . . 0.0 109.93 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.08 99.57 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.454 0.701 . . . . 0.0 110.316 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.62 15.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 168.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -106.95 130.21 23.21 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.541 1.136 . . . . 0.0 109.368 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.0 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.314 2.676 . . . . 0.0 110.791 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.2 103.5 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 121.497 1.465 . . . . 0.0 109.901 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -58.05 120.3 8.33 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.315 1.01 . . . . 0.0 111.931 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -86.97 18.2 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.704 1.202 . . . . 0.0 111.875 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -72.54 98.56 2.33 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 p -77.26 -168.35 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.255 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.52 97.99 0.16 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.15 0.58 . . . . 0.0 110.023 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -115.13 13.13 16.76 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.501 1.12 . . . . 0.0 109.703 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.22 81.8 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.697 0.799 . . . . 0.0 111.576 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -64.16 -32.34 73.87 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -94.51 -25.28 16.92 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.685 0.394 . . . . 0.0 111.846 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.02 -51.99 40.73 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.922 0.489 . . . . 0.0 109.995 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.37 -9.75 81.24 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.354 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.96 83.39 0.6 Allowed Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.428 0.537 . . . . 0.0 113.194 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -128.84 146.25 50.98 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -65.45 104.61 1.01 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 97.06 0.16 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.47 160.25 3.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 O-C-N 124.016 0.822 . . . . 0.0 110.818 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -71.21 111.61 6.69 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.51 124.07 18.37 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.019 0.824 . . . . 0.0 110.811 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -70.34 129.76 40.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.42 95.09 0.59 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -74.66 159.49 32.02 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.803 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m -55.52 129.63 39.63 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 97' ' ' ILE . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 85' ' ' PRO . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG3' HD21 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HG ' HD13 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp -78.36 6.26 8.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 83.49 0.3 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.998 0.904 . . . . 0.0 108.868 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 9.1 p30 178.11 -28.74 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.553 1.941 . . . . 0.0 108.31 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -70.82 160.93 31.84 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.422 1.089 . . . . 0.0 110.594 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 p -56.69 95.17 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.079 0.952 . . . . 0.0 111.212 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -144.52 108.58 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.141 0.976 . . . . 0.0 108.594 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.48 73.25 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.249 1.033 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.749 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.08 64.58 4.25 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.438 -0.346 . . . . 0.0 113.119 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.5 137.78 54.71 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.805 0.842 . . . . 0.0 109.377 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.76 154.55 18.16 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.971 0.908 . . . . 0.0 110.063 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.45 152.9 26.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.575 0.75 . . . . 0.0 110.264 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.64 34.95 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.258 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.53 147.7 28.71 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.391 2.06 . . . . 0.0 111.721 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.5 -179.15 4.66 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.03 104.11 1.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -67.42 124.57 23.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.436 0.636 . . . . 0.0 110.468 -176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -83.16 104.07 13.06 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.55 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.32 116.42 38.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.781 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.0 p -97.79 165.98 11.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.435 0.694 . . . . 0.0 110.136 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.55 -65.21 3.49 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.459 0.474 . . . . 0.0 112.892 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.68 -164.86 22.39 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 123.729 0.311 . . . . 0.0 112.667 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.76 -24.91 18.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 111.615 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -69.45 106.67 3.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 110.638 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.81 -149.53 17.91 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.631 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.6 94.0 2.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -70.64 126.13 28.76 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.509 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -100.31 148.01 25.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.045 0.938 . . . . 0.0 110.076 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.31 165.02 15.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.304 0.642 . . . . 0.0 111.361 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.0 179.53 5.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.063 0.945 . . . . 0.0 108.703 171.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.01 131.63 22.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.787 0.435 . . . . 0.0 110.067 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -78.34 121.78 24.91 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.486 0.714 . . . . 0.0 109.973 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -78.81 105.13 9.91 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.59 175.22 5.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.66 136.2 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.31 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.09 -175.55 32.96 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.495 0.497 . . . . 0.0 112.937 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.17 138.54 64.66 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.236 0.614 . . . . 0.0 110.544 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.29 136.79 41.43 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.682 2.255 . . . . 0.0 111.71 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.3 169.17 12.79 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 123.008 2.472 . . . . 0.0 112.834 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.8 p -75.3 151.37 38.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.09 164.59 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.183 0.593 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.5 p -75.67 137.46 40.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.558 0.743 . . . . 0.0 111.657 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.7 p -91.44 155.14 18.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 110.454 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.73 161.01 21.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.044 0.537 . . . . 0.0 110.992 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -126.42 15.4 7.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.255 1.022 . . . . 0.0 112.684 -170.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -68.48 -42.93 77.97 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 t -80.69 -5.12 56.56 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.727 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.78 -19.88 15.16 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.578 0.751 . . . . 0.0 110.589 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.6 144.5 40.53 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.62 119.65 0.8 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -90.97 157.14 17.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.414 0.686 . . . . 0.0 111.145 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -102.95 109.52 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.931 0.892 . . . . 0.0 108.62 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -78.94 120.65 23.84 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.89 136.71 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.629 0.371 . . . . 0.0 110.534 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -78.15 143.12 37.53 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.091 0.556 . . . . 0.0 110.077 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.44 141.08 50.27 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -70.39 175.37 4.77 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.744 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -69.14 143.84 54.01 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 77' ' ' LYS . 7.6 m -76.78 155.2 33.31 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.663 HG22 HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -64.53 128.93 37.9 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.037 0.535 . . . . 0.0 109.94 178.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.539 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.573 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' HG21 ' A' ' 60' ' ' THR . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.704 ' HB3' ' HG2' ' A' ' 127' ' ' LYS . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 3.2 m-20 -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.573 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt -74.0 -31.81 63.12 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.704 ' HG2' ' HB3' ' A' ' 108' ' ' LEU . 30.9 mmmt -73.46 95.43 2.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.486 167.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -149.43 165.96 30.52 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.556 0.742 . . . . 0.0 109.971 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.85 127.42 54.02 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -128.01 144.59 51.11 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 109.41 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.29 105.27 2.48 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.669 0.788 . . . . 0.0 110.696 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -146.65 149.85 34.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.16 0.984 . . . . 0.0 109.208 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 123.901 0.88 . . . . 0.0 111.048 -176.765 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.988 0.423 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.77 161.57 11.67 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.535 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -80.55 99.12 7.92 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -69.5 107.18 3.26 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.381 0.672 . . . . 0.0 109.69 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -142.01 137.83 31.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.443 0.697 . . . . 0.0 110.533 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . -167.36 42.73 0.25 Allowed Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.128 -1.373 . . . . 0.0 114.588 165.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 6' ' ' GLY . 56.2 Cg_endo -93.74 114.2 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.764 0 CA-C-N 121.384 2.592 . . . . 0.0 111.212 173.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.17 139.07 58.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.33 112.62 1.81 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.456 0.702 . . . . 0.0 109.396 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -58.56 120.77 9.46 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.272 0.983 . . . . 0.0 110.948 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.36 132.75 43.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.699 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 tt -126.24 142.34 43.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.316 1.046 . . . . 0.0 108.6 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.4 m -71.26 125.46 27.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.191 0.597 . . . . 0.0 110.48 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.06 169.4 46.08 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.366 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 80.73 0.59 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.06 74.73 3.63 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.734 0.813 . . . . 0.0 109.734 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -164.13 129.13 2.81 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.403 -172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.64 -141.73 11.82 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -164.39 152.37 12.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.342 0.657 . . . . 0.0 110.106 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -82.61 97.64 8.6 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.305 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -77.19 113.7 15.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.892 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.55 149.84 49.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.827 0.451 . . . . 0.0 110.518 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -95.53 169.76 9.82 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.444 0.697 . . . . 0.0 110.156 -173.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -80.03 96.88 6.59 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.83 169.67 17.6 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.372 0.669 . . . . 0.0 110.745 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.92 152.34 51.66 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.59 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 154.2 23.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.056 0.542 . . . . 0.0 109.944 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -106.25 118.54 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.98 169.88 50.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.826 0.704 . . . . 0.0 112.945 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.18 148.47 45.15 Favored Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 123.402 0.681 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 152.1 81.86 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.629 2.219 . . . . 0.0 111.703 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.23 147.43 95.02 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.57 2.18 . . . . 0.0 112.157 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 t -69.15 104.99 2.32 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.655 0.741 . . . . 0.0 110.414 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -72.82 -66.48 0.66 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.225 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -131.4 154.82 48.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.877 0.871 . . . . 0.0 110.226 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 p -76.5 136.58 39.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.539 HD13 ' HB3' ' A' ' 39' ' ' ALA . 4.0 pp -72.51 154.51 40.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.905 0.482 . . . . 0.0 112.024 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.2 p -104.0 11.04 35.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.548 0.739 . . . . 0.0 111.726 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -69.87 -20.41 63.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.344 0.658 . . . . 0.0 111.923 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 -75.04 -36.11 61.87 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -82.6 -42.36 18.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -168.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.89 148.05 50.79 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.536 0.607 . . . . 0.0 110.406 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.73 86.11 0.16 Allowed Glycine 0 C--N 1.343 0.919 0 O-C-N 123.583 0.552 . . . . 0.0 112.865 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.93 52.64 1.93 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.46 105.77 11.01 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.334 0.654 . . . . 0.0 109.37 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -68.67 122.42 18.49 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.119 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -58.82 142.03 51.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.244 0.618 . . . . 0.0 111.343 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.13 168.26 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.045 0.538 . . . . 0.0 111.394 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -74.38 118.78 17.73 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.28 149.71 49.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.165 0.586 . . . . 0.0 110.402 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.68 122.02 26.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 110.677 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.04 119.57 38.91 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.815 1.246 . . . . 0.0 107.854 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -74.55 143.6 44.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.965 0.506 . . . . 0.0 110.719 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 HD12 ' A' ' 78' ' ' ILE . 3.6 m -76.33 117.14 17.7 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 HG22 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 103' ' ' ARG . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.16 -50.88 68.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 127' ' ' LYS . 14.9 ptpt 46.2 23.02 0.17 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 126.03 1.732 . . . . 0.0 114.565 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -127.47 94.78 4.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.02 112.56 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.266 0.979 . . . . 0.0 109.884 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -105.55 97.24 7.1 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -69.91 161.53 29.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.256 0.622 . . . . 0.0 110.842 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -88.67 -13.29 40.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.918 0.487 . . . . 0.0 111.811 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.203 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.8 63.36 0.01 OUTLIER Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -75.1 86.96 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.308 0.575 . . . . 0.0 109.812 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -84.31 111.33 19.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -56.71 147.97 21.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.004 0.922 . . . . 0.0 111.564 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 111.49 3.76 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.89 -0.95 . . . . 0.0 111.837 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.06 129.15 14.8 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.442 2.095 . . . . 0.0 111.11 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.97 83.94 2.24 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -110.68 133.86 52.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.89 0.876 . . . . 0.0 109.622 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -154.03 135.55 14.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.748 0.819 . . . . 0.0 109.25 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -88.57 97.87 11.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.487 0.715 . . . . 0.0 109.274 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 tt -69.53 118.33 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 t -75.65 153.31 37.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 0.0 110.926 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.48 -125.42 0.14 Allowed Glycine 0 C--N 1.352 1.465 0 O-C-N 123.464 0.477 . . . . 0.0 112.978 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.36 159.69 32.62 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.991 0.396 . . . . 0.0 112.424 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.9 tp -161.12 127.28 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -145.3 144.6 30.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.56 0.744 . . . . 0.0 110.323 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.21 173.88 52.11 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.171 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -139.08 134.81 33.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.113 0.565 . . . . 0.0 110.251 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -91.88 151.98 20.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -87.49 -176.19 5.5 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -71.64 169.13 16.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.143 0.977 . . . . 0.0 111.155 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.02 157.26 21.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -113.77 94.05 4.66 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.4 0.68 . . . . 0.0 110.405 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -91.92 126.59 37.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.654 0.782 . . . . 0.0 109.652 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -84.47 151.19 24.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.453 0.701 . . . . 0.0 109.734 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.34 143.95 44.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.075 0.55 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.65 134.42 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.12 -136.56 0.8 Allowed Glycine 0 CA--C 1.537 1.407 0 O-C-N 123.497 0.498 . . . . 0.0 113.573 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.4 142.61 46.93 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.702 0.801 . . . . 0.0 111.196 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -72.48 172.98 13.96 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.174 2.583 . . . . 0.0 112.589 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.69 178.01 0.81 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.908 2.405 . . . . 0.0 113.244 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.1 p -72.81 169.69 16.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.385 0.674 . . . . 0.0 112.279 -175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -69.52 170.01 11.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.206 1.002 . . . . 0.0 112.269 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 p -75.15 161.27 29.53 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.177 0.991 . . . . 0.0 112.597 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.2 p -87.17 172.68 9.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.724 0.81 . . . . 0.0 110.828 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -123.08 170.89 9.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.667 0.787 . . . . 0.0 110.962 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.4 m -127.16 39.78 3.84 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.183 0.993 . . . . 0.0 109.464 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -69.93 -26.76 64.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.446 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -67.8 -29.18 68.29 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -39.87 77.57 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.502 171.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.77 124.9 24.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.153 0.581 . . . . 0.0 110.803 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.73 -103.02 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 74.79 1.27 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -121.19 107.37 12.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.833 0.853 . . . . 0.0 109.685 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -73.34 152.67 40.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.432 0.293 . . . . 0.0 110.334 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -83.13 164.38 20.27 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.375 0.67 . . . . 0.0 111.444 -174.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -67.37 156.57 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.788 0.835 . . . . 0.0 111.989 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.26 132.88 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.042 0.537 . . . . 0.0 110.305 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.4 174.96 10.97 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.57 0.7 . . . . 0.0 111.665 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.93 175.13 10.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.614 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -121.37 162.92 19.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.356 1.062 . . . . 0.0 109.759 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -97.76 146.48 25.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.324 0.649 . . . . 0.0 110.232 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t -67.96 141.66 56.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.3 t-20 -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.667 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 103' ' ' ARG . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.494 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.477 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HG3' HD21 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.667 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt -75.11 -27.49 59.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp 68.09 -66.93 0.21 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 126.637 1.975 . . . . 0.0 111.582 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -51.59 128.96 24.65 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.133 1.373 . . . . 0.0 111.276 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -62.51 138.34 58.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 110.42 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.8 t -66.77 87.51 0.13 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 110.163 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.05 89.96 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.918 0.887 . . . . 0.0 109.537 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -157.34 -44.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.815 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.456 0.703 . . . . 0.0 110.115 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.67 -94.97 0.62 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 78.67 -41.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.604 1.562 . . . . 0.0 112.746 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -72.83 162.04 29.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.416 0.687 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -77.39 177.89 7.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.384 0.673 . . . . 0.0 111.687 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 -143.31 14.32 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.23 -173.63 1.92 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.046 2.498 . . . . 0.0 111.521 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.81 143.19 57.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.758 0.423 . . . . 0.0 109.979 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -57.42 111.31 1.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.718 0.807 . . . . 0.0 110.399 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -61.34 116.28 4.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.208 0.603 . . . . 0.0 111.054 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -85.1 98.25 10.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.016 0.926 . . . . 0.0 109.566 -168.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.13 135.31 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.991 0.916 . . . . 0.0 109.958 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -85.64 168.57 14.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.807 0.843 . . . . 0.0 110.474 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -135.21 -33.01 0.28 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 116.551 -0.295 . . . . 0.0 112.575 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 138.86 21.51 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.932 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.01 147.76 21.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 108.1 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -167.52 146.07 4.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.61 0.364 . . . . 0.0 110.656 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.91 148.27 19.76 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -90.6 124.17 34.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.684 0.794 . . . . 0.0 110.53 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -98.84 121.01 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -82.17 164.45 21.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.79 173.38 12.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 112.293 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 138.38 31.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.75 0.82 . . . . 0.0 110.114 -171.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -91.37 141.2 29.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.536 0.735 . . . . 0.0 110.562 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.12 160.67 24.36 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -120.07 109.58 15.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.469 0.708 . . . . 0.0 109.305 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.34 109.24 3.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.384 0.673 . . . . 0.0 109.903 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.41 117.21 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.173 0.989 . . . . 0.0 108.927 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.84 69.15 0.18 Allowed Glycine 0 C--N 1.343 0.953 0 O-C-N 123.366 0.416 . . . . 0.0 112.875 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -102.83 114.18 65.43 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.99 132.33 9.45 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.87 2.38 . . . . 0.0 112.787 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.98 112.1 3.21 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.583 2.189 . . . . 0.0 111.283 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.7 p -67.67 146.5 53.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.605 0.762 . . . . 0.0 111.96 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -88.42 129.03 35.52 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.991 0.916 . . . . 0.0 110.506 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 m -77.68 120.53 22.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.767 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.4 p -75.52 -89.27 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.251 0.62 . . . . 0.0 111.399 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.9 172.3 5.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.001 0.92 . . . . 0.0 110.995 -175.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 p -126.08 37.94 4.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.269 1.028 . . . . 0.0 108.26 169.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -65.71 -41.71 91.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.696 -175.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -66.44 -38.2 86.85 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -80.52 -2.65 47.0 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.431 0.692 . . . . 0.0 112.717 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.55 137.54 57.99 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.52 78.93 0.57 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.565 0.541 . . . . 0.0 113.822 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.95 -4.16 61.69 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.142 0.401 . . . . 0.0 112.614 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.02 150.77 28.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.821 0.848 . . . . 0.0 110.164 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.54 157.29 15.96 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.779 0.831 . . . . 0.0 109.734 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -94.55 175.04 6.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.422 0.689 . . . . 0.0 110.722 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.16 136.89 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.852 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -76.58 154.41 34.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.941 0.896 . . . . 0.0 110.951 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.4 126.1 24.9 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.993 0.917 . . . . 0.0 111.9 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -68.16 130.91 44.35 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.244 1.018 . . . . 0.0 110.635 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -74.38 111.17 9.3 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.821 0.849 . . . . 0.0 110.345 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.7 m -80.25 134.47 36.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -69.69 142.49 53.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.975 0.51 . . . . 0.0 110.069 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.491 ' HB ' HG22 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.574 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.2 t30 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 HD13 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HG3' HD21 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.627 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.627 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.463 HD11 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt -82.11 -24.62 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.89 109.53 2.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -126.26 140.73 52.3 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.599 0.76 . . . . 0.0 109.398 -168.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -93.58 -15.42 25.43 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.835 0.854 . . . . 0.0 111.378 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 t 64.46 173.08 0.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.905 1.282 . . . . 0.0 111.092 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -158.8 102.11 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.875 -0.516 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -94.81 -52.33 4.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.258 1.529 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.827 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.81 86.09 1.07 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -58.85 114.62 2.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.096 0.958 . . . . 0.0 111.192 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -61.04 117.54 5.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.491 1.116 . . . . 0.0 109.615 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -53.63 -52.76 58.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.608 1.163 . . . . 0.0 112.546 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.15 141.9 3.42 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.273 -0.737 . . . . 0.0 112.282 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.61 140.65 21.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.78 2.32 . . . . 0.0 112.039 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.82 142.06 46.15 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.164 0.585 . . . . 0.0 110.399 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -94.12 142.5 27.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.882 0.873 . . . . 0.0 109.932 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.9 144.23 54.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 0.0 110.292 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.1 136.3 34.51 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.653 0.781 . . . . 0.0 110.576 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 tt -141.32 150.44 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.104 0.962 . . . . 0.0 108.865 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -74.79 161.97 29.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.078 0.551 . . . . 0.0 111.792 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.32 -32.52 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.08 75.04 2.39 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.037 0.351 . . . . 0.0 112.846 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.55 144.93 24.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 108.384 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -168.77 125.25 0.97 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.292 0.637 . . . . 0.0 109.457 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.84 137.82 14.38 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -95.98 157.96 15.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.759 0.824 . . . . 0.0 110.466 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -76.14 160.89 29.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.554 0.742 . . . . 0.0 111.048 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -102.3 172.04 7.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.656 0.782 . . . . 0.0 110.991 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.6 142.49 29.92 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.796 0.839 . . . . 0.0 110.807 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -90.99 141.26 29.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.69 0.796 . . . . 0.0 109.774 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -67.06 116.39 7.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.871 0.869 . . . . 0.0 110.943 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.7 124.04 25.24 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.439 0.695 . . . . 0.0 109.917 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -75.54 154.46 36.81 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.537 0.735 . . . . 0.0 110.286 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.71 166.52 23.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.314 0.646 . . . . 0.0 111.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.0 136.42 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.074 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.64 -162.32 27.16 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.292 0.37 . . . . 0.0 112.782 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -98.26 130.84 27.46 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.015 0.526 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.4 168.02 23.54 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.978 2.452 . . . . 0.0 112.008 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -49.65 145.62 17.0 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.299 2.666 . . . . 0.0 113.123 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.6 p -76.22 -83.15 0.07 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.68 168.67 26.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.81 0.444 . . . . 0.0 111.594 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 p -107.6 158.61 17.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.838 1.255 . . . . 0.0 109.927 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.0 p -69.32 147.1 51.59 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.823 0.449 . . . . 0.0 111.417 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 39' ' ' ALA . 1.8 pt? -65.15 169.86 5.13 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.115 0.966 . . . . 0.0 112.029 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -101.39 27.65 6.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.374 0.67 . . . . 0.0 111.909 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.438 ' H ' ' HG ' ' A' ' 37' ' ' LEU . . . -71.75 -44.67 63.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.62 0.368 . . . . 0.0 111.615 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 44' ' ' ILE . 13.1 t -82.0 -19.19 41.02 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.518 0.327 . . . . 0.0 110.451 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.65 117.62 7.09 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -71.58 0.76 Allowed Glycine 0 C--N 1.342 0.916 0 O-C-N 124.242 0.964 . . . . 0.0 114.7 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.1 4.73 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -80.51 155.94 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.465 0.706 . . . . 0.0 111.719 -174.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.5 151.13 30.94 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.681 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 2.9 mptp? -84.27 122.39 28.82 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.566 0.747 . . . . 0.0 109.621 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.38 135.24 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.439 0.696 . . . . 0.0 109.911 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 120.42 38.99 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.106 0.963 . . . . 0.0 109.055 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.18 146.91 43.04 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.68 0.792 . . . . 0.0 109.694 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.34 158.43 26.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.179 0.591 . . . . 0.0 111.603 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -67.35 146.62 53.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.39 0.676 . . . . 0.0 111.392 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -63.95 137.02 57.82 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 110.632 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t -67.86 135.0 51.84 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.543 0.527 . . . . 0.0 109.595 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' HG21 ' A' ' 62' ' ' THR . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 87' ' ' ASN . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HG3' HD21 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HG2' HG23 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.691 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt -86.17 29.64 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 125' ' ' LEU . 56.1 mtpt -57.06 -26.81 60.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 110.717 169.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -63.51 111.9 2.54 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.88 154.03 39.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -69.83 -35.48 74.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.396 0.678 . . . . 0.0 111.271 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -149.12 149.17 30.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.217 0.607 . . . . 0.0 110.716 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -156.56 108.63 2.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.769 0.827 . . . . 0.0 109.863 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.678 1.191 . . . . 0.0 108.413 177.491 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.99 126.42 1.15 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.509 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.29 175.76 5.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.208 1.003 . . . . 0.0 108.919 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -119.32 138.09 53.27 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.02 0.528 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -150.07 178.01 9.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.732 0.813 . . . . 0.0 110.116 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.66 -111.59 0.5 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-O 118.895 -0.947 . . . . 0.0 112.177 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.22 122.58 11.34 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.358 2.706 . . . . 0.0 113.429 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -115.21 -175.03 2.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.042 0.937 . . . . 0.0 109.292 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.41 82.66 2.08 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -130.25 116.66 18.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.404 1.082 . . . . 0.0 108.272 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -100.16 114.23 27.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.491 0.716 . . . . 0.0 109.988 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.84 132.94 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.327 0.651 . . . . 0.0 109.451 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -156.88 101.2 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.334 1.054 . . . . 0.0 108.558 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.5 -30.48 27.2 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.016 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.48 -163.88 37.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.09 -45.96 7.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.771 0.828 . . . . 0.0 109.59 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.3 tptm 61.8 103.43 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 111.1 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.36 139.8 11.24 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.445 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -114.21 100.41 8.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.111 0.964 . . . . 0.0 108.417 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -68.94 106.59 2.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.519 0.728 . . . . 0.0 111.323 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -78.05 98.26 5.69 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 -169.55 2.64 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.162 0.585 . . . . 0.0 109.892 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -130.77 154.41 48.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 0.0 110.439 -174.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -114.07 136.94 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 109.195 173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -76.4 144.74 39.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.94 0.496 . . . . 0.0 109.996 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -80.51 165.29 22.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.42 0.688 . . . . 0.0 111.319 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.46 147.96 26.81 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.433 0.693 . . . . 0.0 111.156 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.58 147.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.794 0.837 . . . . 0.0 109.974 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.3 179.78 14.5 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -99.09 151.47 37.4 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 123.904 0.882 . . . . 0.0 111.209 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.27 140.3 76.5 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.248 2.632 . . . . 0.0 113.191 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.45 174.17 13.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.968 2.445 . . . . 0.0 113.392 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -86.46 148.77 25.4 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 0.0 110.545 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.42 158.28 20.26 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.529 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.2 p -80.98 159.17 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.219 0.608 . . . . 0.0 112.109 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -97.76 178.98 4.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.952 0.901 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.35 152.21 50.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.961 0.504 . . . . 0.0 111.159 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -119.78 21.34 12.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.251 1.02 . . . . 0.0 110.463 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -61.43 -34.34 75.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.256 0.623 . . . . 0.0 111.088 176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' HG22 ' A' ' 48' ' ' THR . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 -54.59 -61.2 2.46 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 45' ' ' LYS . 11.4 t -71.97 -6.16 40.05 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.978 -165.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 tp -73.0 111.83 8.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.28 -157.71 26.03 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.766 -0.197 . . . . 0.0 113.09 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.23 -170.7 12.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.078 0.37 . . . . 0.0 112.408 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -109.4 171.77 7.24 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.834 0.854 . . . . 0.0 110.842 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -89.98 164.41 14.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.173 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -114.51 157.58 22.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.267 0.627 . . . . 0.0 109.351 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.94 137.67 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.042 0.537 . . . . 0.0 111.246 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 140.26 30.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.046 0.938 . . . . 0.0 108.634 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.78 147.42 26.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.449 0.699 . . . . 0.0 110.399 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -100.1 -178.35 3.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.411 0.684 . . . . 0.0 110.782 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -104.84 175.68 5.41 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.277 1.031 . . . . 0.0 110.057 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -136.73 151.92 49.77 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 78' ' ' ILE . 90.8 m -115.33 100.6 8.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.707 1.203 . . . . 0.0 108.343 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB3' HG23 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.456 ' HB2' HD12 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG3' HD21 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 129' ' ' GLU . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 124' ' ' VAL . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HG3' HG23 ' A' ' 95' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.36 -35.51 79.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 71.03 -61.88 0.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.428 1.491 . . . . 0.0 110.535 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.77 133.79 55.64 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 163.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -110.11 142.87 41.01 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 m -80.54 68.1 6.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.267 0.627 . . . . 0.0 109.544 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.94 110.4 11.53 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -77.07 99.26 5.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 123.543 0.737 . . . . 0.0 109.169 176.391 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.82 6.55 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 62.61 23.02 13.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.232 1.013 . . . . 0.0 112.165 -178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -97.98 108.3 20.98 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.804 0.842 . . . . 0.0 109.528 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -88.36 152.57 21.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.201 1.001 . . . . 0.0 110.765 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.48 149.75 19.44 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.253 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.87 132.41 15.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.802 2.334 . . . . 0.0 112.581 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.52 125.02 26.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.771 0.429 . . . . 0.0 109.959 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -75.37 130.88 39.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.1 0.56 . . . . 0.0 109.978 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.8 119.0 23.8 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.123 0.569 . . . . 0.0 110.172 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.7 124.79 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.883 0.873 . . . . 0.0 110.2 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 t -122.72 164.89 17.46 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.138 0.975 . . . . 0.0 109.764 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.9 146.32 11.64 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.75 -160.9 36.03 Favored Glycine 0 C--N 1.343 0.945 0 O-C-N 123.674 0.279 . . . . 0.0 112.439 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 tp -173.12 90.87 0.09 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -84.48 103.11 13.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.438 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.52 117.07 4.33 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.93 174.28 8.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.5 0.72 . . . . 0.0 110.307 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -138.64 161.22 37.68 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.81 0.844 . . . . 0.0 109.634 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -132.01 148.04 52.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.984 0.914 . . . . 0.0 109.561 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.0 169.09 18.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.177 0.591 . . . . 0.0 110.294 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 157.26 43.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.783 0.833 . . . . 0.0 109.399 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.23 114.58 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.113 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -76.38 164.05 26.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.735 0.814 . . . . 0.0 110.974 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -58.55 153.88 15.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.542 1.137 . . . . 0.0 113.448 -173.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.91 161.27 39.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.478 1.111 . . . . 0.0 109.078 170.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.94 146.75 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.2 0.6 . . . . 0.0 109.912 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.28 -145.52 5.43 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.325 0.391 . . . . 0.0 112.794 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -120.26 139.85 29.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.465 0.706 . . . . 0.0 110.467 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.02 163.44 33.1 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.984 2.456 . . . . 0.0 111.962 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -50.74 139.27 40.06 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.352 2.701 . . . . 0.0 113.169 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 p -86.53 -90.46 0.11 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.206 0.602 . . . . 0.0 112.291 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.21 159.64 37.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.472 0.709 . . . . 0.0 110.335 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.8 m -150.03 123.94 9.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 108.966 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.5 p -72.73 -179.72 3.23 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.617 0.767 . . . . 0.0 111.864 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -126.91 163.55 23.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.177 0.991 . . . . 0.0 109.834 175.408 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.5 m -125.71 20.25 7.84 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.105 0.562 . . . . 0.0 110.757 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.37 -42.58 87.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.734 0.814 . . . . 0.0 110.854 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -67.43 -37.33 82.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -82.6 -1.6 51.34 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 45' ' ' LYS . 4.4 mm? -111.71 121.55 45.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.32 -81.68 1.49 Allowed Glycine 0 C--N 1.353 1.495 0 O-C-N 123.388 0.43 . . . . 0.0 112.415 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.54 179.32 42.68 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -88.98 141.43 28.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.197 0.599 . . . . 0.0 110.446 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.43 117.46 34.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.065 0.946 . . . . 0.0 108.584 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 168.29 20.3 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -82.39 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.235 0.614 . . . . 0.0 110.911 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -90.27 153.7 20.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.543 0.737 . . . . 0.0 111.35 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.91 167.82 1.48 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.011 1.325 . . . . 0.0 113.333 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -86.83 160.01 18.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.226 -175.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.62 128.74 35.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.497 0.719 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.2 p -78.97 122.14 25.79 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.399 0.679 . . . . 0.0 110.54 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 78' ' ' ILE . 14.0 m -69.9 123.45 21.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.644 0.778 . . . . 0.0 109.922 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 61' ' ' THR . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HB3' HG22 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.674 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.674 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG3' HD21 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' HB3' HG12 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 121' ' ' ILE . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 2.8 m-20 -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 58.32 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.895 1.372 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -73.06 112.79 9.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.556 0.742 . . . . 0.0 109.067 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.89 153.17 46.96 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -55.03 123.09 12.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.912 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -71.57 87.3 0.91 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.683 0.754 . . . . 0.0 109.079 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -87.04 78.31 8.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.847 1.259 . . . . 0.0 110.103 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.43 1.092 . . . . 0.0 108.679 179.5 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.553 HG22 HD12 ' A' ' 78' ' ' ILE . 25.8 m . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.218 0.532 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.555 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HB3' HG22 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 111' ' ' VAL . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HG3' HD21 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.599 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.7 m120 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 . . . . . 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.637 HG21 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t . . . . . 0 CA--C 1.558 1.275 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.486 HD21 ' HB1' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 87' ' ' ASN . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD21 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.448 HD13 HD11 ' A' ' 78' ' ' ILE . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.3 m120 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.617 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt . . . . . 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 16.2 ptt180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.56 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.475 HD21 ' HB1' ' A' ' 73' ' ' ALA . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' HG22 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.514 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.66 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HA ' HG23 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HD2' HG21 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG21 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 . . . . . 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.46 HD21 ' HB1' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.403 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.477 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.475 ' HG3' HD21 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.22 0.057 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 44' ' ' ILE . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.077 0.465 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 121' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.61 ' HB3' HG22 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 90' ' ' LEU . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.489 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.768 0.318 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.557 0.694 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' H ' HD22 ' A' ' 82' ' ' LEU . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 17.5 m120 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.424 HG13 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.779 -0.153 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 90' ' ' LEU . 5.6 p-10 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.672 ' HB2' HD22 ' A' ' 87' ' ' ASN . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 103' ' ' ARG . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 120' ' ' VAL . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 118' ' ' ASP . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.585 HD12 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG2' HD12 ' A' ' 44' ' ' ILE . 2.3 ppt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m . . . . . 0 CA--C 1.554 1.124 0 CA-C-O 120.857 0.36 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' CG1' ' A' ' 120' ' ' VAL . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.569 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG3' HD21 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.407 ' CG1' ' HB2' ' A' ' 64' ' ' ASN . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.464 HD13 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 121.094 0.473 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 75' ' ' LYS . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 64' ' ' ASN . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' HD22 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.564 HD22 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 121' ' ' ILE . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 111' ' ' VAL . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.556 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 100' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.693 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.627 HG22 HD12 ' A' ' 78' ' ' ILE . 14.5 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.627 HD12 HG22 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.551 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.425 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt . . . . . 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 . . . . . 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m . . . . . 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 97' ' ' ILE . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 85' ' ' PRO . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG3' HD21 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HG ' HD13 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 . . . . . 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.663 HG22 HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.539 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.573 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 102' ' ' ILE . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.9 OUTLIER -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.573 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 HD12 ' A' ' 78' ' ' ILE . 3.6 m . . . . . 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 HG22 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 103' ' ' ARG . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 0.2 OUTLIER -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.667 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 103' ' ' ARG . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.494 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.477 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HG3' HD21 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.667 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 119.552 -0.261 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.491 ' HB ' HG22 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.574 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 HD13 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HG3' HD21 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.627 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.627 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.463 HD11 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 . . . . . 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.244 0.802 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' HG21 ' A' ' 62' ' ' THR . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 87' ' ' ASN . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HG3' HD21 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HG2' HG23 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.691 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.466 0.174 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 78' ' ' ILE . 90.8 m . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.437 HD21 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB3' HG23 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.456 ' HB2' HD12 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG3' HD21 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 102' ' ' ILE . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 124' ' ' VAL . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HG3' HG23 ' A' ' 95' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.968 0.413 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 78' ' ' ILE . 14.0 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 61' ' ' THR . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HB3' HG22 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.674 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.674 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG3' HD21 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' HB3' HG12 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.8 OUTLIER -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.46 -72.63 0.11 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -157.29 141.17 16.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.423 0.689 . . . . 0.0 110.2 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -158.27 138.13 12.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.793 0.837 . . . . 0.0 109.051 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -75.09 130.26 38.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.004 0.522 . . . . 0.0 109.923 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.2 168.37 54.6 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.323 -0.709 . . . . 0.0 113.257 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.93 96.85 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.278 2.652 . . . . 0.0 112.603 -173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.44 123.63 23.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.659 0.784 . . . . 0.0 109.399 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -121.66 131.2 53.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 109.588 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.22 157.41 24.92 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.265 1.026 . . . . 0.0 109.58 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 99.94 12.83 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.99 89.87 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.3 p -95.93 96.12 8.7 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.244 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.33 31.05 4.56 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.38 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.87 40.53 2.98 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 123.087 0.375 . . . . 0.0 112.939 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.32 78.45 9.76 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -140.96 116.34 10.07 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.347 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.59 150.7 19.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.13 179.77 7.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.341 0.656 . . . . 0.0 109.796 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -108.85 160.08 16.27 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -91.13 134.17 34.75 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.85 140.28 29.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.011 0.925 . . . . 0.0 111.586 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.53 -166.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.535 1.134 . . . . 0.0 109.593 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -75.82 147.67 38.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.865 0.466 . . . . 0.0 110.035 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -103.35 -77.81 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.846 0.458 . . . . 0.0 109.8 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -166.29 37.93 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.378 0.671 . . . . 0.0 110.608 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.73 148.59 24.31 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.798 0.839 . . . . 0.0 112.154 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.21 118.34 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.9 -103.58 0.48 Allowed Glycine 0 C--N 1.346 1.133 0 O-C-N 123.461 0.475 . . . . 0.0 112.673 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.07 139.18 42.44 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.646 0.778 . . . . 0.0 110.675 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.62 157.58 28.4 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.687 2.258 . . . . 0.0 111.202 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.68 159.88 38.45 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.286 1.991 . . . . 0.0 112.449 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.8 p -67.26 163.95 19.39 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.446 0.698 . . . . 0.0 110.602 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -103.21 167.83 9.57 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 110.874 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.5 p -75.73 162.34 28.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.801 0.84 . . . . 0.0 110.142 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 p -82.86 -96.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.995 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 39' ' ' ALA . 2.4 pp -170.68 -173.94 1.49 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.698 0.799 . . . . 0.0 110.655 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -140.04 20.25 2.46 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.91 0.884 . . . . 0.0 110.114 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.406 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -61.01 -49.85 75.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.73 0.812 . . . . 0.0 111.766 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.15 -30.37 71.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.233 1.013 . . . . 0.0 112.45 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.11 -44.53 75.96 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.563 0.745 . . . . 0.0 110.34 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.12 -33.94 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.656 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 36.9 mmt180 -70.3 -21.1 62.97 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.701 0.8 . . . . 0.0 112.18 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.1 tp -79.61 -35.3 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -67.36 -33.38 75.1 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.478 0.656 . . . . 0.0 109.655 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 38.4 t70 -72.47 -34.32 67.62 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.469 1.107 . . . . 0.0 111.395 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 9.2 ptt180 -74.1 -35.97 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 120.516 0.198 . . . . 0.0 110.676 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 13.4 t -86.93 15.84 5.52 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.65 0.78 . . . . 0.0 111.906 -174.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -56.8 148.12 21.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.445 0.698 . . . . 0.0 111.512 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.5 168.76 54.8 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.314 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.51 -148.61 4.0 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 122.711 0.196 . . . . 0.0 112.831 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -125.63 146.76 49.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.428 0.691 . . . . 0.0 109.973 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -66.94 147.71 52.88 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.023 0.929 . . . . 0.0 110.299 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 54' ' ' LYS . 11.2 mmpt? -92.25 176.58 6.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.181 0.592 . . . . 0.0 111.619 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.3 m -86.33 160.92 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.435 0.694 . . . . 0.0 110.977 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -114.71 153.74 29.71 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.164 0.986 . . . . 0.0 110.162 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.61 141.92 42.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.637 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -111.7 165.29 12.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.54 0.736 . . . . 0.0 110.464 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.5 106.47 12.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.738 0.815 . . . . 0.0 109.252 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.3 p -78.23 143.71 36.88 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.698 0.399 . . . . 0.0 110.007 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.553 HG22 HD12 ' A' ' 78' ' ' ILE . 25.8 m -64.51 115.62 5.34 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 123.734 0.646 . . . . 0.0 110.2 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.8 OUTLIER -123.04 157.47 32.69 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.161 0.984 . . . . 0.0 109.81 -171.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.14 130.91 54.82 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 5.4 t-20 -90.87 85.51 6.02 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' HG ' ' A' ' 125' ' ' LEU . 8.5 t -79.93 112.03 17.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 N-CA-C 103.528 -2.768 . . . . 0.0 103.528 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.1 tm? -68.48 124.05 22.49 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 111.426 -2.625 . . . . 0.0 104.859 148.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.94 107.48 34.68 Favored Pre-proline 0 N--CA 1.471 0.618 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.17 -24.25 76.41 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.105 2.537 . . . . 0.0 114.601 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.4 32.41 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.588 0.355 . . . . 0.0 111.009 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.6 p -90.12 -12.04 39.48 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.27 0.628 . . . . 0.0 110.822 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.72 35.32 24.33 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.379 1.471 . . . . 0.0 112.009 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.8 p -130.68 129.88 43.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.059 0.543 . . . . 0.0 111.57 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -84.62 141.85 30.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.479 0.712 . . . . 0.0 109.728 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 64' ' ' ASN . 0.2 OUTLIER -140.75 151.42 44.45 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.231 0.612 . . . . 0.0 110.009 -170.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -108.34 107.58 18.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.71 150.6 25.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.841 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.03 146.4 49.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.868 0.867 . . . . 0.0 109.365 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 61' ' ' THR . 21.9 mt -85.81 125.83 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.97 -79.84 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.91 162.29 26.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.528 1.058 . . . . 0.0 113.087 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.553 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -81.84 138.15 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -106.95 -55.98 2.26 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.772 0.829 . . . . 0.0 109.197 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -81.64 109.08 15.74 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 t -66.5 116.42 34.04 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.492 1.12 . . . . 0.0 111.773 -170.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.65 167.15 25.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.215 1.943 . . . . 0.0 111.394 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.32 70.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.118 0.567 . . . . 0.0 110.694 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -102.35 48.43 0.87 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.365 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.82 -45.86 82.01 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.433 1.093 . . . . 0.0 111.439 172.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -22.72 67.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.998 0.817 . . . . 0.0 112.037 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.5 mt -84.05 -41.1 17.55 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.725 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -21.45 61.12 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.242 1.017 . . . . 0.0 113.02 174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 99.1 mtt180 -63.33 -45.27 92.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.466 0.706 . . . . 0.0 110.024 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -70.24 -23.07 62.85 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.313 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.29 3.33 24.34 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.232 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.85 83.19 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.17 142.05 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.847 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.65 147.58 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.36 120.93 9.03 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.132 0.973 . . . . 0.0 110.59 -175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.87 -9.72 15.99 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.906 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.39 136.93 32.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 117.152 0.476 . . . . 0.0 110.728 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.41 142.41 35.97 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 110.534 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 78' ' ' ILE . 4.6 tt -138.21 154.17 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.751 1.62 . . . . 0.0 107.755 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 55.6 mtt180 -113.78 130.82 56.4 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -119.98 177.63 4.91 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.25 1.02 . . . . 0.0 108.81 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.26 -18.07 64.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 122.469 0.307 . . . . 0.0 111.389 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.54 -73.8 0.19 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.278 0.631 . . . . 0.0 109.496 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.81 7.05 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.8 125.18 28.22 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 164.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.1 155.49 43.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.788 0.835 . . . . 0.0 109.038 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.36 125.34 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.005 0.922 . . . . 0.0 108.893 172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.45 119.5 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 121.499 0.666 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.1 p -114.04 8.58 17.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.833 0.853 . . . . 0.0 112.135 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 38.0 m -147.42 173.42 12.65 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.604 0.761 . . . . 0.0 111.269 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.96 159.28 73.78 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.526 173.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.83 126.45 22.46 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.136 2.557 . . . . 0.0 113.607 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.61 174.57 45.27 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 123.885 0.755 . . . . 0.0 114.102 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -64.3 -25.72 68.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.311 0.644 . . . . 0.0 111.998 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.17 -12.08 59.9 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.512 0.725 . . . . 0.0 111.999 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.19 35.63 29.7 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -163.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' THR . 7.7 p -107.49 105.79 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.705 0.802 . . . . 0.0 110.254 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.6 mp -91.1 111.12 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 2.4 m-20 -63.75 133.91 54.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.932 0.333 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -133.25 162.75 30.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.66 131.15 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.949 0.899 . . . . 0.0 109.572 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.447 ' HG ' ' CG1' ' A' ' 65' ' ' VAL . 97.3 mt -66.95 130.72 44.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 130' ' ' SER . 4.2 mp -80.63 -4.08 52.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.649 0.38 . . . . 0.0 110.084 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 127' ' ' LYS . 10.8 mmpt? 67.15 18.82 10.43 Favored 'General case' 0 C--N 1.364 1.224 0 C-N-CA 125.694 1.597 . . . . 0.0 111.63 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -171.74 167.43 6.42 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 124.847 1.259 . . . . 0.0 108.779 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.18 105.9 10.84 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.508 ' HB3' HD22 ' A' ' 126' ' ' LEU . 78.1 p -65.4 116.72 7.0 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.038 0.535 . . . . 0.0 110.128 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.04 114.84 3.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.564 0.746 . . . . 0.0 110.514 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -89.75 91.1 8.5 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.502 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.36 143.35 9.09 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.197 0.31 . . . . 0.0 112.487 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.9 143.69 27.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.611 1.164 . . . . 0.0 108.672 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -132.26 117.12 17.78 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.207 0.603 . . . . 0.0 110.023 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -70.73 112.78 7.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.87 158.07 53.11 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.011 -0.883 . . . . 0.0 113.067 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.57 138.7 71.75 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.21 2.607 . . . . 0.0 112.639 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.53 -173.08 2.22 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.218 1.007 . . . . 0.0 110.439 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -75.83 85.35 2.8 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.3 mtm-85 -71.6 134.98 46.77 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.197 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -75.86 107.17 7.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.883 0.873 . . . . 0.0 111.88 -165.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -85.54 163.01 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.66 0.784 . . . . 0.0 111.16 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -160.36 172.26 17.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.656 0.782 . . . . 0.0 109.955 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.76 122.26 1.02 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.64 149.68 47.01 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 117.026 0.413 . . . . 0.0 113.005 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -153.59 75.83 1.06 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -80.13 145.48 32.34 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.801 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.94 -141.19 4.06 Favored Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.443 0.464 . . . . 0.0 112.849 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.64 167.04 28.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 109.979 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -77.78 124.17 27.63 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.9 tpt85 -71.8 91.24 1.14 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.182 0.515 . . . . 0.0 110.268 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -101.32 141.86 33.57 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.061 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 164.06 32.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.685 1.194 . . . . 0.0 108.864 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -125.07 112.38 16.45 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.94 -177.81 4.45 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.193 0.997 . . . . 0.0 109.971 175.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -75.86 130.57 38.74 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.7 137.47 45.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.665 0.386 . . . . 0.0 110.178 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.2 mt -67.19 134.64 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 122.965 0.506 . . . . 0.0 109.658 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.29 82.1 0.34 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -68.43 160.05 78.01 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 123.323 0.649 . . . . 0.0 110.764 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -53.44 105.9 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 122.807 2.338 . . . . 0.0 111.697 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.46 -10.55 12.09 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.791 2.328 . . . . 0.0 112.832 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -154.43 157.42 38.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.04 0.936 . . . . 0.0 109.574 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.87 158.65 42.01 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.028 0.931 . . . . 0.0 109.765 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 t -106.19 160.26 15.47 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.538 0.735 . . . . 0.0 111.15 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 p -95.74 175.31 6.57 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.575 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 p -113.09 4.31 16.56 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.805 0.842 . . . . 0.0 112.141 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.18 82.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.11 0.564 . . . . 0.0 111.503 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HA ' ' HD2' ' A' ' 43' ' ' ARG . 48.2 mt-10 -63.8 -28.45 69.87 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.829 0.852 . . . . 0.0 112.176 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -69.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.933 0.493 . . . . 0.0 110.527 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.23 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.935 0.494 . . . . 0.0 110.588 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HD2' ' HA ' ' A' ' 40' ' ' GLU . 66.8 mtt180 -70.24 -31.24 68.55 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.911 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.35 -35.13 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.513 0.673 . . . . 0.0 109.622 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -63.38 -28.73 70.19 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.798 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.5 -17.02 25.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.504 0.721 . . . . 0.0 112.117 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -66.65 -34.84 78.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 25.7 m -65.51 -32.33 73.88 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.852 176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.45 105.27 1.43 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.874 0.869 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.5 -156.21 31.59 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.531 0.519 . . . . 0.0 111.833 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.41 -18.76 0.05 OUTLIER Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.871 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -79.95 132.14 35.98 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.073 0.937 . . . . 0.0 110.732 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.53 157.11 32.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.305 0.642 . . . . 0.0 110.411 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.27 147.23 30.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.537 0.735 . . . . 0.0 109.252 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.41 144.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 122.662 0.385 . . . . 0.0 110.825 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -74.78 140.32 43.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 tp -74.61 116.25 15.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -77.84 171.32 15.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.36 98.53 7.51 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.667 0.387 . . . . 0.0 110.67 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.1 m -69.16 150.38 47.57 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 m -58.91 124.4 19.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 3.0 m -125.15 161.08 27.62 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.99 147.0 45.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -122.41 88.92 3.02 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 74' ' ' LYS . 17.5 m -80.11 131.09 34.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.78 123.11 19.62 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 147.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -95.19 99.53 4.56 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.48 -18.52 54.41 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.483 2.789 . . . . 0.0 114.573 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.95 -39.2 83.44 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.828 0.451 . . . . 0.0 110.797 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -103.97 -12.31 16.9 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.323 0.649 . . . . 0.0 111.82 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 59.3 35.35 23.26 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.89 1.276 . . . . 0.0 110.723 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -136.77 162.87 32.02 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.551 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.71 155.36 23.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.698 0.399 . . . . 0.0 110.013 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.535 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.8 ttmt -148.53 112.63 5.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -171.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -105.43 102.46 11.93 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.8 m -130.33 149.93 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 113.031 -1.895 . . . . 0.0 109.709 -172.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -72.27 157.99 36.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.189 0.995 . . . . 0.0 111.221 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.78 137.99 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 mp -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 165.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.27 149.21 20.71 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -168.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -93.82 141.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.555 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.8 mm? -94.24 -59.47 1.95 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.054 0.942 . . . . 0.0 108.474 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 41.2 tt0 -83.82 115.21 22.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -67.8 120.83 76.48 Favored Pre-proline 0 CA--C 1.55 0.973 0 O-C-N 124.007 0.817 . . . . 0.0 110.979 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HB3' HG22 ' A' ' 97' ' ' ILE . 58.3 Cg_exo -57.26 142.06 94.67 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.119 1.879 . . . . 0.0 111.889 166.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.73 74.52 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.701 0.762 . . . . 0.0 110.378 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -88.01 62.97 7.11 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.867 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -56.39 -30.58 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 122.508 0.323 . . . . 0.0 110.265 174.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.66 -32.2 28.63 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.984 0.914 . . . . 0.0 112.882 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -94.35 -43.38 8.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.685 0.394 . . . . 0.0 110.548 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -53.47 -25.84 17.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.213 1.005 . . . . 0.0 113.633 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -66.19 -33.57 76.06 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.006 0.922 . . . . 0.0 110.984 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -83.44 -7.04 59.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.155 0.982 . . . . 0.0 110.209 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . . . 92.91 1.37 67.64 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.574 0.607 . . . . 0.0 112.393 -174.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.61 98.99 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.973 0.909 . . . . 0.0 109.311 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 111' ' ' VAL . 22.7 mt -104.65 144.13 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.839 0.856 . . . . 0.0 110.652 -168.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.578 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.5 tt -99.05 146.76 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.724 0.809 . . . . 0.0 110.121 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 111' ' ' VAL . 60.8 ttp180 -52.28 129.32 27.82 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.253 1.421 . . . . 0.0 113.296 -171.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.58 -22.39 19.75 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.783 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -86.08 131.78 34.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.045 0.538 . . . . 0.0 111.093 -173.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -78.31 135.52 37.53 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.62 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.1 tt -129.63 150.96 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 125.084 1.354 . . . . 0.0 109.424 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' HG3' HD21 ' A' ' 82' ' ' LEU . 87.5 mtt180 -113.07 131.25 55.88 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.8 p -118.16 176.53 5.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.849 0.86 . . . . 0.0 109.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 66.6 mm-40 -63.11 -18.64 63.64 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.253 0.621 . . . . 0.0 111.085 173.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.04 -69.32 0.64 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 123.974 0.91 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.21 -160.58 12.75 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.904 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.63 129.95 39.44 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 166.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.59 167.69 19.59 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.403 1.081 . . . . 0.0 109.528 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.78 132.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 98' ' ' ARG . 27.5 m -68.91 120.6 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.15 0.5 . . . . 0.0 110.133 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.8 p -116.46 3.66 13.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.645 0.778 . . . . 0.0 112.32 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.599 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 25.0 t -152.96 174.31 14.29 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.409 0.684 . . . . 0.0 109.766 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 146.85 85.96 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.371 0.668 . . . . 0.0 110.19 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.751 ' HB3' HG13 ' A' ' 121' ' ' ILE . 12.8 Cg_endo -56.66 116.78 3.44 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.884 2.39 . . . . 0.0 111.589 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.84 167.26 11.15 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.422 0.451 . . . . 0.0 113.101 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.15 -23.47 67.33 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.253 0.621 . . . . 0.0 112.27 -174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -75.24 -8.45 56.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.151 0.98 . . . . 0.0 112.087 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.92 34.43 24.38 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' THR . 45.7 t -117.62 110.91 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.663 0.785 . . . . 0.0 109.747 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.751 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.9 mp -92.69 111.47 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 109.508 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.599 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.7 m120 -72.91 127.1 31.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.099 0.56 . . . . 0.0 111.581 -176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . -135.57 174.7 10.32 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.253 1.021 . . . . 0.0 111.462 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.31 126.33 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.762 0.825 . . . . 0.0 110.081 171.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 109' ' ' ALA . 87.6 mt -68.62 127.64 33.78 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.424 0.452 . . . . 0.0 110.177 174.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.05 50.63 1.85 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.829 0.851 . . . . 0.0 108.993 175.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -70.61 88.15 0.69 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.151 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -166.86 162.36 15.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.144 0.978 . . . . 0.0 109.566 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -73.98 116.57 14.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.5 p -72.69 86.95 1.23 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.147 0.579 . . . . 0.0 109.63 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -74.69 101.63 4.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.602 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -75.69 -44.5 41.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.162 0.985 . . . . 0.0 111.55 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 CA--C 1.553 1.064 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.28 -178.841 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.34 118.92 8.94 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.254 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -73.22 101.67 3.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.294 0.637 . . . . 0.0 110.043 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -64.77 117.79 8.02 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -65.86 -46.29 78.98 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.734 0.814 . . . . 0.0 111.702 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.87 165.14 12.25 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.189 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.85 106.31 1.65 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.136 2.557 . . . . 0.0 111.819 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.77 127.07 29.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.613 0.765 . . . . 0.0 111.369 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -86.43 138.57 31.67 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.812 0.845 . . . . 0.0 109.988 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.47 138.6 34.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.911 0.485 . . . . 0.0 110.374 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -82.02 145.16 30.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.803 0.841 . . . . 0.0 110.243 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.32 162.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -58.4 148.37 28.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.148 0.579 . . . . 0.0 111.208 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.54 -27.16 71.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.974 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.1 -116.44 2.19 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.41 164.15 15.05 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.141 0.977 . . . . 0.0 108.708 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -162.02 115.66 1.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.74 133.45 6.4 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -87.42 168.92 12.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.603 0.761 . . . . 0.0 111.383 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -68.56 163.96 22.4 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.001 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -103.7 177.51 4.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.833 0.853 . . . . 0.0 109.461 174.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -125.34 160.67 28.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.246 0.618 . . . . 0.0 110.731 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -94.2 -168.85 1.94 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.161 0.984 . . . . 0.0 109.509 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.15 159.36 21.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.466 0.707 . . . . 0.0 110.256 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -74.04 151.15 40.28 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.302 0.641 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -89.01 169.18 11.74 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.6 0.76 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.39 157.59 44.0 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.822 0.449 . . . . 0.0 111.17 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -79.14 144.45 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.966 0.906 . . . . 0.0 109.865 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.13 -100.91 0.29 Allowed Glycine 0 C--N 1.345 1.037 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -135.16 149.16 69.34 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.952 0.901 . . . . 0.0 109.802 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 31.3 Cg_exo -61.24 149.1 90.91 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.987 2.458 . . . . 0.0 112.965 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 31' ' ' PRO . 19.5 Cg_exo -67.01 -165.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.844 3.029 . . . . 0.0 113.528 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.4 p -52.45 133.07 35.52 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 112.043 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -70.53 172.09 9.09 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.946 0.899 . . . . 0.0 112.282 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.6 p -91.88 127.69 37.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.44 0.696 . . . . 0.0 109.612 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.4 p -80.76 159.08 25.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.166 0.587 . . . . 0.0 110.905 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -65.75 160.63 22.53 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.68 0.792 . . . . 0.0 112.146 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -90.23 16.73 8.07 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.735 0.814 . . . . 0.0 112.823 -173.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.33 61.63 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 16.3 mm-40 -83.6 -17.12 42.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.537 0.335 . . . . 0.0 111.22 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.89 -30.81 64.23 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.025 0.53 . . . . 0.0 109.682 167.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.77 -36.45 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.113 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.9 tpp180 -64.65 -39.15 93.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.226 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 tp -76.54 -31.46 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.156 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -61.46 -36.14 79.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.694 . . . . 0.0 109.777 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.75 -36.89 76.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.461 0.704 . . . . 0.0 111.545 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -65.02 -39.66 93.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.02 0.373 . . . . 0.0 110.383 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 t -86.51 -21.7 26.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.135 0.574 . . . . 0.0 111.915 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.07 92.8 4.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 109.407 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.65 -116.03 2.81 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.763 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.26 120.31 1.04 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -81.29 127.0 32.24 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 117.135 0.467 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -81.64 156.49 25.09 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.7 0.8 . . . . 0.0 111.163 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -91.51 121.9 33.61 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.334 0.654 . . . . 0.0 109.667 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.6 t -72.36 132.84 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.759 0.424 . . . . 0.0 109.933 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.46 117.8 34.95 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.946 0.898 . . . . 0.0 109.391 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.9 tp -74.74 140.35 44.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.231 1.013 . . . . 0.0 111.781 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.21 133.28 38.94 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.872 0.869 . . . . 0.0 109.952 173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -79.78 140.63 36.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.684 0.794 . . . . 0.0 109.812 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.0 p -68.68 158.22 34.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.878 0.871 . . . . 0.0 112.123 -174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.637 HG21 ' HA3' ' A' ' 94' ' ' GLY . 8.7 t -51.67 147.14 6.84 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.064 1.346 . . . . 0.0 113.016 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 26.4 m -131.73 150.01 52.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.991 0.917 . . . . 0.0 109.043 -174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.95 136.63 52.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.44 0.696 . . . . 0.0 109.381 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.486 HD21 ' HB1' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -109.16 95.58 5.73 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.617 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -79.32 138.26 20.32 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 103.464 -2.791 . . . . 0.0 103.464 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.95 133.84 33.85 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 111.208 -2.724 . . . . 0.0 105.006 148.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.21 122.2 75.57 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.44 1.096 . . . . 0.0 109.745 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.89 -10.24 27.27 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.476 2.117 . . . . 0.0 112.477 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.05 -69.72 0.69 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.782 0.833 . . . . 0.0 110.814 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.1 p -90.96 -10.32 42.82 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.322 0.649 . . . . 0.0 112.402 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.04 34.18 14.08 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.706 1.202 . . . . 0.0 111.865 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -111.58 159.5 18.09 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.721 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -86.6 158.19 19.55 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -156.09 99.89 1.98 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -97.23 103.29 15.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.0 151.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.19 -1.823 . . . . 0.0 109.147 -171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -69.05 153.37 43.89 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.782 0.676 . . . . 0.0 110.272 -175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 121' ' ' ILE . 25.3 mt -88.18 131.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.43 -75.82 0.43 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.75 151.2 19.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.0 141.84 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -104.11 -55.79 2.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.855 0.862 . . . . 0.0 108.827 -176.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 40.7 tt0 -75.89 97.82 4.05 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.4 p -70.08 115.64 36.21 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.053 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.53 168.4 24.54 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.827 2.351 . . . . 0.0 112.492 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.63 -29.86 66.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.237 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.1 p-10 -95.6 54.86 1.61 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.771 0.829 . . . . 0.0 109.881 169.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.29 -46.18 72.67 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.352 0.661 . . . . 0.0 109.536 177.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -29.75 69.1 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.234 0.614 . . . . 0.0 112.28 -168.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 87' ' ' ASN . 82.8 mt -74.12 -48.27 30.61 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.425 174.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.73 -24.04 54.99 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 54.8 mtm180 -70.12 -39.0 75.7 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.706 0.402 . . . . 0.0 110.436 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -69.76 -19.51 63.52 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.321 172.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 101.58 4.93 52.19 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.118 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -84.3 88.79 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 mt -100.79 143.22 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.237 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.24 142.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 111' ' ' VAL . 3.3 tmt_? -57.7 127.67 33.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.774 0.829 . . . . 0.0 110.765 -173.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.97 -14.75 34.08 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.043 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.94 140.03 30.69 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.103 0.478 . . . . 0.0 110.766 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.0 mptt -82.29 137.49 34.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 108' ' ' LEU . 1.9 tt -134.21 153.15 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.262 1.425 . . . . 0.0 108.81 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HG3' HD21 ' A' ' 82' ' ' LEU . 68.1 mtt180 -111.18 130.56 55.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -110.46 173.2 6.44 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.69 -26.05 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.651 0.38 . . . . 0.0 111.449 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.88 -64.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 0.0 111.586 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.3 -177.28 36.1 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.822 -175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' ILE . 58.3 tp -64.93 130.53 43.77 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 164.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.15 165.79 24.58 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.569 1.147 . . . . 0.0 108.999 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 126' ' ' LEU . 9.1 p -116.66 133.56 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.874 0.87 . . . . 0.0 109.041 170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 98' ' ' ARG . 24.8 m -69.1 107.91 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.948 0.88 . . . . 0.0 110.275 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.2 p -91.71 -1.06 57.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.51 1.124 . . . . 0.0 112.462 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 34.6 t -140.17 174.5 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.834 0.853 . . . . 0.0 109.342 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.62 157.31 72.41 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.769 0.828 . . . . 0.0 110.973 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 121' ' ' ILE . 50.7 Cg_endo -69.59 119.24 6.23 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.723 2.282 . . . . 0.0 111.83 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.67 172.84 52.45 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 116.015 -0.538 . . . . 0.0 113.232 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.72 -17.86 61.58 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.934 0.894 . . . . 0.0 111.78 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.75 -20.59 61.86 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.852 0.861 . . . . 0.0 111.253 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.34 58.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.691 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 62' ' ' THR . 38.9 t -111.57 131.92 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.786 0.834 . . . . 0.0 109.399 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.448 HD13 HD11 ' A' ' 78' ' ' ILE . 1.2 mp -120.93 122.9 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.557 0.743 . . . . 0.0 109.077 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 11.3 m120 -68.58 132.4 46.87 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.618 0.367 . . . . 0.0 110.298 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.87 168.2 17.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.81 0.844 . . . . 0.0 111.247 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 t -127.84 132.41 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.951 0.9 . . . . 0.0 108.878 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.617 ' HG ' HG11 ' A' ' 65' ' ' VAL . 78.1 mt -62.24 124.77 21.75 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.397 0.435 . . . . 0.0 110.523 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 110' ' ' VAL . 95.5 mt -82.97 13.49 3.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.821 0.848 . . . . 0.0 111.293 171.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.419 ' HD3' HD13 ' A' ' 125' ' ' LEU . 50.1 mtpt -66.74 85.71 0.12 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.984 0.914 . . . . 0.0 109.92 171.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -155.66 153.75 30.51 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.945 0.898 . . . . 0.0 108.9 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -76.26 105.26 7.21 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.451 0.643 . . . . 0.0 109.613 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -62.34 -30.3 71.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 0.0 111.074 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -101.68 112.63 25.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.739 0.816 . . . . 0.0 109.447 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -166.64 99.12 0.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.65 0.78 . . . . 0.0 109.782 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 C--O 1.257 1.457 0 C-N-CA 124.662 1.185 . . . . 0.0 108.342 176.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.5 177.17 41.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -85.61 124.14 31.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.813 0.445 . . . . 0.0 110.21 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -152.1 -179.02 7.14 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.198 0.999 . . . . 0.0 109.739 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -159.07 149.05 19.14 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 0.0 110.18 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.07 -141.26 4.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.838 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.04 101.23 0.48 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.721 2.281 . . . . 0.0 111.688 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.42 123.91 19.96 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.182 0.593 . . . . 0.0 110.623 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -125.74 127.92 46.95 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -121.85 136.13 54.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.122 0.969 . . . . 0.0 109.713 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.96 153.31 44.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.235 0.614 . . . . 0.0 110.605 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.57 173.16 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.774 0.83 . . . . 0.0 110.565 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 98.0 m -132.69 120.08 21.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 109.196 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.24 93.71 0.42 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.16 158.93 51.78 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -132.98 111.73 11.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.33 0.565 . . . . 0.0 109.52 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -150.0 127.73 11.7 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.646 1.178 . . . . 0.0 108.434 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.5 -165.29 20.75 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.601 0.563 . . . . 0.0 112.956 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.6 176.7 8.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.959 0.504 . . . . 0.0 109.996 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -124.44 157.88 34.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.413 0.685 . . . . 0.0 110.135 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -100.58 -175.41 2.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.512 0.725 . . . . 0.0 109.788 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -131.9 160.49 35.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.627 0.771 . . . . 0.0 110.423 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -73.16 81.65 1.3 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -67.68 135.13 52.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.195 0.998 . . . . 0.0 110.812 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -87.1 114.81 24.03 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.602 0.761 . . . . 0.0 110.282 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -148.04 -175.25 4.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.797 0.839 . . . . 0.0 109.49 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.74 118.35 10.88 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.963 0.505 . . . . 0.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mm -63.73 114.18 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.263 1.025 . . . . 0.0 111.489 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.91 -132.64 2.7 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.8 132.87 38.98 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.27 118.47 4.95 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.265 1.977 . . . . 0.0 111.253 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.88 101.19 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.93 2.42 . . . . 0.0 112.103 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 m -111.21 92.44 4.04 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.642 0.777 . . . . 0.0 109.551 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -82.6 130.96 35.21 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.847 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 t -79.76 132.03 36.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.813 0.445 . . . . 0.0 109.87 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -92.05 -72.4 0.59 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.957 0.503 . . . . 0.0 110.576 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.08 171.73 18.77 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.233 0.539 . . . . 0.0 112.066 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 t -124.07 19.0 9.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.667 1.187 . . . . 0.0 108.548 166.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -65.78 -23.17 66.65 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.932 0.893 . . . . 0.0 111.994 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.37 -35.81 76.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.434 0.694 . . . . 0.0 111.474 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.3 m-20 -66.33 -36.43 82.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.609 0.764 . . . . 0.0 110.285 175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mt -74.8 -24.86 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 19.6 mmm180 -82.6 -21.37 35.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.453 0.701 . . . . 0.0 111.681 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 41' ' ' ASP . 3.6 tp -81.18 -31.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -67.71 -24.79 65.42 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.45 169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 32.3 t70 -84.45 -27.92 27.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.993 0.917 . . . . 0.0 111.035 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 16.2 ptt180 -68.05 -38.72 82.79 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.417 0.553 . . . . 0.0 109.56 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -81.01 -10.46 59.7 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.357 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.05 -60.32 2.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.151 0.581 . . . . 0.0 109.732 172.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.05 60.43 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.698 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.83 -145.78 40.57 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.944 0.438 . . . . 0.0 112.796 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -97.69 134.08 41.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.545 0.738 . . . . 0.0 109.223 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -106.95 134.92 49.37 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.134 0.974 . . . . 0.0 110.343 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 60.04 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.695 1.598 . . . . 0.0 112.691 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.39 137.03 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.127 0.571 . . . . 0.0 110.329 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -91.29 149.01 21.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.496 0.719 . . . . 0.0 109.467 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.04 136.84 45.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.535 0.734 . . . . 0.0 109.873 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -61.95 1.46 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.954 0.501 . . . . 0.0 110.86 -176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -154.52 157.18 37.95 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.997 0.519 . . . . 0.0 110.561 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -117.03 141.39 48.31 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.359 0.664 . . . . 0.0 110.979 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 78' ' ' ILE . 75.1 m -127.4 89.73 3.01 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.56 ' HB ' HG22 ' A' ' 120' ' ' VAL . 14.9 m -135.03 147.56 49.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.327 0.651 . . . . 0.0 110.431 -169.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.59 163.73 15.36 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.701 1.2 . . . . 0.0 109.428 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.475 HD21 ' HB1' ' A' ' 73' ' ' ALA . 3.6 t30 -131.86 90.97 2.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 26.4 m -80.77 128.81 38.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.82 130.22 37.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 147.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -99.74 106.64 41.62 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.12 -12.62 33.33 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.061 2.507 . . . . 0.0 114.355 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.33 -48.39 42.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.747 0.419 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -107.21 -6.45 17.29 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.143 0.577 . . . . 0.0 111.474 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 55.9 53.7 8.97 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.495 1.518 . . . . 0.0 111.486 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.6 p -135.67 135.83 40.42 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.959 0.904 . . . . 0.0 110.16 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -83.45 149.83 26.41 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -150.64 119.16 6.47 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.825 1.25 . . . . 0.0 107.831 -165.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HD3' HG21 ' A' ' 120' ' ' VAL . 35.3 ttmt -102.4 105.28 15.84 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -176.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.74 155.79 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.325 1.45 . . . . 0.0 109.492 -171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -65.11 151.11 46.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.812 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' HG22 ' A' ' 61' ' ' THR . 78.5 mt -85.73 126.43 40.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -97.94 -82.16 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -145.92 143.97 29.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -165.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.514 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.23 129.68 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.125 0.57 . . . . 0.0 110.131 176.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -86.41 -49.0 7.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.5 tp10 -82.48 108.38 15.85 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.8 p -81.21 112.99 37.79 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.38 166.1 30.78 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.783 2.322 . . . . 0.0 112.385 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.53 -28.22 69.7 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.519 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.9 p-10 -97.06 50.21 1.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.834 0.854 . . . . 0.0 109.781 170.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 -41.68 61.94 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.942 0.897 . . . . 0.0 110.43 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HA ' ' HE ' ' A' ' 92' ' ' ARG . 11.9 pt-20 -62.41 -28.17 69.6 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.66 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -75.35 -51.33 13.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.171 0.988 . . . . 0.0 109.841 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.76 -21.77 43.19 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' HE ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mtm105 -70.01 -38.62 76.0 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.832 0.453 . . . . 0.0 110.51 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -69.37 -17.18 63.66 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.83 0.852 . . . . 0.0 110.794 171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 104.05 -2.23 44.33 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.641 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 115' ' ' PRO . 51.0 mm -81.39 83.87 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 122.087 0.946 . . . . 0.0 109.072 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.0 mt -97.53 143.56 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.063 -171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 tt -96.84 146.09 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.72 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HA ' HG23 ' A' ' 111' ' ' VAL . 53.8 ttt180 -55.47 130.16 41.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.946 0.898 . . . . 0.0 112.264 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.97 -7.14 25.51 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 123.787 0.679 . . . . 0.0 112.83 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -102.11 135.19 44.13 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.307 0.643 . . . . 0.0 111.396 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.4 mptt -77.36 143.03 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.18 0.592 . . . . 0.0 109.902 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 tt -134.46 158.69 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 125.671 1.589 . . . . 0.0 107.94 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 82' ' ' LEU . 84.3 mtt180 -118.03 131.22 56.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.4 p -120.96 179.35 4.4 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.406 0.682 . . . . 0.0 110.197 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.47 -27.8 67.84 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.31 0.644 . . . . 0.0 111.427 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.99 -71.46 0.35 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.341 0.656 . . . . 0.0 110.4 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.5 -160.1 11.78 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.26 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 tp -70.62 130.68 42.43 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.38 164.54 27.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.636 0.774 . . . . 0.0 110.218 172.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.5 p -111.93 129.48 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 165.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 98' ' ' ARG . 35.7 m -67.93 118.07 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 118.706 0.685 . . . . 0.0 109.793 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.4 p -108.74 14.4 24.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.332 1.053 . . . . 0.0 111.836 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 24.0 t -153.16 171.12 18.97 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.979 0.912 . . . . 0.0 109.247 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -80.68 168.41 25.56 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 123.092 0.557 . . . . 0.0 109.861 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.548 ' HG2' HG23 ' A' ' 95' ' ' ILE . 51.8 Cg_exo -56.48 117.01 3.6 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.522 2.148 . . . . 0.0 112.637 169.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.82 167.34 54.5 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.532 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -66.58 -20.33 65.98 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.486 0.714 . . . . 0.0 111.703 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.33 -1.77 19.38 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.274 0.63 . . . . 0.0 111.353 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.97 26.53 62.11 Favored Glycine 0 C--N 1.358 1.798 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG22 ' HB ' ' A' ' 62' ' ' THR . 91.1 t -128.94 125.6 63.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 123.921 0.888 . . . . 0.0 110.365 -169.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.3 mp -101.81 109.88 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 12.9 t-20 -64.87 135.07 55.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.373 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.02 169.53 16.98 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.644 1.178 . . . . 0.0 111.363 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.39 126.65 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.327 1.051 . . . . 0.0 109.579 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.7 mt -65.17 131.85 47.61 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 111.622 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.94 94.1 2.54 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.826 0.85 . . . . 0.0 110.499 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -71.52 86.29 0.87 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.863 0.84 . . . . 0.0 108.821 167.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -117.16 161.47 19.4 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.795 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.61 85.23 3.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.4 t -73.13 151.29 41.64 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.626 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.46 120.98 15.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.94 92.29 1.8 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.6 m . . . . . 0 C--O 1.249 1.064 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.387 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.25 8.67 86.09 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.874 -0.403 . . . . 0.0 114.089 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -134.69 96.54 3.57 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -67.47 -15.82 63.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.192 0.997 . . . . 0.0 113.179 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 79.45 -21.65 0.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.964 1.306 . . . . 0.0 113.287 169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.19 80.21 0.35 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.73 -9.23 11.09 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.833 2.355 . . . . 0.0 113.526 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -115.42 145.3 42.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.036 0.934 . . . . 0.0 110.651 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -150.58 138.81 20.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.684 1.194 . . . . 0.0 108.283 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.04 134.59 37.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.068 0.461 . . . . 0.0 111.202 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.57 156.69 19.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.017 0.927 . . . . 0.0 109.243 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -148.82 121.06 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.134 0.492 . . . . 0.0 110.22 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.8 m -144.88 121.14 10.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.816 0.846 . . . . 0.0 108.898 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.5 162.74 49.55 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.338 0.398 . . . . 0.0 112.18 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.94 -148.35 5.81 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -162.86 157.26 21.07 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.455 0.702 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -167.07 133.68 2.31 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.88 130.49 5.5 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -86.25 108.73 18.52 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.547 0.739 . . . . 0.0 110.203 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -88.74 127.85 35.61 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.63 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.28 143.82 42.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.966 0.906 . . . . 0.0 109.751 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -128.51 123.87 34.64 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.211 0.604 . . . . 0.0 110.013 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -94.86 149.0 21.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.765 0.826 . . . . 0.0 109.724 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -97.99 165.58 11.84 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.197 0.599 . . . . 0.0 110.383 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -115.51 159.22 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.781 0.832 . . . . 0.0 110.001 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -121.63 172.02 8.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.246 0.618 . . . . 0.0 110.187 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.36 140.02 53.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 0.0 110.348 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.7 mm -126.27 107.88 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.86 42.5 0.91 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.42 127.1 59.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.594 0.757 . . . . 0.0 109.809 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -85.68 111.97 1.25 Allowed 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 122.449 2.099 . . . . 0.0 112.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.73 102.53 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.938 2.425 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.3 m -81.45 90.02 6.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.463 0.705 . . . . 0.0 109.901 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.17 141.21 50.71 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.223 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 p -86.75 140.4 29.78 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.4 p -71.45 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.869 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -177.51 157.2 1.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.589 0.755 . . . . 0.0 111.378 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.7 m -126.4 9.2 7.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.535 1.134 . . . . 0.0 109.923 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.19 -46.99 75.4 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.719 0.807 . . . . 0.0 112.224 -174.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.11 -17.28 61.42 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.091 0.244 . . . . 0.0 111.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.6 t70 -70.44 -36.99 74.27 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.23 -35.51 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.873 0.469 . . . . 0.0 112.133 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 41' ' ' ASP . 5.4 tp -79.42 -34.18 15.92 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 58.0 mttm -64.36 -31.29 72.44 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.181 169.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -69.99 -49.94 46.59 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.382 1.073 . . . . 0.0 111.892 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -70.56 -25.48 63.11 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -74.39 -2.48 25.51 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.55 156.2 35.28 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 166.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.96 -153.34 5.94 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.2 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.08 134.15 2.66 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.3 151.83 23.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.437 0.695 . . . . 0.0 110.909 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.34 164.36 18.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.667 0.787 . . . . 0.0 110.723 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -76.5 164.67 25.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.948 0.899 . . . . 0.0 112.2 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -116.24 132.07 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.904 0.882 . . . . 0.0 110.019 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -126.67 134.21 50.77 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.962 0.905 . . . . 0.0 110.028 178.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -160.92 128.3 4.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.759 0.824 . . . . 0.0 110.097 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -95.13 100.88 12.62 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.701 0.8 . . . . 0.0 109.988 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -73.07 101.47 3.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -70.05 122.15 18.84 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.075 0.55 . . . . 0.0 111.172 -170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.1 m -78.78 118.71 21.1 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 4.0 m -133.69 164.08 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 0.0 108.024 -168.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.3 132.53 55.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.42 97.37 8.12 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 t -80.45 130.84 35.3 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 N-CA-C 101.403 -3.555 . . . . 0.0 101.403 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.75 121.38 25.27 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 144.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.6 101.08 9.42 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.13 -23.15 60.75 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.319 2.68 . . . . 0.0 114.459 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.41 -42.2 88.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.894 0.478 . . . . 0.0 111.184 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.4 p -107.32 -5.34 17.86 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.682 0.793 . . . . 0.0 111.409 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 66.16 15.81 10.22 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.753 1.621 . . . . 0.0 111.807 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.1 p -118.39 130.75 56.16 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.502 -0.749 . . . . 0.0 110.896 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 124.6 32.19 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.611 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 6.6 ptpp? -116.41 153.43 32.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.181 0.993 . . . . 0.0 109.393 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HD2' HG21 ' A' ' 120' ' ' VAL . 27.8 ttpt -110.46 110.17 20.83 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 0.9 OUTLIER -128.72 148.8 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.966 1.306 . . . . 0.0 109.746 -172.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -64.41 150.07 47.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.133 -171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.92 122.9 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -88.29 -73.92 0.47 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.09 153.9 24.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.22 139.67 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 172.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -93.55 -53.07 4.2 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.9 tp10 -84.36 113.36 21.1 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 p -76.03 119.61 78.0 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.09 0.556 . . . . 0.0 110.294 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.82 165.05 30.81 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.835 2.357 . . . . 0.0 113.016 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.55 -32.95 74.82 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.478 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.635 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -93.25 57.99 2.78 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.234 1.016 . . . . 0.0 109.389 170.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -39.06 79.76 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.074 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.2 pm0 -63.81 -28.64 70.0 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.635 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.2 mm? -76.0 -47.3 25.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.12 -19.42 44.44 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -76.56 -29.22 56.57 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.531 0.732 . . . . 0.0 110.936 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -79.95 -9.59 59.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.327 0.651 . . . . 0.0 109.881 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.79 -3.18 73.87 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 123.953 0.787 . . . . 0.0 112.85 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 48.6 mm -81.25 85.48 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.306 1.042 . . . . 0.0 109.03 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.6 mt -94.07 149.97 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.87 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.85 146.85 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.843 0.857 . . . . 0.0 109.761 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.43 130.09 44.88 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 110.692 -173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.52 -1.39 39.69 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.292 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -100.08 135.76 41.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.861 0.465 . . . . 0.0 109.93 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 13.6 mptt -76.48 140.37 41.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.7 tt -130.69 156.81 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 108.336 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.1 mtm180 -115.8 128.92 56.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 169.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 76' ' ' VAL . 68.0 p -114.41 179.93 3.81 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.105 0.962 . . . . 0.0 108.426 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.52 -15.32 63.22 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.079 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -78.91 -69.23 0.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.797 0.839 . . . . 0.0 110.215 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.22 -162.63 16.76 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.461 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.643 ' H ' ' HD3' ' A' ' 127' ' ' LYS . 62.7 tp -71.76 127.44 32.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 164.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.49 167.24 21.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.307 1.043 . . . . 0.0 109.667 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' HD21 ' A' ' 126' ' ' LEU . 9.1 p -110.31 132.37 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 166.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 100' ' ' ALA . 24.1 m -67.32 111.51 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -112.84 12.81 19.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.291 -170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 37.2 t -142.51 172.7 12.33 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.386 0.674 . . . . 0.0 110.504 175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.58 148.36 65.68 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.79 0.836 . . . . 0.0 110.697 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' HG13 ' A' ' 121' ' ' ILE . 78.3 Cg_exo -54.16 116.75 3.26 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.015 2.477 . . . . 0.0 112.468 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 161.92 54.41 Favored Glycine 0 C--N 1.343 0.963 0 O-C-N 123.68 0.612 . . . . 0.0 111.747 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.14 -23.61 64.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.32 0.648 . . . . 0.0 111.753 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -73.9 -11.22 60.29 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.44 1.096 . . . . 0.0 111.204 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.42 20.12 28.2 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG21 ' HD2' ' A' ' 75' ' ' LYS . 95.7 t -114.42 123.06 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.837 0.455 . . . . 0.0 111.091 -172.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.7 mp -108.74 111.29 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 25.7 t-20 -67.69 139.05 56.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.378 0.671 . . . . 0.0 110.919 -176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -134.07 162.17 32.82 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.775 1.23 . . . . 0.0 111.413 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.53 131.87 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.252 1.021 . . . . 0.0 109.669 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 109' ' ' ALA . 94.7 mt -68.14 115.23 7.39 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.888 0.313 . . . . 0.0 110.292 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -115.19 25.4 10.9 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.291 0.636 . . . . 0.0 109.51 170.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 108' ' ' LEU . 29.7 ttpp -70.09 92.9 0.77 Allowed 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.263 0.625 . . . . 0.0 109.556 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -72.74 81.46 1.14 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.414 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.99 78.94 8.14 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 122.158 0.98 . . . . 0.0 110.199 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.0 p -72.46 128.63 36.18 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.394 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.02 84.8 0.52 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.634 0.774 . . . . 0.0 109.687 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -159.14 81.4 0.77 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.249 1.053 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.169 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -163.59 32.99 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.19 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -117.26 134.12 55.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.685 0.794 . . . . 0.0 109.153 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -119.74 107.56 13.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.533 0.733 . . . . 0.0 109.34 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -154.56 158.93 40.53 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.787 0.835 . . . . 0.0 110.181 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.0 136.73 8.89 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.771 -1.016 . . . . 0.0 110.798 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.57 131.03 30.04 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.892 2.395 . . . . 0.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.02 147.55 48.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.706 0.802 . . . . 0.0 110.814 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -87.19 143.86 27.1 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.654 0.381 . . . . 0.0 110.552 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -110.65 157.96 19.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.581 0.753 . . . . 0.0 109.459 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -65.96 122.25 16.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.22 0.608 . . . . 0.0 111.191 -173.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.6 mm -80.43 126.66 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.624 0.77 . . . . 0.0 110.252 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -136.97 106.63 6.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 109.071 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.77 -173.11 49.7 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 112.458 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.23 152.42 41.71 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 123.379 0.105 . . . . 0.0 113.254 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.7 tp -116.65 35.31 4.63 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.39 127.68 33.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.717 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.61 -93.39 0.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 -171.26 3.66 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.579 0.751 . . . . 0.0 109.5 -173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -81.36 124.36 29.32 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -77.22 -70.44 0.47 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.23 0.538 . . . . 0.0 111.615 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -104.2 160.36 14.94 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.629 -162.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.57 -170.04 1.7 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.393 1.477 . . . . 0.0 107.779 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -94.71 97.16 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -63.81 -32.78 74.4 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.65 1.18 . . . . 0.0 112.667 -161.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -147.26 51.54 1.07 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 110.453 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.05 123.59 18.96 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.489 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mt -121.58 96.05 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.27 44.44 1.11 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.29 130.67 61.49 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.015 0.926 . . . . 0.0 109.572 -174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.22 112.91 3.66 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.49 2.127 . . . . 0.0 110.86 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.15 166.27 30.16 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.436 2.09 . . . . 0.0 111.333 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.4 p -66.15 96.05 0.31 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -64.06 116.75 6.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.218 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -73.33 154.92 39.9 Favored 'General case' 0 C--O 1.247 0.949 0 O-C-N 123.768 0.668 . . . . 0.0 110.019 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -63.7 132.71 51.89 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 pp -67.59 -173.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.866 0.466 . . . . 0.0 110.858 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 42' ' ' ILE . 22.7 m -81.51 18.47 1.18 Allowed 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -166.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.08 -57.57 11.6 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.482 0.713 . . . . 0.0 112.398 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.37 -27.94 66.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.753 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 44' ' ' ILE . 33.4 t70 -71.3 -36.42 71.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.071 0.548 . . . . 0.0 110.91 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 38' ' ' SER . 43.5 mm -72.54 -38.43 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 2.6 mpt_? -71.77 -22.5 61.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.057 0.543 . . . . 0.0 112.198 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 41' ' ' ASP . 8.8 tp -79.47 -37.62 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -84.98 3.15 39.82 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 122.175 -0.328 . . . . 0.0 111.514 172.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 20.5 t70 -102.22 -18.61 15.42 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.282 1.033 . . . . 0.0 108.748 170.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 44' ' ' ILE . 5.3 ttt-85 -67.31 -51.28 54.44 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 45' ' ' LYS . 10.0 t -61.67 -35.33 77.67 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -164.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -84.68 151.1 24.67 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.0 87.07 0.63 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.26 148.31 45.57 Favored Glycine 0 C--N 1.343 0.961 0 O-C-N 123.694 0.291 . . . . 0.0 113.703 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -82.58 143.74 30.83 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.67 0.788 . . . . 0.0 110.306 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.254 0.622 . . . . 0.0 109.754 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -73.64 166.55 23.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -84.43 137.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.709 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -84.95 144.08 28.56 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.93 161.71 20.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.557 0.743 . . . . 0.0 109.803 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -87.99 -68.94 0.73 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.284 0.634 . . . . 0.0 109.88 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -174.34 165.28 3.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.998 0.919 . . . . 0.0 110.15 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 155.29 18.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.531 0.732 . . . . 0.0 109.108 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.1 t -71.42 129.98 40.16 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 17.7 m -127.99 155.1 44.82 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.876 0.871 . . . . 0.0 108.766 -171.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -125.57 132.74 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.41 0.684 . . . . 0.0 109.228 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.46 HD21 ' HB1' ' A' ' 73' ' ' ALA . 7.8 t30 -105.51 96.17 6.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 29.6 m -80.46 122.92 36.52 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.32 124.15 23.08 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 146.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.17 102.53 9.68 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.72 -14.4 40.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.224 2.616 . . . . 0.0 114.301 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.8 76.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.333 0.653 . . . . 0.0 111.38 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.2 p -114.54 -1.9 13.28 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.129 0.572 . . . . 0.0 111.269 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 53.95 49.68 18.45 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.354 1.462 . . . . 0.0 111.397 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 p -134.56 144.43 47.96 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.888 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.46 151.95 23.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.978 0.511 . . . . 0.0 110.453 -173.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.403 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.6 ttmm -147.28 115.32 6.53 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -100.24 104.66 16.17 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.35 148.59 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.147 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -68.85 152.95 44.64 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.401 0.68 . . . . 0.0 110.945 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.5 mt -85.86 129.71 37.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.91 -74.92 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -161.92 150.74 15.49 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.138 0.881 . . . . 0.0 113.028 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.512 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -87.85 120.62 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -81.62 -66.3 0.91 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 0.0 109.816 -175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.17 104.26 6.61 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -79.34 116.11 58.02 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.998 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.38 165.78 25.83 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.517 2.144 . . . . 0.0 111.57 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.64 -30.86 61.7 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.271 0.557 . . . . 0.0 110.615 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.477 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.3 p-10 -97.52 43.12 1.07 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.88 1.272 . . . . 0.0 110.85 173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -33.88 69.54 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.78 -36.1 46.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.78 0.832 . . . . 0.0 112.285 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 80.7 mt -84.8 -46.94 10.89 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.744 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.09 -32.47 22.44 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -77.1 -28.5 54.52 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.254 0.622 . . . . 0.0 111.857 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 63.6 mtp180 -68.95 -22.43 64.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.31 0.644 . . . . 0.0 109.559 168.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.34 -2.18 29.56 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.164 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 38.0 mm -87.99 83.08 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.557 0.743 . . . . 0.0 109.373 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.4 mt -98.3 141.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.05 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 tt -95.55 139.94 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.331 0.652 . . . . 0.0 109.732 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -51.56 115.26 1.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.481 1.113 . . . . 0.0 111.798 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.21 -7.48 14.47 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.696 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.36 132.57 35.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.877 0.471 . . . . 0.0 109.927 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -79.95 143.41 34.2 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.053 0.454 . . . . 0.0 109.829 -174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.2 tt -144.33 153.49 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.092 1.357 . . . . 0.0 108.403 -171.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.475 ' HG3' HD21 ' A' ' 82' ' ' LEU . 11.1 mtm180 -112.6 130.86 55.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.1 p -114.14 179.52 3.93 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.73 -15.14 61.22 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 122.378 -0.201 . . . . 0.0 111.434 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.55 -65.92 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.107 0.563 . . . . 0.0 109.662 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.01 -162.86 15.7 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.949 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.35 127.61 33.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -130.25 158.7 39.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.902 0.881 . . . . 0.0 110.515 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.45 124.83 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.322 1.049 . . . . 0.0 108.328 170.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.89 120.39 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 121.255 0.55 . . . . 0.0 110.206 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 p -113.56 14.01 18.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.857 0.863 . . . . 0.0 111.704 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 65.9 m -145.21 173.63 11.77 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.252 1.021 . . . . 0.0 109.88 171.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -77.66 162.36 68.48 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.228 0.611 . . . . 0.0 109.536 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 121' ' ' ILE . 71.2 Cg_exo -56.24 119.28 6.36 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.807 2.338 . . . . 0.0 112.673 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.38 163.25 54.81 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.192 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.08 -17.01 61.01 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.857 0.863 . . . . 0.0 112.822 -172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.579 ' HB2' HG12 ' A' ' 120' ' ' VAL . 19.0 m-20 -75.7 -14.94 60.35 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.629 0.371 . . . . 0.0 111.653 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.43 7.15 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -171.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.2 p -136.56 129.79 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 123.869 0.868 . . . . 0.0 109.773 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 115' ' ' PRO . 1.8 mp -108.26 116.65 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 31.9 m-80 -64.73 130.44 43.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.595 0.358 . . . . 0.0 111.221 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.59 169.01 16.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 110.738 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.12 126.86 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.003 0.921 . . . . 0.0 109.44 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 109' ' ' ALA . 92.9 mt -65.05 125.38 24.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.29 10.26 3.86 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.49 0.316 . . . . 0.0 111.014 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 89.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.153 0.981 . . . . 0.0 109.689 168.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -89.38 147.9 23.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.213 1.005 . . . . 0.0 109.955 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -74.18 83.89 1.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.087 0.946 . . . . 0.0 109.183 171.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.3 p -100.83 29.7 4.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.704 0.802 . . . . 0.0 110.759 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.96 -39.98 95.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.46 0.704 . . . . 0.0 109.599 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -87.98 78.19 8.29 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.139 170.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 C--O 1.25 1.126 0 C-N-CA 123.432 0.693 . . . . 0.0 109.998 178.292 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.05 174.51 47.64 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.746 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -131.25 154.01 48.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 110.042 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -88.59 90.51 8.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.501 0.72 . . . . 0.0 109.524 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.87 120.2 27.9 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.12 137.58 2.25 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.572 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.1 109.31 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.253 2.635 . . . . 0.0 112.758 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -133.05 96.68 3.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.099 0.96 . . . . 0.0 109.828 -172.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 64.87 7.14 3.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.808 1.243 . . . . 0.0 113.947 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -83.01 116.18 22.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.63 150.5 28.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.766 . . . . 0.0 110.613 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.5 pt -79.51 147.56 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.423 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -133.46 126.53 31.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.428 0.691 . . . . 0.0 109.41 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.4 -136.34 3.06 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.5 57.68 3.45 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.973 0.387 . . . . 0.0 112.715 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.57 -30.94 47.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.134 0.573 . . . . 0.0 109.506 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.04 118.71 31.05 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.17 45.72 1.27 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 123.076 0.235 . . . . 0.0 113.075 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -81.55 106.14 13.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.981 0.512 . . . . 0.0 110.118 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -107.58 136.7 46.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.49 0.716 . . . . 0.0 110.497 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -70.26 142.91 52.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.552 1.141 . . . . 0.0 110.966 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.12 132.81 48.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -107.92 159.04 16.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.33 0.652 . . . . 0.0 110.582 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -81.4 -1.69 46.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.405 0.682 . . . . 0.0 111.848 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -65.15 113.05 3.69 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.352 0.661 . . . . 0.0 110.214 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -82.22 71.97 9.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.694 0.797 . . . . 0.0 109.27 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -72.64 101.0 2.93 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.906 -173.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -82.32 87.67 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.501 0.72 . . . . 0.0 109.681 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.78 -20.67 49.89 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.157 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -76.85 129.18 79.67 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.372 0.669 . . . . 0.0 110.203 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.92 160.52 45.8 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.945 2.43 . . . . 0.0 111.358 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.79 84.28 0.41 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.591 2.194 . . . . 0.0 112.07 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 p -94.43 155.1 17.12 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.309 1.044 . . . . 0.0 110.295 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.27 94.4 0.37 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.62 0.768 . . . . 0.0 110.501 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 m -97.51 116.54 29.92 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.8 p -98.74 173.66 6.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.223 0.609 . . . . 0.0 111.003 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD22 ' HG3' ' A' ' 40' ' ' GLU . 5.4 tt -70.61 94.99 1.04 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.959 0.904 . . . . 0.0 109.508 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.3 m -103.42 14.22 31.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.165 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.5 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.171 0.588 . . . . 0.0 110.887 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' A' ' 37' ' ' LEU . 44.7 mt-10 -60.33 -34.42 73.8 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.139 0.976 . . . . 0.0 110.987 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.6 m-20 -67.54 -36.5 81.1 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.352 1.061 . . . . 0.0 110.475 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.85 -40.88 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -68.15 -26.2 65.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.863 0.865 . . . . 0.0 112.126 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 44' ' ' ILE . 5.5 tp -82.0 -36.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 121.704 0.764 . . . . 0.0 109.735 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -74.33 -14.73 60.93 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.101 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.46 -33.21 19.12 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.083 0.953 . . . . 0.0 110.479 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 48' ' ' THR . 6.2 ptt180 -68.67 -35.88 77.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 117.836 0.289 . . . . 0.0 110.454 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.7 t -75.82 -26.92 57.68 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.403 0.281 . . . . 0.0 111.241 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 tp -78.25 -55.18 5.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.879 0.472 . . . . 0.0 110.708 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.44 -15.49 60.18 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.712 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -73.11 80.79 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.24 166.02 14.06 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.015 0.926 . . . . 0.0 110.656 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -89.56 114.39 25.94 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -71.7 105.98 3.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.69 147.84 4.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.223 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -95.07 102.49 14.3 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -92.1 167.03 12.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.44 0.696 . . . . 0.0 111.031 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -76.12 149.37 37.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.011 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -65.51 101.4 0.59 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -64.23 158.88 22.04 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.96 0.904 . . . . 0.0 111.77 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.3 m -59.17 128.48 37.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.727 0.811 . . . . 0.0 110.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.9 m -126.03 151.29 47.31 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 109.492 -167.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.5 129.34 56.57 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 7.1 t30 -100.42 93.29 5.57 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 34.3 m -80.32 140.9 16.01 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 101.975 -3.342 . . . . 0.0 101.975 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -86.6 128.06 34.96 Favored 'General case' 0 C--O 1.249 1.046 0 N-CA-C 102.194 -3.261 . . . . 0.0 102.194 145.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 125' ' ' LEU . 17.8 t70 -101.2 103.49 26.46 Favored Pre-proline 0 N--CA 1.463 0.197 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 56.2 Cg_endo -68.27 -13.7 38.48 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.0 2.467 . . . . 0.0 113.203 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -42.25 83.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.081 0.552 . . . . 0.0 110.483 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -101.01 -9.66 21.24 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.605 0.762 . . . . 0.0 111.41 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 65.47 19.38 11.55 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.035 1.334 . . . . 0.0 111.754 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.2 p -129.02 143.61 50.92 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.634 -0.666 . . . . 0.0 110.409 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.66 135.6 33.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.269 0.628 . . . . 0.0 111.037 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 4.8 ttmm -123.69 129.93 51.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.642 1.577 . . . . 0.0 108.055 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -105.36 109.72 21.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.81 155.5 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.358 1.063 . . . . 0.0 110.694 -171.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -67.44 151.87 46.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.862 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 121' ' ' ILE . 43.2 mt -86.24 131.08 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.02 -82.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 168.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.89 161.2 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.474 1.034 . . . . 0.0 113.53 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -95.06 124.3 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.576 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.538 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.5 mm? -83.76 -62.2 1.64 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 109.209 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 44.7 tt0 -75.31 115.31 14.82 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -70.79 114.94 30.88 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 124.311 1.007 . . . . 0.0 110.87 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.61 ' HB3' HG22 ' A' ' 97' ' ' ILE . 82.1 Cg_exo -53.75 150.61 28.48 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.611 2.874 . . . . 0.0 113.294 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.53 77.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.768 0.827 . . . . 0.0 109.808 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.412 HD22 ' HB2' ' A' ' 90' ' ' LEU . 3.1 p-10 -98.12 57.64 1.28 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.298 1.039 . . . . 0.0 109.818 172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -56.3 -37.6 70.1 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.411 0.685 . . . . 0.0 110.375 176.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.96 -23.55 54.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 25.2 mt -95.33 -38.23 10.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.709 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.27 -30.9 30.03 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -66.9 -27.1 67.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.334 0.653 . . . . 0.0 111.224 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 90' ' ' LEU . 45.1 mtp180 -82.13 -32.41 30.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.406 1.082 . . . . 0.0 109.895 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 131.09 -9.19 5.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.469 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 18.7 mm -79.44 83.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -96.5 142.19 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.837 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.1 tt -93.99 144.84 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 122.939 0.495 . . . . 0.0 110.217 -172.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -51.52 123.08 9.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.406 1.083 . . . . 0.0 112.279 -172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.12 -10.88 37.13 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.636 0.585 . . . . 0.0 113.416 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.48 137.22 32.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.148 0.474 . . . . 0.0 110.662 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.99 135.66 35.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.585 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 78' ' ' ILE . 3.0 tt -130.02 157.31 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 126.483 1.913 . . . . 0.0 107.784 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.538 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.7 mtt-85 -116.55 137.11 52.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -117.68 -176.63 3.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.72 0.808 . . . . 0.0 109.714 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.24 -26.88 68.7 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.831 0.452 . . . . 0.0 111.156 172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -77.66 -68.06 0.66 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.49 0.716 . . . . 0.0 110.91 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.33 -163.2 15.5 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.83 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 126' ' ' LEU . 63.0 tp -69.15 127.64 33.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -126.4 156.92 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.352 1.061 . . . . 0.0 109.468 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -114.05 125.54 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.232 1.013 . . . . 0.0 109.051 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.0 119.45 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.291 0.567 . . . . 0.0 110.256 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.8 p -119.51 3.27 11.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.504 0.722 . . . . 0.0 111.92 -173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 23.0 t -149.05 171.58 16.17 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.442 0.697 . . . . 0.0 110.016 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -83.16 152.06 64.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.589 0.756 . . . . 0.0 111.7 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.71 109.36 0.76 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.495 2.13 . . . . 0.0 112.107 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.59 154.15 22.38 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.765 168.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -58.32 -22.07 51.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.033 0.933 . . . . 0.0 112.611 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.03 5.15 4.54 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.206 1.002 . . . . 0.0 113.116 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.17 40.73 82.02 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.1 109.26 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.439 0.695 . . . . 0.0 110.519 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 78' ' ' ILE . 2.6 mp -101.2 109.64 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 45.6 t-20 -73.26 129.63 38.46 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 120.974 0.416 . . . . 0.0 110.128 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.97 170.56 15.17 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.807 1.243 . . . . 0.0 110.794 -174.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.89 122.83 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.677 0.791 . . . . 0.0 109.091 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.1 mt -64.91 130.17 42.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 171.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.489 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.3 mp -81.58 14.8 2.38 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.469 0.708 . . . . 0.0 110.404 173.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HE3' HD13 ' A' ' 125' ' ' LEU . 26.0 ttpp -76.85 7.81 4.38 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 125.404 1.482 . . . . 0.0 110.881 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.713 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 8.1 p30 -79.52 -17.36 54.23 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.155 0.582 . . . . 0.0 110.753 166.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.75 140.67 58.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 109.884 174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.3 p -65.17 87.97 0.07 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.461 0.704 . . . . 0.0 110.389 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -75.1 104.29 5.61 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 86.02 7.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.249 1.043 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.97 19.18 6.54 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.623 0.577 . . . . 0.0 112.783 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -80.79 112.69 18.4 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -140.46 139.45 35.19 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.937 0.895 . . . . 0.0 109.416 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -119.8 137.24 54.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.359 0.664 . . . . 0.0 110.491 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.82 -164.47 36.7 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.53 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.08 159.74 33.63 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.386 2.057 . . . . 0.0 111.894 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.25 128.78 36.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.045 0.538 . . . . 0.0 109.713 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -70.35 132.58 45.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -125.34 116.8 22.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 0.0 109.386 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 143.57 40.89 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.991 0.516 . . . . 0.0 110.635 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.2 mt -85.64 113.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.682 0.793 . . . . 0.0 109.694 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.3 m -82.98 119.17 24.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.07 -135.94 4.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 116.72 -0.218 . . . . 0.0 112.758 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.37 -172.4 13.6 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.7 tp -166.98 137.98 3.19 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -146.66 118.71 8.23 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.681 0.792 . . . . 0.0 108.889 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.46 153.14 50.32 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -76.72 166.56 23.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -71.75 135.78 46.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.159 0.584 . . . . 0.0 111.331 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.65 82.47 8.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.156 0.983 . . . . 0.0 109.322 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 67.64 132.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.246 1.418 . . . . 0.0 111.463 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.29 158.69 15.47 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.316 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -70.87 151.9 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.632 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -87.36 118.01 26.52 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -71.66 148.64 46.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.459 0.704 . . . . 0.0 111.481 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -69.43 150.76 46.89 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.612 0.765 . . . . 0.0 110.801 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.42 88.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.404 0.621 . . . . 0.0 109.618 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.13 -5.88 63.58 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.464 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -86.94 114.67 59.43 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.45 120.16 3.94 Favored 'Trans proline' 0 CA--C 1.56 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 111.974 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.95 128.31 13.04 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.74 2.293 . . . . 0.0 112.031 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -78.51 154.78 30.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.471 0.708 . . . . 0.0 110.617 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -70.42 149.09 47.62 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.0 p -75.21 157.6 34.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.785 0.834 . . . . 0.0 112.017 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.7 m -79.19 137.02 37.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.131 0.973 . . . . 0.0 110.802 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -128.71 -178.64 4.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.485 0.714 . . . . 0.0 111.321 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -127.83 37.95 4.11 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.891 0.877 . . . . 0.0 110.701 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -65.69 -22.44 66.62 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.076 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.59 -36.19 83.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.446 1.098 . . . . 0.0 110.464 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.54 -29.37 66.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.578 0.751 . . . . 0.0 111.064 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.29 -37.21 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.034 0.534 . . . . 0.0 109.826 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -73.06 -31.42 64.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.13 0.572 . . . . 0.0 111.7 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 47' ' ' ARG . 7.1 tp -76.83 -32.42 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -68.71 -25.46 64.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.151 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.27 -35.18 28.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.374 0.67 . . . . 0.0 110.866 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -65.5 -37.63 87.35 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.816 0.446 . . . . 0.0 111.016 -173.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 9.5 t -61.99 -20.06 63.49 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.95 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.6 84.82 2.65 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.28 71.96 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.93 -33.05 77.02 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -124.23 122.65 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.398 0.679 . . . . 0.0 110.949 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -108.25 151.76 25.51 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.414 1.085 . . . . 0.0 109.102 169.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -74.49 88.68 2.13 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.99 126.35 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.604 0.761 . . . . 0.0 110.009 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -81.34 132.9 35.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.179 0.592 . . . . 0.0 109.8 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.4 149.89 36.85 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -100.68 171.23 7.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.751 0.821 . . . . 0.0 110.692 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HB3' ' HA3' ' A' ' 119' ' ' GLY . 51.2 m-85 -65.51 98.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.912 0.485 . . . . 0.0 109.843 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.8 t -65.66 131.72 47.05 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.518 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.3 m -67.85 94.79 0.48 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.493 0.717 . . . . 0.0 109.623 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 120' ' ' VAL . 18.1 m -132.33 151.86 51.67 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.471 1.108 . . . . 0.0 108.763 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.98 134.76 54.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.674 0.79 . . . . 0.0 109.908 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -102.26 93.24 5.09 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -80.66 142.63 13.61 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 101.315 -3.587 . . . . 0.0 101.315 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -96.97 135.75 38.51 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 110.81 -2.904 . . . . 0.0 104.195 153.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.53 114.54 61.54 Favored Pre-proline 0 N--CA 1.48 1.064 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.215 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 20.8 Cg_endo -61.04 -20.58 68.28 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.052 2.501 . . . . 0.0 113.553 170.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.23 -51.95 11.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 111.771 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -103.78 -10.02 18.6 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.308 0.643 . . . . 0.0 112.263 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 62.96 25.2 14.94 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.731 1.212 . . . . 0.0 111.485 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -129.6 138.83 51.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.97 0.908 . . . . 0.0 109.373 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -87.35 143.89 27.04 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.993 0.517 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.98 149.26 41.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.978 0.911 . . . . 0.0 108.653 167.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.94 105.13 12.31 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.49 149.92 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.116 1.366 . . . . 0.0 109.735 -169.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.58 152.09 44.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.014 0.926 . . . . 0.0 110.857 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 121' ' ' ILE . 30.0 mt -90.55 132.16 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.09 -85.52 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.16 149.55 36.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -165.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -86.79 118.37 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' H ' HD22 ' A' ' 82' ' ' LEU . 2.1 mm? -74.29 -66.0 0.78 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -84.06 106.77 15.97 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -75.85 122.64 87.4 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.008 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.52 167.89 24.11 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.84 2.36 . . . . 0.0 112.421 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.78 -40.01 40.04 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.36 1.064 . . . . 0.0 111.606 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.62 63.2 7.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.334 1.053 . . . . 0.0 111.33 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -48.1 68.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.204 0.602 . . . . 0.0 110.431 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -23.95 67.01 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.03 -49.54 6.7 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.844 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HB1' HG21 ' A' ' 81' ' ' ILE . . . -55.76 -28.01 53.8 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.103 0.961 . . . . 0.0 113.02 176.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -68.74 -28.12 66.53 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.8 0.84 . . . . 0.0 110.335 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -82.74 -27.82 30.86 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.385 1.074 . . . . 0.0 109.424 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.02 20.72 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.42 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mm -89.3 84.44 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 124.169 0.988 . . . . 0.0 108.525 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -101.05 148.15 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.109 -167.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.1 tt -94.56 143.65 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -53.53 119.42 4.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.047 0.939 . . . . 0.0 111.403 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.93 -8.1 16.69 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 123.476 0.56 . . . . 0.0 112.882 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -96.98 149.07 22.33 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.198 0.599 . . . . 0.0 110.861 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.51 137.59 32.4 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.633 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.41 156.33 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.178 1.391 . . . . 0.0 108.13 -175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 108' ' ' LEU . 1.1 tmt_? -121.07 125.34 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.7 p -111.39 -178.12 3.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.488 0.715 . . . . 0.0 109.487 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -55.29 -40.23 70.81 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.917 0.887 . . . . 0.0 111.996 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.38 -70.18 0.53 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.536 0.735 . . . . 0.0 111.009 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -148.13 -162.3 10.06 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.185 -175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD12 ' HG2' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -72.83 138.94 46.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 168.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.89 31.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.55 0.74 . . . . 0.0 109.858 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.45 129.64 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.699 1.199 . . . . 0.0 108.264 167.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.0 m -67.9 121.63 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.533 0.682 . . . . 0.0 109.704 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.3 p -114.8 14.9 17.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.038 0.935 . . . . 0.0 111.581 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 21.3 t -157.07 165.94 34.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.914 0.885 . . . . 0.0 109.371 169.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -90.66 139.93 26.46 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.702 0.801 . . . . 0.0 109.817 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.45 112.93 0.34 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 124.801 3.668 . . . . 0.0 113.52 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.73 170.7 39.4 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.978 0.799 . . . . 0.0 112.345 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -67.2 -22.34 65.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.52 -11.71 61.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.994 1.317 . . . . 0.0 112.499 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 59' ' ' TYR . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 114.156 0.422 . . . . 0.0 114.156 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 62' ' ' THR . 88.9 t -105.93 140.97 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.302 0.641 . . . . 0.0 109.975 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 78' ' ' ILE . 1.7 mp -115.38 111.14 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 17.5 m120 -67.49 130.92 44.58 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.539 0.609 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.29 15.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.707 1.203 . . . . 0.0 111.751 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.424 HG13 ' HD3' ' A' ' 68' ' ' PRO . 25.4 t -127.07 132.75 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 124.804 1.241 . . . . 0.0 108.884 168.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 53.0 mt -61.43 134.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.34 0.518 . . . . 0.0 111.484 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.92 44.26 1.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.279 1.032 . . . . 0.0 110.067 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -150.97 98.85 2.64 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.17 0.988 . . . . 0.0 109.254 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -129.24 155.99 44.69 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.52 56.52 3.65 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.112 0.965 . . . . 0.0 109.476 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.3 p -74.49 98.98 3.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.991 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -93.84 -164.1 1.13 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.653 1.181 . . . . 0.0 109.988 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.55 83.75 1.53 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.453 0.701 . . . . 0.0 109.38 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.555 1.151 0 C-N-CA 123.697 0.799 . . . . 0.0 109.572 178.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mmm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.5 -135.3 4.88 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-O 119.578 -0.568 . . . . 0.0 111.848 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 64.11 20.96 12.41 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.518 1.127 . . . . 0.0 111.981 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -88.25 110.56 20.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 0.0 109.45 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -80.65 142.75 33.65 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.005 0.522 . . . . 0.0 109.694 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.03 146.15 44.22 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.763 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.99 137.65 41.77 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.876 2.384 . . . . 0.0 112.47 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.33 154.61 41.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.844 0.858 . . . . 0.0 111.613 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -86.85 128.84 35.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.571 0.748 . . . . 0.0 109.283 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.52 115.96 29.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -93.9 139.24 31.14 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.978 0.511 . . . . 0.0 110.703 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 69.1 mt -78.15 129.98 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.688 0.795 . . . . 0.0 109.265 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.2 t -143.52 161.01 39.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.187 0.595 . . . . 0.0 110.507 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.73 166.54 36.79 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.543 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.65 -156.21 32.39 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 122.717 0.199 . . . . 0.0 112.884 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 tp -173.29 85.3 0.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.71 120.93 21.77 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.41 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.98 123.76 7.26 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.699 0.624 . . . . 0.0 111.841 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -111.22 155.95 22.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -134.58 146.47 49.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.06 143.14 28.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.82 -165.94 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.231 0.612 . . . . 0.0 110.613 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 158.9 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.739 0.415 . . . . 0.0 110.859 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -81.23 134.64 35.64 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.334 1.054 . . . . 0.0 110.258 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -83.09 170.21 15.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.592 0.757 . . . . 0.0 111.249 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -71.94 171.46 11.75 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.829 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 162.47 21.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.524 1.13 . . . . 0.0 109.094 171.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.4 mt -116.45 134.36 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.171 0.588 . . . . 0.0 109.848 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.91 -158.24 34.16 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.41 0.444 . . . . 0.0 112.574 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.81 141.71 39.57 Favored Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 123.864 0.866 . . . . 0.0 110.432 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.04 163.66 20.19 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.224 2.616 . . . . 0.0 112.566 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.06 146.77 71.92 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.66 2.24 . . . . 0.0 112.01 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -113.83 -66.83 1.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.443 0.697 . . . . 0.0 111.931 -172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -73.96 118.81 17.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.451 0.7 . . . . 0.0 111.191 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.7 m -143.94 105.78 4.33 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.24 1.016 . . . . 0.0 108.861 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 37.1 p -77.61 -179.92 6.17 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.637 0.775 . . . . 0.0 111.284 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.52 161.56 34.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.497 0.719 . . . . 0.0 109.736 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 42' ' ' ILE . 40.5 m -121.74 31.93 6.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.259 0.624 . . . . 0.0 110.184 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.07 -51.92 67.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.08 0.552 . . . . 0.0 111.389 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.92 -34.99 72.35 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.619 0.768 . . . . 0.0 112.111 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.65 -41.31 88.42 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.43 0.692 . . . . 0.0 110.73 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 38' ' ' SER . 49.6 mm -65.97 -34.61 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 123.744 0.818 . . . . 0.0 110.123 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 20.7 mmm180 -74.55 -23.16 58.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.837 0.455 . . . . 0.0 110.444 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -83.07 -41.74 17.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 C-N-CA 123.955 0.902 . . . . 0.0 110.499 179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.57 -25.87 68.16 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.657 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.86 -42.75 23.62 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 111.091 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 33.9 ptt180 -66.89 -35.39 79.9 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -169.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -69.56 -8.92 51.47 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.28 159.65 33.07 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.558 0.343 . . . . 0.0 110.349 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -147.62 -74.58 0.02 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.2 163.38 12.44 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -81.87 137.46 35.22 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.86 0.864 . . . . 0.0 109.508 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.99 123.87 33.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.547 0.739 . . . . 0.0 109.407 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -68.93 143.33 54.47 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.524 0.33 . . . . 0.0 110.213 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.21 169.24 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.717 0.807 . . . . 0.0 111.766 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -79.46 152.68 30.13 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.367 0.667 . . . . 0.0 111.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.54 163.17 26.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.286 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.02 168.44 14.91 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.049 0.54 . . . . 0.0 109.848 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -89.3 138.89 31.04 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.515 0.726 . . . . 0.0 109.363 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -68.61 126.43 29.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.883 0.473 . . . . 0.0 110.324 174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 78' ' ' ILE . 23.4 m -64.85 114.2 4.34 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 151.93 41.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.108 0.963 . . . . 0.0 109.736 -171.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.02 50.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -94.65 96.07 9.17 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.3 m -80.1 117.54 26.12 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 177.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 128.21 35.08 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 111.51 -2.586 . . . . 0.0 104.115 145.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -98.37 111.64 60.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.3 -18.46 30.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 123.533 2.822 . . . . 0.0 114.467 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.21 -59.98 2.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 p -93.43 -6.76 46.31 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.957 0.503 . . . . 0.0 111.967 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 56.92 47.04 18.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.073 1.349 . . . . 0.0 111.906 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 p -132.14 144.35 50.63 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.354 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.72 146.92 25.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -145.39 121.36 10.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -93.4 108.28 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 150.77 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.072 -177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.58 154.18 42.38 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 124.08 0.863 . . . . 0.0 110.005 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.536 HD12 HG22 ' A' ' 61' ' ' THR . 24.5 mt -92.93 125.55 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.399 0.679 . . . . 0.0 109.393 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 -83.49 0.4 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.89 134.77 30.54 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -164.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -90.57 122.84 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -80.92 -48.52 12.22 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 33.4 tt0 -97.28 100.05 11.51 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 m -79.81 117.0 65.09 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.268 0.627 . . . . 0.0 109.469 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.54 166.33 29.73 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.709 2.273 . . . . 0.0 112.974 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.89 -31.0 62.44 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.46 1.104 . . . . 0.0 112.334 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 90' ' ' LEU . 5.6 p-10 -87.36 59.08 5.33 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.509 0.724 . . . . 0.0 109.844 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -57.8 -43.85 85.92 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.161 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -55.82 -30.76 61.91 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.417 0.687 . . . . 0.0 112.641 -175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.672 ' HB2' HD22 ' A' ' 87' ' ' ASN . 3.9 mm? -81.1 -54.5 5.49 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.163 0.985 . . . . 0.0 110.357 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 -29.16 17.77 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 80.4 mtp180 -70.28 -35.67 73.87 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.366 0.666 . . . . 0.0 110.778 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.85 -13.24 60.27 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.425 0.69 . . . . 0.0 110.317 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.57 3.99 58.28 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.842 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 51.4 mm -84.51 93.84 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.6 144.51 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.04 0.536 . . . . 0.0 110.614 -166.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 tt -96.33 151.79 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.085 0.554 . . . . 0.0 109.61 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -49.67 139.99 11.91 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.91 1.284 . . . . 0.0 112.572 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.15 -24.36 29.4 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.215 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -84.42 135.47 34.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.056 0.543 . . . . 0.0 111.936 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.1 mptt -83.5 134.35 34.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.03 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 103' ' ' ARG . 2.6 tt -132.16 158.2 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.25 1.42 . . . . 0.0 108.67 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.509 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.0 mtt180 -119.05 128.64 54.54 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 168.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.3 p -107.49 -174.64 2.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.38 0.672 . . . . 0.0 109.34 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.78 -20.52 64.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.694 0.283 . . . . 0.0 110.444 171.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.81 -66.95 0.83 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.948 0.899 . . . . 0.0 111.063 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.0 -177.77 37.03 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.389 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.51 126.73 28.78 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.58 162.49 31.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.021 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.81 125.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -68.76 123.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.5 p -114.61 8.59 16.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.175 0.99 . . . . 0.0 111.837 -173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.8 t -139.44 163.34 32.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.736 0.814 . . . . 0.0 110.012 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -83.52 155.13 65.95 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.55 112.46 1.14 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.073 2.516 . . . . 0.0 112.631 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.1 174.73 40.24 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.015 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.64 -34.7 76.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 120' ' ' VAL . 30.2 t70 -63.94 -27.46 69.16 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.028 0.931 . . . . 0.0 111.823 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.99 6.52 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 118' ' ' ASP . 7.2 p -126.45 138.35 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.008 0.923 . . . . 0.0 110.172 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.1 mp -112.57 109.12 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.7 133.03 49.38 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.054 0.388 . . . . 0.0 110.789 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.07 161.01 31.98 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.385 1.074 . . . . 0.0 110.41 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -114.53 123.38 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.526 ' HG ' ' HB ' ' A' ' 65' ' ' VAL . 66.1 mt -63.34 118.77 8.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.61 -37.44 87.32 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 0.0 111.094 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 58.37 -81.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.414 1.486 . . . . 0.0 110.631 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -70.62 100.27 1.81 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 122.28 46.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.5 t -59.66 145.2 45.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.049 0.939 . . . . 0.0 110.057 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.84 102.58 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.887 0.875 . . . . 0.0 110.527 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -143.65 146.1 32.98 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.853 1.261 . . . . 0.0 109.365 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 C--O 1.25 1.1 0 C-N-CA 124.111 0.965 . . . . 0.0 108.992 179.261 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.66 -174.4 35.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.295 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -63.07 122.35 15.86 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 0.0 110.662 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -77.47 70.14 3.82 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.521 0.677 . . . . 0.0 109.458 173.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -92.0 111.58 23.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.644 0.778 . . . . 0.0 109.241 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.81 73.64 0.38 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.49 170.04 19.0 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.404 2.069 . . . . 0.0 111.534 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.08 91.56 3.68 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.308 0.643 . . . . 0.0 110.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.34 81.98 1.04 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -80.14 149.38 30.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.223 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.7 163.87 27.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.416 0.686 . . . . 0.0 110.016 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.74 149.45 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.216 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 p -111.81 118.75 36.42 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.688 0.395 . . . . 0.0 110.089 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.43 140.16 8.34 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.79 73.62 0.11 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.1 tp -122.09 99.04 6.22 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -147.7 124.34 11.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.091 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.28 129.29 1.39 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -118.92 168.6 10.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.494 0.718 . . . . 0.0 110.458 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -139.18 155.81 47.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.735 1.214 . . . . 0.0 108.652 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -102.41 141.35 35.38 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.42 97.89 9.76 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.843 0.457 . . . . 0.0 109.865 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 129.78 40.74 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -145.97 99.37 3.25 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.616 0.766 . . . . 0.0 110.506 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -94.5 103.1 15.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.22 1.008 . . . . 0.0 109.84 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -78.7 158.78 28.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.209 1.003 . . . . 0.0 110.761 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -117.26 156.42 27.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.339 1.056 . . . . 0.0 109.574 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.9 mt -97.56 137.57 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.663 0.785 . . . . 0.0 109.904 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.61 167.85 52.12 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.275 0.36 . . . . 0.0 112.456 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -74.46 135.44 75.58 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 122.786 0.434 . . . . 0.0 110.391 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.57 143.15 86.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.884 2.389 . . . . 0.0 111.713 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.8 161.73 44.17 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.62 2.213 . . . . 0.0 111.887 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -62.91 123.85 19.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.125 0.57 . . . . 0.0 110.529 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -66.77 155.92 36.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.521 0.728 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 m -113.77 126.99 55.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.601 0.76 . . . . 0.0 109.603 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.5 p -89.13 173.72 8.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.799 0.439 . . . . 0.0 110.739 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -62.63 162.44 10.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.42 1.088 . . . . 0.0 112.956 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -118.9 30.59 7.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.426 1.09 . . . . 0.0 110.036 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.04 65.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.73 0.812 . . . . 0.0 112.78 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.01 -36.59 84.9 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.185 0.594 . . . . 0.0 111.05 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.36 -33.5 71.52 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.615 0.766 . . . . 0.0 110.632 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.4 mt -66.5 -48.86 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.562 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -72.15 -24.56 61.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.125 0.416 . . . . 0.0 112.125 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.585 HD12 ' HG2' ' A' ' 47' ' ' ARG . 9.0 tp -78.62 -34.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -74.25 -14.36 60.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.047 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -85.85 -38.48 18.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.664 0.386 . . . . 0.0 110.585 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG2' HD12 ' A' ' 44' ' ' ILE . 2.3 ppt_? -67.38 -24.48 65.69 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.1 m -52.52 -34.79 51.37 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.526 1.13 . . . . 0.0 112.402 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.05 103.31 0.59 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.018 0.527 . . . . 0.0 110.658 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.4 -131.69 3.07 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.58 74.6 0.3 Allowed Glycine 0 C--N 1.351 1.407 0 O-C-N 123.994 0.467 . . . . 0.0 113.515 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -79.79 122.4 26.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -76.81 135.37 38.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 110.835 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -81.94 114.31 20.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.5 103.66 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.85 153.9 20.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.508 0.723 . . . . 0.0 110.25 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -134.2 176.48 8.55 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.81 0.844 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -120.6 164.81 15.93 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.699 0.8 . . . . 0.0 109.593 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -51.82 128.73 24.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.145 0.978 . . . . 0.0 112.204 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -81.34 141.24 34.21 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 110.424 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 78' ' ' ILE . 23.2 m -72.35 103.13 3.33 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.449 1.1 . . . . 0.0 110.48 -176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 m -138.43 145.72 41.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 0.0 110.062 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.08 136.46 53.09 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.362 0.665 . . . . 0.0 109.625 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' HB2' ' CG1' ' A' ' 120' ' ' VAL . 5.5 t30 -103.97 86.86 2.65 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.6 t -81.56 118.69 29.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.024 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.5 tm? -67.0 123.18 19.49 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 147.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -94.62 112.51 58.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HG2' HD21 ' A' ' 128' ' ' ASN . 93.0 Cg_endo -76.56 -4.37 14.92 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.714 2.276 . . . . 0.0 113.691 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.8 -48.03 41.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.702 0.401 . . . . 0.0 110.199 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -108.13 -5.04 17.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.238 0.615 . . . . 0.0 111.567 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 58.66 47.91 12.4 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 110.837 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.5 p -139.2 137.3 35.88 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.934 0.894 . . . . 0.0 110.055 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.3 155.3 21.41 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.323 0.649 . . . . 0.0 111.448 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -144.18 154.17 42.86 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.121 1.368 . . . . 0.0 107.845 -174.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.79 106.93 12.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.881 0.848 . . . . 0.0 108.898 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.52 152.32 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 113.425 -1.716 . . . . 0.0 108.845 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -69.42 152.92 44.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 110.831 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 61' ' ' THR . 47.7 mt -90.23 125.82 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.15 -80.82 0.43 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -145.36 134.2 22.41 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.4 1.0 . . . . 0.0 113.467 -166.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.66 133.62 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.6 mm? -89.8 -71.12 0.63 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.808 0.843 . . . . 0.0 109.164 -176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -72.47 113.36 9.41 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -68.02 119.31 66.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.431 1.082 . . . . 0.0 111.96 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.48 145.02 81.96 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.926 2.418 . . . . 0.0 112.658 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.8 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.549 0.739 . . . . 0.0 110.89 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -95.99 58.8 1.93 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.128 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -60.51 -37.74 82.11 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.638 0.775 . . . . 0.0 111.638 178.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -63.69 -17.98 63.52 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.805 0.729 . . . . 0.0 112.695 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.26 -40.56 10.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.126 0.571 . . . . 0.0 110.938 170.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.89 -19.48 17.92 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 8.1 ptm180 -62.23 -35.11 77.92 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.395 0.435 . . . . 0.0 110.625 172.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -79.0 -23.27 44.52 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.371 1.069 . . . . 0.0 110.5 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 61' ' ' THR . . . 118.08 3.44 15.34 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.515 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.93 83.66 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 121.728 0.775 . . . . 0.0 108.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.4 mt -91.26 147.86 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.729 1.212 . . . . 0.0 109.79 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 tt -93.8 143.76 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -56.95 122.57 12.6 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.896 0.878 . . . . 0.0 111.537 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.06 -7.15 37.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.11 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.92 134.93 34.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.912 0.485 . . . . 0.0 110.877 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.25 145.34 37.59 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.764 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 2.2 tt -142.43 155.42 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.135 1.374 . . . . 0.0 108.407 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG3' HD21 ' A' ' 82' ' ' LEU . 81.3 mtt180 -116.94 123.71 47.63 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.9 p -105.75 -174.66 2.59 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.734 0.813 . . . . 0.0 108.989 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.2 -30.12 70.52 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.544 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 -69.57 0.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.494 0.718 . . . . 0.0 110.654 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.64 -159.34 11.06 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.683 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 126' ' ' LEU . 50.2 tp -71.22 120.24 16.51 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.76 157.28 34.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.536 1.135 . . . . 0.0 109.025 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.01 127.17 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.711 0.804 . . . . 0.0 109.158 171.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.8 m -67.13 117.73 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-O 121.662 0.744 . . . . 0.0 110.726 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.7 p -113.19 15.48 19.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.252 1.021 . . . . 0.0 111.809 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 43.7 t -155.07 157.78 38.08 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.603 0.761 . . . . 0.0 110.534 173.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.84 140.79 89.19 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.208 1.003 . . . . 0.0 111.037 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.83 119.9 7.44 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.978 2.452 . . . . 0.0 113.2 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.31 155.93 49.43 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.493 0.496 . . . . 0.0 112.005 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.42 -18.07 64.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.316 0.647 . . . . 0.0 110.725 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -65.68 -10.22 34.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.687 1.195 . . . . 0.0 112.174 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.59 79.71 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.297 0.373 . . . . 0.0 112.647 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.407 ' CG1' ' HB2' ' A' ' 64' ' ' ASN . 90.1 t -116.26 113.69 43.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 124.392 1.077 . . . . 0.0 108.942 -173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.93 109.22 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 31.4 m-80 -64.29 128.66 36.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.734 0.814 . . . . 0.0 111.627 -177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.79 170.55 14.23 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.363 1.065 . . . . 0.0 111.573 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.19 125.8 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 124.135 0.974 . . . . 0.0 110.792 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 65' ' ' VAL . 42.9 mt -64.52 119.81 11.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.792 0.437 . . . . 0.0 110.727 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.464 HD13 ' HG ' ' A' ' 108' ' ' LEU . 4.9 mp -75.92 -27.32 57.58 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 95.59 0.08 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.936 0.894 . . . . 0.0 111.189 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.467 HD21 ' HG2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -121.86 166.0 15.04 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 171.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.25 96.11 0.1 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.32 0.581 . . . . 0.0 109.438 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.7 p -66.39 116.64 7.62 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.332 -171.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -59.69 118.12 5.75 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.291 1.036 . . . . 0.0 110.551 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -93.71 -10.93 32.72 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.747 0.819 . . . . 0.0 112.061 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.87 0.868 . . . . 0.0 108.933 179.468 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.14 121.15 0.55 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.83 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.99 85.88 2.19 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.704 0.802 . . . . 0.0 109.262 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -126.67 -178.65 4.45 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.803 0.841 . . . . 0.0 109.582 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.86 163.91 33.61 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.156 0.582 . . . . 0.0 110.32 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.84 68.47 0.34 Allowed Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.657 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.03 134.79 8.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.604 2.203 . . . . 0.0 111.633 174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -111.81 135.67 52.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.476 0.711 . . . . 0.0 109.533 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -133.48 135.2 44.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.6 0.76 . . . . 0.0 109.849 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -125.88 116.83 22.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.01 0.924 . . . . 0.0 108.646 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -74.7 136.32 41.84 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.1 mm -76.1 75.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 O-C-N 123.912 0.758 . . . . 0.0 109.226 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -104.7 50.65 0.78 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.65 -163.87 29.38 Favored Glycine 0 C--O 1.242 0.647 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.235 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.38 35.53 92.18 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 112.118 -0.393 . . . . 0.0 112.118 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.27 -4.97 28.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.303 1.041 . . . . 0.0 110.765 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.21 94.51 1.17 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.418 0.687 . . . . 0.0 109.354 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.54 103.5 0.19 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 145.72 55.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.363 0.665 . . . . 0.0 110.945 -174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -169.26 153.77 5.54 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.97 91.4 2.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.05 126.24 28.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.309 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.42 -177.64 6.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.499 0.72 . . . . 0.0 111.106 -171.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -83.92 93.77 8.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.148 0.579 . . . . 0.0 109.484 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -83.42 0.12 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.255 0.622 . . . . 0.0 109.485 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -178.94 151.19 0.51 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.019 1.328 . . . . 0.0 109.609 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -96.32 132.02 42.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.244 0.617 . . . . 0.0 109.459 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.0 mt -90.1 91.99 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.54 20.71 2.04 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.554 -0.581 . . . . 0.0 114.208 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -87.81 111.8 44.67 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 117.437 0.618 . . . . 0.0 109.351 172.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -88.71 134.12 2.7 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 122.681 2.254 . . . . 0.0 112.494 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.43 134.66 36.67 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.49 2.127 . . . . 0.0 111.074 170.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 t -85.09 -177.92 6.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.275 0.63 . . . . 0.0 111.12 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -59.45 124.45 20.08 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.959 0.904 . . . . 0.0 110.096 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -113.25 145.58 40.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.799 . . . . 0.0 110.247 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.7 p -78.12 169.01 18.97 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.819 0.848 . . . . 0.0 110.762 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -129.75 177.51 7.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.876 0.871 . . . . 0.0 111.844 -175.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.7 p -123.26 39.86 3.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.253 1.021 . . . . 0.0 109.588 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.438 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -69.5 -15.26 63.22 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.207 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.82 -30.28 70.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.915 0.886 . . . . 0.0 109.867 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 36.8 t70 -67.86 -28.73 67.79 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.146 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.01 -41.11 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.535 0.734 . . . . 0.0 110.162 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -67.81 -26.33 66.02 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.07 -32.11 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 0.0 111.162 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 97.1 mttt -67.38 -30.54 70.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.197 0.523 . . . . 0.0 109.96 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.52 -30.9 42.03 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.551 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -69.45 -39.0 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.947 0.403 . . . . 0.0 110.194 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 t -78.36 -21.24 49.76 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.971 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 tt -76.6 89.47 3.32 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.03 43.51 0.07 OUTLIER Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.541 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.55 90.22 0.13 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.45 124.99 28.98 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.085 0.554 . . . . 0.0 110.596 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -67.29 111.58 4.08 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.196 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -63.31 120.07 10.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.841 0.856 . . . . 0.0 110.279 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.38 160.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.837 0.855 . . . . 0.0 112.035 -176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -107.17 137.05 45.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.584 0.753 . . . . 0.0 110.627 -173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.5 104.38 13.1 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -106.95 106.03 16.36 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -70.23 110.66 5.34 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.8 p -77.66 157.97 29.93 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.054 0.542 . . . . 0.0 111.373 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -58.93 146.34 38.14 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.069 0.947 . . . . 0.0 111.952 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.3 m -125.42 153.4 43.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.334 1.054 . . . . 0.0 108.745 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.35 152.47 32.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.963 0.905 . . . . 0.0 109.657 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.404 HD22 ' HB2' ' A' ' 75' ' ' LYS . 28.5 t-20 -121.96 89.69 3.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 21.8 m -78.51 117.13 23.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.836 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -63.05 122.61 16.48 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 145.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.26 112.59 58.07 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.73 -28.54 86.67 Favored 'Trans proline' 0 C--N 1.367 1.54 0 C-N-CA 123.125 2.55 . . . . 0.0 113.244 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.72 81.9 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.184 0.593 . . . . 0.0 111.544 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 p -98.53 -11.27 22.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.425 0.69 . . . . 0.0 111.535 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 59.56 37.28 22.78 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.101 1.36 . . . . 0.0 111.471 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.9 p -135.49 143.83 46.04 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.461 0.705 . . . . 0.0 110.002 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -83.77 155.75 22.88 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.213 0.605 . . . . 0.0 111.041 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -147.8 122.25 9.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.449 1.5 . . . . 0.0 107.684 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HB2' HD22 ' A' ' 64' ' ' ASN . 27.5 ttpp -102.81 104.76 15.07 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.95 148.58 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.102 1.761 . . . . 0.0 109.11 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.66 51.51 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 110.572 -171.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.97 122.74 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -90.07 -74.42 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.76 144.53 17.95 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.78 1.173 . . . . 0.0 113.486 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.549 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.93 137.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.274 0.63 . . . . 0.0 109.924 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.43 -53.9 3.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.899 0.88 . . . . 0.0 109.06 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 10.6 tp10 -81.56 108.71 15.36 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 173.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -76.02 120.55 82.17 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.334 174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.73 165.13 32.2 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 122.169 1.913 . . . . 0.0 111.98 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.33 -25.73 67.73 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.367 174.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 90' ' ' LEU . 4.6 p-10 -94.84 54.9 1.79 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.926 0.869 . . . . 0.0 109.381 170.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -53.65 -42.49 67.89 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.265 1.026 . . . . 0.0 111.017 -178.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.564 ' HG3' HD22 ' A' ' 90' ' ' LEU . 12.6 pt-20 -58.0 -29.21 65.09 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.564 HD22 ' HG3' ' A' ' 89' ' ' GLU . 3.9 mm? -74.59 -53.09 10.05 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 174.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.04 62.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -69.44 -36.82 77.02 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.518 0.727 . . . . 0.0 110.6 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -79.58 -5.43 54.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.313 1.045 . . . . 0.0 110.891 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.21 -9.02 63.03 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.769 -0.461 . . . . 0.0 113.55 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 115' ' ' PRO . 47.7 mm -80.33 86.62 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 109.484 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 121' ' ' ILE . 14.2 mt -90.91 145.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.234 0.614 . . . . 0.0 110.289 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.7 tt -95.18 145.48 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 111' ' ' VAL . 61.8 ttt-85 -54.97 118.8 4.6 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.379 1.072 . . . . 0.0 112.257 -174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.92 -17.31 11.91 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 123.987 0.803 . . . . 0.0 112.955 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -82.48 132.27 35.21 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.116 0.484 . . . . 0.0 111.049 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -79.63 142.93 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.173 0.589 . . . . 0.0 110.439 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -136.8 158.86 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.322 1.449 . . . . 0.0 108.971 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.556 ' HG3' HD21 ' A' ' 82' ' ' LEU . 90.1 mtt180 -116.03 131.19 57.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 169.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.2 p -120.71 177.1 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.889 0.876 . . . . 0.0 109.311 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -60.88 -28.47 68.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.731 0.412 . . . . 0.0 111.376 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.77 -67.66 0.58 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.355 0.662 . . . . 0.0 110.803 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.92 -162.33 15.75 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.42 -0.354 . . . . 0.0 112.394 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.35 133.49 47.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 165.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -137.75 163.35 31.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.883 0.873 . . . . 0.0 110.493 174.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.35 128.63 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.359 1.064 . . . . 0.0 108.64 168.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 100' ' ' ALA . 30.8 m -68.46 116.12 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.01 0.823 . . . . 0.0 110.312 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.2 p -106.92 10.95 30.4 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.839 0.856 . . . . 0.0 112.127 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 49.8 m -146.42 173.87 11.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.223 1.009 . . . . 0.0 109.732 170.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -88.66 166.73 21.29 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.693 ' HG3' HG23 ' A' ' 95' ' ' ILE . 22.9 Cg_endo -60.93 121.73 10.13 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.102 1.868 . . . . 0.0 112.739 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.17 173.14 46.18 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.45 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -58.14 -24.54 59.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -76.4 -3.54 37.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.597 0.759 . . . . 0.0 112.588 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.66 35.97 49.76 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.119 0.39 . . . . 0.0 112.682 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.06 126.45 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.5 0.72 . . . . 0.0 109.866 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.5 mp -97.36 111.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 3.5 m-20 -71.92 135.41 46.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.704 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -130.71 168.67 16.78 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.693 1.197 . . . . 0.0 110.159 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.36 126.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 109' ' ' ALA . 61.2 mt -63.59 138.82 58.66 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 124.014 0.821 . . . . 0.0 109.835 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.2 mt -92.96 44.65 1.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.875 0.845 . . . . 0.0 108.813 175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -78.63 85.48 4.67 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.343 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -173.8 166.97 4.45 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.621 1.168 . . . . 0.0 108.709 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -127.19 107.06 9.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.9 p -119.32 60.0 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 108.924 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.45 125.95 25.61 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.885 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -161.0 122.76 3.01 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.93 0.892 . . . . 0.0 108.818 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.252 1.203 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.84 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.02 117.05 2.78 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -71.26 88.74 0.85 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.911 0.484 . . . . 0.0 109.852 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.02 96.12 0.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.665 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 11.4 pt20 -87.01 165.33 15.91 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.219 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.01 80.94 0.36 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HG3' ' A' ' 5' ' ' GLN . 96.2 Cg_endo -77.61 98.89 1.24 Allowed 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.553 2.169 . . . . 0.0 111.189 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.36 109.93 5.01 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.208 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -70.65 153.91 42.38 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -115.6 118.15 32.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -54.91 107.04 0.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.269 0.627 . . . . 0.0 110.296 177.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.4 mt -70.38 112.01 4.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 t -66.49 121.2 14.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.37 151.57 36.61 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.726 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 141.92 36.79 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.164 -0.375 . . . . 0.0 112.164 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.94 109.08 18.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -152.54 106.59 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.1 152.78 47.48 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.649 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 1.2 tpmt? -82.73 116.28 22.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.513 0.725 . . . . 0.0 110.144 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -72.48 124.72 25.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -84.07 86.94 7.13 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -70.6 152.95 43.36 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.35 -172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.28 151.75 39.79 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.312 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB3' ' HD1' ' A' ' 26' ' ' TYR . 10.4 mpt_? -82.47 129.63 34.94 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -84.15 36.87 0.59 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.778 0.831 . . . . 0.0 111.64 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 24' ' ' ARG . 13.3 m-85 -93.96 97.44 10.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -67.51 108.91 3.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.767 0.427 . . . . 0.0 110.22 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.4 mt -57.75 131.25 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.312 1.045 . . . . 0.0 110.516 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 42.29 2.25 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -168.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.36 124.73 88.89 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.195 0.998 . . . . 0.0 110.697 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.38 157.0 5.47 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.127 2.551 . . . . 0.0 113.063 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.63 102.96 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.853 2.369 . . . . 0.0 110.455 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.9 p -86.16 -62.2 1.57 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.213 0.605 . . . . 0.0 111.237 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.16 125.73 54.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.708 0.803 . . . . 0.0 109.64 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -74.85 91.28 2.43 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.118 0.961 . . . . 0.0 109.975 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -79.67 -37.42 35.9 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.348 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 38' ' ' SER . 1.4 pp -62.87 -31.58 72.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.275 0.63 . . . . 0.0 111.676 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' N ' HD12 ' A' ' 37' ' ' LEU . 34.2 m 56.55 24.5 8.78 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.628 1.171 . . . . 0.0 112.935 174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -56.82 -55.89 28.53 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.699 0.799 . . . . 0.0 112.03 -173.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.86 -33.81 74.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.114 0.566 . . . . 0.0 111.718 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.68 -54.47 42.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.246 0.618 . . . . 0.0 110.539 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.04 -37.08 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.444 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 9.4 mpt_? -72.39 -23.7 61.15 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.141 0.576 . . . . 0.0 110.254 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -78.65 -34.11 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.676 0.79 . . . . 0.0 109.778 171.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.89 -9.25 58.46 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.78 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -96.43 -27.62 14.82 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.675 0.79 . . . . 0.0 110.939 169.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' ILE . 19.5 ptt180 -64.81 -36.26 83.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.245 0.545 . . . . 0.0 109.896 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 t -70.78 -11.81 61.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.754 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.86 79.44 2.12 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.69 122.54 5.84 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.828 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.03 86.42 0.13 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.972 0.386 . . . . 0.0 112.233 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -81.53 123.06 28.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.087 0.555 . . . . 0.0 109.642 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -69.3 143.75 53.73 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.095 0.558 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -133.72 84.02 2.09 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.924 0.89 . . . . 0.0 108.756 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.43 144.2 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.96 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 122.65 39.19 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.74 133.39 51.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.738 0.815 . . . . 0.0 108.875 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.63 124.05 26.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.524 0.73 . . . . 0.0 110.394 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.13 96.39 4.91 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 p -125.48 95.98 4.65 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.334 1.054 . . . . 0.0 109.351 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.627 HG22 HD12 ' A' ' 78' ' ' ILE . 14.5 m -95.38 120.57 35.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -126.03 152.15 46.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.61 0.764 . . . . 0.0 110.371 -166.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.17 136.97 54.99 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.062 0.945 . . . . 0.0 108.829 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -110.68 92.63 4.12 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' HB3' ' A' ' 74' ' ' LYS . 2.8 m -79.39 126.12 38.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.46 117.13 6.27 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 143.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -87.65 103.78 5.38 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 125.427 1.491 . . . . 0.0 106.998 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 125' ' ' LEU . 69.2 Cg_endo -69.36 6.3 1.23 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.112 2.541 . . . . 0.0 114.988 -175.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 -52.42 5.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.0 p -101.48 -9.42 21.07 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.535 0.734 . . . . 0.0 112.208 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.32 40.65 11.07 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.09 1.356 . . . . 0.0 111.595 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.3 p -132.14 163.12 29.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.752 0.821 . . . . 0.0 110.215 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.85 145.78 27.66 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.542 ' HB3' HG23 ' A' ' 65' ' ' VAL . 29.6 ttmt -144.27 111.0 5.66 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -169.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.18 102.75 11.87 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.355 1.074 . . . . 0.0 108.137 -171.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.78 145.92 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.331 -1.758 . . . . 0.0 108.715 -172.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -68.6 151.46 46.7 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 123.736 0.647 . . . . 0.0 110.37 -174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.627 HD12 HG22 ' A' ' 61' ' ' THR . 42.4 mt -86.75 134.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.1 mt -96.88 -79.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 154.91 31.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.856 1.207 . . . . 0.0 113.905 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.551 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -85.25 145.59 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.012 175.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.0 mm? -107.0 -58.18 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.782 0.833 . . . . 0.0 109.018 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.7 tt0 -72.49 112.99 9.03 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 169.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 m -67.84 115.76 31.2 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 124.256 0.972 . . . . 0.0 110.936 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.425 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 74.3 Cg_endo -73.16 153.13 51.43 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.921 1.747 . . . . 0.0 110.547 170.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.57 74.62 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.712 0.405 . . . . 0.0 110.33 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -94.39 45.9 1.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.063 0.545 . . . . 0.0 110.817 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -61.96 -31.55 71.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 10.9 pt-20 -50.35 -32.39 17.14 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.915 0.886 . . . . 0.0 112.575 171.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 44.9 mt -94.14 -33.94 13.14 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.528 0.731 . . . . 0.0 111.487 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -58.19 -14.05 6.23 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 16.9 ptm180 -64.09 -30.93 71.96 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 170.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -90.23 6.87 40.97 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.655 1.182 . . . . 0.0 110.781 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.072 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.11 83.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.78 144.59 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.629 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 tt -94.71 143.87 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -56.21 114.28 1.91 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 111.674 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.87 -11.28 13.57 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.389 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.6 137.94 35.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.145 0.472 . . . . 0.0 110.952 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HD2' HD11 ' A' ' 126' ' ' LEU . 39.3 mmtm -77.77 139.5 39.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.883 0.373 . . . . 0.0 110.787 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.7 tt -138.31 150.86 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.825 1.25 . . . . 0.0 109.143 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' HD21 ' A' ' 82' ' ' LEU . 41.3 mtt180 -115.1 131.89 56.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 75.9 p -115.9 -177.08 3.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 109.115 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.87 -21.1 63.37 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.812 0.445 . . . . 0.0 111.14 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.07 -67.93 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.411 0.685 . . . . 0.0 110.555 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.79 -160.1 11.93 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.37 131.56 42.8 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 165.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -133.55 165.62 24.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.241 1.016 . . . . 0.0 110.695 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.18 130.29 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.288 1.035 . . . . 0.0 109.022 167.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.9 m -67.15 124.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.451 HG21 HG23 ' A' ' 124' ' ' VAL . 9.4 t -125.84 13.28 7.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.416 0.627 . . . . 0.0 110.735 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 60.4 m -145.19 171.42 14.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.312 1.045 . . . . 0.0 109.208 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -81.27 145.55 56.15 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.532 0.733 . . . . 0.0 110.934 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' HG13 ' A' ' 121' ' ' ILE . 84.6 Cg_exo -51.79 117.74 3.81 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.837 3.025 . . . . 0.0 114.303 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 151.29 50.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.6 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -68.05 -18.96 64.83 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 117.637 0.718 . . . . 0.0 112.874 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.59 -9.14 58.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.06 0.544 . . . . 0.0 111.581 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.27 21.66 34.52 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.389 0.519 . . . . 0.0 111.963 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t -108.28 110.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.782 0.833 . . . . 0.0 109.691 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.3 mp -105.95 112.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.718 0.807 . . . . 0.0 108.961 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 28.2 m-80 -64.43 126.86 29.16 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.196 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -130.4 173.51 10.75 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.746 1.219 . . . . 0.0 110.726 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.451 HG23 HG21 ' A' ' 112' ' ' THR . 6.4 t -129.08 130.53 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.661 0.785 . . . . 0.0 109.726 168.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.1 mt -64.5 117.44 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.359 0.412 . . . . 0.0 111.203 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 101' ' ' LYS . 76.7 mt -72.81 -46.34 53.66 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.869 0.867 . . . . 0.0 109.64 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm 72.11 -0.98 3.04 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.831 1.252 . . . . 0.0 112.504 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -93.43 171.94 8.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.447 0.699 . . . . 0.0 110.074 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -96.12 91.64 6.03 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -76.56 85.31 3.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.02 0.438 . . . . 0.0 110.598 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.15 86.98 4.27 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -111.31 130.04 55.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.253 1.249 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.157 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.42 163.59 31.39 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.687 -0.233 . . . . 0.0 112.539 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -124.64 108.76 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.341 0.656 . . . . 0.0 110.082 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -72.99 90.25 1.48 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.589 0.756 . . . . 0.0 109.228 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.96 133.69 9.11 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.4 -152.11 22.8 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.49 -0.616 . . . . 0.0 111.833 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.84 -21.86 24.27 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.893 2.395 . . . . 0.0 112.409 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.27 138.1 43.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.564 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 75.35 -16.28 0.6 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.07 1.748 . . . . 0.0 112.462 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -85.18 119.73 25.89 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.189 0.596 . . . . 0.0 110.017 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.19 155.71 27.79 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.881 0.872 . . . . 0.0 110.198 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 pt -72.17 95.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 110.048 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -76.9 -5.3 47.91 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.051 0.94 . . . . 0.0 112.173 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.13 120.92 19.92 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.408 0.443 . . . . 0.0 112.472 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.05 91.31 1.72 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.36 88.26 1.55 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.635 0.774 . . . . 0.0 109.111 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -162.3 74.82 0.43 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.8 76.28 1.72 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.688 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -76.06 97.32 4.02 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.877 0.471 . . . . 0.0 110.429 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -65.44 97.79 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.087 0.955 . . . . 0.0 109.602 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -75.56 -177.16 3.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 111.646 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.8 102.51 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.445 1.098 . . . . 0.0 112.028 -172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -128.39 130.63 47.97 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.028 0.931 . . . . 0.0 108.71 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -74.08 -15.13 61.07 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.479 0.487 . . . . 0.0 111.888 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -67.51 99.49 0.76 Allowed 'General case' 0 C--N 1.356 0.858 0 C-N-CA 122.663 0.385 . . . . 0.0 110.448 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -97.21 108.6 21.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.04 103.55 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.211 0.605 . . . . 0.0 109.93 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.08 99.57 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.454 0.701 . . . . 0.0 110.316 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.62 15.16 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 168.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -106.95 130.21 23.21 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.541 1.136 . . . . 0.0 109.368 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.0 -169.99 0.91 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.314 2.676 . . . . 0.0 110.791 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.2 103.5 0.1 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 121.497 1.465 . . . . 0.0 109.901 164.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -58.05 120.3 8.33 Favored 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.315 1.01 . . . . 0.0 111.931 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -86.97 18.2 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.704 1.202 . . . . 0.0 111.875 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -72.54 98.56 2.33 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 p -77.26 -168.35 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.255 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -63.52 97.99 0.16 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.15 0.58 . . . . 0.0 110.023 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -115.13 13.13 16.76 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.501 1.12 . . . . 0.0 109.703 172.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.48 -36.22 81.8 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.697 0.799 . . . . 0.0 111.576 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.22 -26.37 68.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 7.3 m-20 -69.83 -39.08 76.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.001 0.521 . . . . 0.0 110.08 173.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.2 mt -68.82 -34.5 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 123.322 0.649 . . . . 0.0 110.14 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.74 -20.84 41.88 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.303 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 2.3 tp -79.47 -33.29 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.0 mmpt? -60.13 -39.4 86.16 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.439 168.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.25 -36.23 71.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.453 0.701 . . . . 0.0 111.327 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -64.16 -32.34 73.87 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.061 0.226 . . . . 0.0 110.478 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -94.51 -25.28 16.92 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.685 0.394 . . . . 0.0 111.846 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.1 tp -68.02 -51.99 40.73 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.922 0.489 . . . . 0.0 109.995 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.37 -9.75 81.24 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.354 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.96 83.39 0.6 Allowed Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.428 0.537 . . . . 0.0 113.194 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -128.84 146.25 50.98 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 168.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -65.45 104.61 1.01 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 97.06 0.16 Allowed 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.47 160.25 3.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 O-C-N 124.016 0.822 . . . . 0.0 110.818 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -71.21 111.61 6.69 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.51 124.07 18.37 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.019 0.824 . . . . 0.0 110.811 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -70.34 129.76 40.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.42 95.09 0.59 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -74.66 159.49 32.02 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.803 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 ' HA3' ' A' ' 94' ' ' GLY . 13.9 m -55.52 129.63 39.63 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.002 0.43 . . . . 0.0 110.533 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HG2' ' A' ' 75' ' ' LYS . 21.5 m -122.34 154.59 37.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.469 1.108 . . . . 0.0 108.544 -167.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.25 124.8 47.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 6.0 t30 -99.31 98.63 9.56 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 22.2 m -79.64 145.83 8.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 175.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -89.74 127.06 35.89 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 145.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.65 108.71 52.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 128' ' ' ASN . 68.1 Cg_endo -72.62 -3.24 13.12 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.775 2.317 . . . . 0.0 113.558 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.57 22.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.613 0.365 . . . . 0.0 110.374 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 p -98.66 -14.13 19.98 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.294 0.638 . . . . 0.0 111.656 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 66.15 24.22 10.87 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.041 1.336 . . . . 0.0 110.898 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 p -125.27 140.74 52.57 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.596 -0.69 . . . . 0.0 110.687 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.75 125.16 33.02 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.228 0.611 . . . . 0.0 110.828 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -117.02 128.11 54.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.036 1.734 . . . . 0.0 109.351 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.9 ttmt -103.36 105.82 16.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.26 150.43 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.508 -169.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -65.24 151.57 45.85 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 124.02 0.928 . . . . 0.0 110.527 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.4 mt -87.29 132.04 33.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -89.93 -77.89 0.38 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 166.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.89 159.4 26.72 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -85.61 136.84 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.86 175.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mm? -93.54 -63.88 1.15 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 37.2 tt0 -76.19 118.89 19.38 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 m -67.0 121.32 77.58 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 124.179 0.925 . . . . 0.0 111.42 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 97' ' ' ILE . 89.2 Cg_exo -53.8 146.93 43.27 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.279 2.653 . . . . 0.0 113.312 169.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.73 -42.81 79.9 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.521 0.729 . . . . 0.0 110.439 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -87.99 61.62 6.44 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.585 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -40.58 78.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.428 0.691 . . . . 0.0 110.786 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -52.15 -27.49 14.59 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 40.7 mt -97.17 -29.67 13.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.089 0.556 . . . . 0.0 112.324 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.16 -34.82 46.64 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.858 0.863 . . . . 0.0 112.902 174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -67.73 -29.63 68.91 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.681 0.613 . . . . 0.0 111.336 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -80.84 -8.25 59.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.996 0.919 . . . . 0.0 110.667 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 95.6 -1.61 64.08 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 123.13 0.395 . . . . 0.0 112.928 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 43.7 mm -83.07 95.19 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 109.288 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.7 mt -95.16 149.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.572 0.749 . . . . 0.0 110.062 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 85' ' ' PRO . 15.4 tt -99.15 145.19 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -59.11 122.06 12.84 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.638 0.775 . . . . 0.0 111.949 -175.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.54 -15.72 12.79 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 123.566 0.603 . . . . 0.0 112.712 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.29 135.56 35.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.016 0.527 . . . . 0.0 110.712 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -79.28 148.99 31.95 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.0 tt -148.95 155.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.548 1.539 . . . . 0.0 107.967 -173.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG3' HD21 ' A' ' 82' ' ' LEU . 71.5 mtt180 -115.46 131.5 56.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -113.29 -176.75 2.97 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.883 0.873 . . . . 0.0 109.752 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.19 -28.8 69.92 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.193 0.597 . . . . 0.0 111.264 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.38 -64.97 1.07 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.825 0.85 . . . . 0.0 111.059 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.78 -157.51 9.68 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.532 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HG ' HD13 ' A' ' 126' ' ' LEU . 58.9 tp -73.37 128.73 36.32 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 166.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -127.9 153.84 46.2 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.487 1.115 . . . . 0.0 109.659 174.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.22 122.26 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.0 0.92 . . . . 0.0 108.645 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 123' ' ' ALA . 34.4 m -66.28 124.29 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -175.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 p -111.14 13.51 21.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.953 0.901 . . . . 0.0 111.761 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 33.4 t -156.48 173.26 17.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.663 0.785 . . . . 0.0 109.899 173.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -77.48 161.54 71.94 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.713 0.805 . . . . 0.0 110.029 168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.38 120.18 7.87 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.788 2.325 . . . . 0.0 112.19 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.41 168.22 17.13 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 168.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -65.33 -22.81 66.87 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.051 0.541 . . . . 0.0 112.426 -172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 120' ' ' VAL . 7.0 m-20 -74.05 -7.95 54.35 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.424 0.69 . . . . 0.0 112.127 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.66 40.61 12.2 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 118' ' ' ASP . 7.3 p -133.6 118.85 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.62 0.768 . . . . 0.0 109.864 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -96.38 119.15 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 113' ' ' SER . 3.6 t-20 -63.66 126.36 27.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . . . -129.01 171.81 11.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.116 0.966 . . . . 0.0 110.305 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -126.72 124.8 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.73 0.812 . . . . 0.0 109.712 170.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -64.8 129.76 40.98 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 108' ' ' LEU . 5.5 mp -78.36 6.26 8.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.61 0.364 . . . . 0.0 110.935 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 83.49 0.3 Allowed 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.998 0.904 . . . . 0.0 108.868 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 9.1 p30 178.11 -28.74 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.553 1.941 . . . . 0.0 108.31 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -70.82 160.93 31.84 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.422 1.089 . . . . 0.0 110.594 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 p -56.69 95.17 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.079 0.952 . . . . 0.0 111.212 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -144.52 108.58 4.76 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.141 0.976 . . . . 0.0 108.594 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.48 73.25 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.249 1.033 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.08 64.58 4.25 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 116.438 -0.346 . . . . 0.0 113.119 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.5 137.78 54.71 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.805 0.842 . . . . 0.0 109.377 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.76 154.55 18.16 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.971 0.908 . . . . 0.0 110.063 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -157.45 152.9 26.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.575 0.75 . . . . 0.0 110.264 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.64 34.95 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.258 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.53 147.7 28.71 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.391 2.06 . . . . 0.0 111.721 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.5 -179.15 4.66 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.03 104.11 1.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -67.42 124.57 23.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.436 0.636 . . . . 0.0 110.468 -176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -83.16 104.07 13.06 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.55 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.2 mm -96.32 116.42 38.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 124.186 0.994 . . . . 0.0 108.781 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.0 p -97.79 165.98 11.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.435 0.694 . . . . 0.0 110.136 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.55 -65.21 3.49 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.459 0.474 . . . . 0.0 112.892 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.68 -164.86 22.39 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 123.729 0.311 . . . . 0.0 112.667 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.76 -24.91 18.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.623 0.769 . . . . 0.0 111.615 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -69.45 106.67 3.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 110.638 -176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.81 -149.53 17.91 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.631 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.6 94.0 2.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -70.64 126.13 28.76 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.509 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -100.31 148.01 25.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.045 0.938 . . . . 0.0 110.076 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.31 165.02 15.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.304 0.642 . . . . 0.0 111.361 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.0 179.53 5.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.063 0.945 . . . . 0.0 108.703 171.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.01 131.63 22.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.787 0.435 . . . . 0.0 110.067 174.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -78.34 121.78 24.91 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.486 0.714 . . . . 0.0 109.973 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -78.81 105.13 9.91 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.59 175.22 5.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.8 mt -62.66 136.2 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.31 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.09 -175.55 32.96 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.495 0.497 . . . . 0.0 112.937 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.17 138.54 64.66 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.236 0.614 . . . . 0.0 110.544 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.29 136.79 41.43 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.682 2.255 . . . . 0.0 111.71 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.3 169.17 12.79 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 123.008 2.472 . . . . 0.0 112.834 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.8 p -75.3 151.37 38.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.516 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.09 164.59 22.32 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.183 0.593 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.5 p -75.67 137.46 40.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.558 0.743 . . . . 0.0 111.657 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.7 p -91.44 155.14 18.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.57 0.748 . . . . 0.0 110.454 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.73 161.01 21.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.044 0.537 . . . . 0.0 110.992 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -126.42 15.4 7.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.86 0.864 . . . . 0.0 110.073 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 124.255 1.022 . . . . 0.0 112.684 -170.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.77 -27.81 67.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.341 0.656 . . . . 0.0 112.146 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 44' ' ' ILE . 34.0 t70 -66.87 -39.58 87.59 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.398 0.618 . . . . 0.0 110.543 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.58 -34.72 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.989 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 13.9 mmm180 -73.29 -26.74 61.2 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 41' ' ' ASP . 9.0 tp -76.97 -37.08 26.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -61.31 -37.8 84.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.21 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.12 -39.36 93.87 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 111.648 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -68.48 -42.93 77.97 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 117.82 0.282 . . . . 0.0 110.701 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 t -80.69 -5.12 56.56 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.727 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.3 tp -101.78 -19.88 15.16 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.578 0.751 . . . . 0.0 110.589 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.6 144.5 40.53 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.62 119.65 0.8 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -90.97 157.14 17.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.414 0.686 . . . . 0.0 111.145 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -102.95 109.52 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.931 0.892 . . . . 0.0 108.62 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -78.94 120.65 23.84 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.89 136.71 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.629 0.371 . . . . 0.0 110.534 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.8 mmt-85 -78.15 143.12 37.53 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.091 0.556 . . . . 0.0 110.077 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.44 141.08 50.27 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -70.39 175.37 4.77 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.744 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -69.14 143.84 54.01 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 77' ' ' LYS . 7.6 m -76.78 155.2 33.31 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.663 HG22 HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -64.53 128.93 37.9 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.037 0.535 . . . . 0.0 109.94 178.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.539 ' HB ' HG22 ' A' ' 120' ' ' VAL . 41.0 m -135.6 145.37 46.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.778 0.831 . . . . 0.0 110.368 -169.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -118.25 141.35 48.6 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.541 1.137 . . . . 0.0 109.583 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.07 90.33 3.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.573 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -78.8 127.6 38.84 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.29 126.09 29.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 112.351 -2.204 . . . . 0.0 105.111 148.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.55 109.86 14.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -58.33 -19.55 43.53 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.955 3.104 . . . . 0.0 115.227 -172.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.92 -65.38 1.02 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.577 0.351 . . . . 0.0 111.115 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.1 p -75.57 -23.33 56.54 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.534 0.734 . . . . 0.0 111.93 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 62.1 61.73 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.167 1.387 . . . . 0.0 110.304 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.7 p -134.34 150.13 50.91 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.593 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.5 149.68 24.8 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 119.016 0.826 . . . . 0.0 109.792 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -148.92 111.79 4.84 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -104.49 103.33 13.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.97 152.84 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.668 1.587 . . . . 0.0 109.546 -171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' HG21 ' A' ' 60' ' ' THR . 6.3 ttpm? -65.71 146.12 55.17 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.692 0.797 . . . . 0.0 110.958 -173.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.663 HD12 HG22 ' A' ' 61' ' ' THR . 30.8 mt -83.47 132.33 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.94 -76.29 0.44 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.02 161.13 19.63 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 119.187 0.903 . . . . 0.0 113.349 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -79.16 143.2 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.329 0.652 . . . . 0.0 110.714 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.5 mm? -101.01 -61.41 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.126 0.971 . . . . 0.0 108.622 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 9.3 tp10 -76.41 107.01 8.37 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.2 p -72.46 119.55 75.61 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.712 0.805 . . . . 0.0 111.446 -170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.17 148.61 77.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.8 2.333 . . . . 0.0 112.129 171.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.93 -24.1 66.75 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.8 p-10 -98.29 42.72 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.109 0.963 . . . . 0.0 109.985 168.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -48.05 -39.34 19.7 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.76 1.224 . . . . 0.0 110.61 173.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.59 -37.7 65.85 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.6 mm? -76.53 -41.92 44.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.871 0.868 . . . . 0.0 110.732 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.07 39.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 50.2 mtp180 -71.62 -36.65 70.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.088 0.555 . . . . 0.0 110.456 171.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -72.49 -11.99 60.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 61' ' ' THR . . . 88.15 7.75 72.96 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.248 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 32.9 mm -81.6 82.92 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.8 mt -87.69 144.05 10.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.7 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.4 tt -92.96 138.61 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -53.92 117.27 3.06 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.293 0.996 . . . . 0.0 110.162 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.17 -11.37 13.07 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.533 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -88.29 142.89 27.37 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.874 0.837 . . . . 0.0 110.971 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 93.0 mttt -84.17 154.2 23.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.925 0.49 . . . . 0.0 110.49 -175.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 78' ' ' ILE . 4.5 tt -151.35 156.11 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.391 1.077 . . . . 0.0 109.214 -168.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.46 ' HG3' HD21 ' A' ' 82' ' ' LEU . 27.0 mtp85 -112.79 135.5 53.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -121.3 -175.82 3.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.998 0.919 . . . . 0.0 109.718 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -61.24 -34.48 75.2 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.998 0.519 . . . . 0.0 111.299 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.07 -69.92 0.32 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.512 0.725 . . . . 0.0 110.99 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.88 -161.85 13.76 Favored Glycine 0 C--O 1.24 0.51 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.458 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.704 ' HB3' ' HG2' ' A' ' 127' ' ' LYS . 68.5 tp -69.19 129.28 39.42 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.54 167.49 19.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.6 1.16 . . . . 0.0 109.265 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 126' ' ' LEU . 10.6 p -117.09 132.83 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.798 0.839 . . . . 0.0 108.929 169.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' ALA . 12.6 m -68.51 119.54 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 173.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 124' ' ' VAL . 8.4 t -116.48 9.71 14.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 29.3 t -149.99 157.83 43.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.38 1.072 . . . . 0.0 108.382 169.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.44 166.16 44.5 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.861 0.864 . . . . 0.0 111.448 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.19 115.25 2.61 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.0 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.22 170.76 20.08 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.943 -0.572 . . . . 0.0 113.159 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -64.5 -24.78 67.73 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.605 0.703 . . . . 0.0 111.537 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -73.73 -12.35 60.69 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.499 1.52 . . . . 0.0 111.744 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.2 -14.37 64.55 Favored Glycine 0 C--N 1.349 1.294 0 C-N-CA 123.402 0.525 . . . . 0.0 113.74 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 62' ' ' THR . 95.5 t -84.4 137.53 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.605 0.762 . . . . 0.0 110.569 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -106.38 114.89 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.9 OUTLIER -73.54 135.68 43.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.964 0.347 . . . . 0.0 111.525 -174.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -127.92 170.82 12.4 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.393 1.077 . . . . 0.0 111.894 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 112' ' ' THR . 4.2 t -133.36 132.32 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.666 1.186 . . . . 0.0 109.268 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.573 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.5 mt -62.21 118.93 8.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.218 0.533 . . . . 0.0 111.676 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 110' ' ' VAL . 93.5 mt -74.0 -31.81 63.12 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.013 168.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.704 ' HG2' ' HB3' ' A' ' 108' ' ' LEU . 30.9 mmmt -73.46 95.43 2.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.486 167.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -149.43 165.96 30.52 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.556 0.742 . . . . 0.0 109.971 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.85 127.42 54.02 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.6 t -128.01 144.59 51.11 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.035 0.934 . . . . 0.0 109.41 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -69.29 105.27 2.48 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.669 0.788 . . . . 0.0 110.696 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -146.65 149.85 34.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.16 0.984 . . . . 0.0 109.208 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 CA--C 1.557 1.23 0 C-N-CA 123.901 0.88 . . . . 0.0 111.048 -176.765 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.988 0.423 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.77 161.57 11.67 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.535 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -80.55 99.12 7.92 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -69.5 107.18 3.26 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.381 0.672 . . . . 0.0 109.69 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -142.01 137.83 31.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.443 0.697 . . . . 0.0 110.533 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . -167.36 42.73 0.25 Allowed Glycine 0 CA--C 1.543 1.808 0 CA-C-O 118.128 -1.373 . . . . 0.0 114.588 165.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 6' ' ' GLY . 56.2 Cg_endo -93.74 114.2 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.764 0 CA-C-N 121.384 2.592 . . . . 0.0 111.212 173.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.17 139.07 58.73 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.33 112.62 1.81 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.456 0.702 . . . . 0.0 109.396 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -58.56 120.77 9.46 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.272 0.983 . . . . 0.0 110.948 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.36 132.75 43.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.699 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 tt -126.24 142.34 43.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.316 1.046 . . . . 0.0 108.6 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.4 m -71.26 125.46 27.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.191 0.597 . . . . 0.0 110.48 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.06 169.4 46.08 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.366 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 80.73 0.59 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.06 74.73 3.63 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.734 0.813 . . . . 0.0 109.734 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -164.13 129.13 2.81 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.403 -172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.64 -141.73 11.82 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -164.39 152.37 12.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.342 0.657 . . . . 0.0 110.106 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -82.61 97.64 8.6 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.305 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -77.19 113.7 15.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.892 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.55 149.84 49.6 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.827 0.451 . . . . 0.0 110.518 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -95.53 169.76 9.82 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.444 0.697 . . . . 0.0 110.156 -173.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -80.03 96.88 6.59 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.83 169.67 17.6 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.372 0.669 . . . . 0.0 110.745 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.92 152.34 51.66 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.59 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.81 154.2 23.65 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.056 0.542 . . . . 0.0 109.944 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -106.25 118.54 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.98 169.88 50.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.826 0.704 . . . . 0.0 112.945 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.18 148.47 45.15 Favored Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 123.402 0.681 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.56 152.1 81.86 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.629 2.219 . . . . 0.0 111.703 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.23 147.43 95.02 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.57 2.18 . . . . 0.0 112.157 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 t -69.15 104.99 2.32 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.655 0.741 . . . . 0.0 110.414 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -72.82 -66.48 0.66 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.225 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -131.4 154.82 48.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.877 0.871 . . . . 0.0 110.226 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 p -76.5 136.58 39.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.331 0.653 . . . . 0.0 109.696 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.539 HD13 ' HB3' ' A' ' 39' ' ' ALA . 4.0 pp -72.51 154.51 40.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.905 0.482 . . . . 0.0 112.024 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 56.2 p -104.0 11.04 35.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.548 0.739 . . . . 0.0 111.726 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' HB3' HD13 ' A' ' 37' ' ' LEU . . . -69.87 -20.41 63.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.344 0.658 . . . . 0.0 111.923 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.84 -27.31 63.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.961 0.505 . . . . 0.0 111.26 172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.46 -30.04 59.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.652 0.381 . . . . 0.0 110.096 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.09 -37.4 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.71 -25.09 65.49 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.96 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -77.23 -32.48 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.87 0.868 . . . . 0.0 110.842 177.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.48 -31.89 72.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -79.1 -29.07 43.1 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.722 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 44' ' ' ILE . 17.0 ptt180 -75.04 -36.11 61.87 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.915 0.325 . . . . 0.0 110.653 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -82.6 -42.36 18.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -168.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.89 148.05 50.79 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.536 0.607 . . . . 0.0 110.406 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.73 86.11 0.16 Allowed Glycine 0 C--N 1.343 0.919 0 O-C-N 123.583 0.552 . . . . 0.0 112.865 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.93 52.64 1.93 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.46 105.77 11.01 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.334 0.654 . . . . 0.0 109.37 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -68.67 122.42 18.49 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.119 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -58.82 142.03 51.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.244 0.618 . . . . 0.0 111.343 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.13 168.26 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.045 0.538 . . . . 0.0 111.394 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -74.38 118.78 17.73 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.28 149.71 49.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.165 0.586 . . . . 0.0 110.402 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.68 122.02 26.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.188 0.518 . . . . 0.0 110.677 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.04 119.57 38.91 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.815 1.246 . . . . 0.0 107.854 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -74.55 143.6 44.42 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.965 0.506 . . . . 0.0 110.719 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.483 HG22 HD12 ' A' ' 78' ' ' ILE . 3.6 m -76.33 117.14 17.7 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 9.9 m -123.04 159.8 27.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.324 0.649 . . . . 0.0 109.325 -165.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.53 136.99 46.98 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.018 0.927 . . . . 0.0 108.555 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -106.81 91.4 3.65 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 74' ' ' LYS . 18.8 m -79.84 117.58 25.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -66.94 127.06 31.1 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 147.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.71 115.59 64.84 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.4 -21.17 61.17 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.161 2.574 . . . . 0.0 114.419 -174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.38 -52.57 6.42 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.902 0.481 . . . . 0.0 111.029 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -87.52 -12.84 44.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.61 0.764 . . . . 0.0 111.485 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER 63.76 31.72 14.05 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.072 1.349 . . . . 0.0 112.053 175.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -135.19 141.35 45.85 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.003 0.921 . . . . 0.0 110.627 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -85.48 159.54 19.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.954 0.502 . . . . 0.0 111.654 -173.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.5 ttmt -150.19 122.91 8.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.895 1.278 . . . . 0.0 107.728 -171.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -104.19 104.84 14.82 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.79 148.6 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.27 1.428 . . . . 0.0 109.569 -172.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -65.3 154.66 37.59 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 123.827 0.705 . . . . 0.0 110.228 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 HG22 ' A' ' 61' ' ' THR . 59.5 mt -91.23 138.03 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.54 -76.61 0.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 165.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 103' ' ' ARG . 2.4 pm0 -165.57 161.83 18.7 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.905 0.775 . . . . 0.0 112.982 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -82.9 147.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.231 173.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -103.34 -60.23 1.59 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.101 0.961 . . . . 0.0 109.18 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 15.1 tp10 -77.28 117.12 18.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.9 m -66.4 115.15 21.14 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.807 0.692 . . . . 0.0 111.02 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.11 148.86 89.51 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.913 2.408 . . . . 0.0 111.877 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.66 -43.8 76.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.323 1.049 . . . . 0.0 111.71 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -93.65 60.19 2.97 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.539 0.735 . . . . 0.0 110.284 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -36.01 75.45 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.225 0.61 . . . . 0.0 110.046 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -49.7 -33.69 16.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 75.6 mt -93.73 -30.66 14.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.441 0.697 . . . . 0.0 111.793 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.58 -13.74 6.48 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.8 -31.18 72.0 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.151 0.501 . . . . 0.0 110.429 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -87.5 -0.9 57.48 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.704 1.202 . . . . 0.0 111.009 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.89 14.49 77.36 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.882 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 46.4 mm -83.0 84.53 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.41 140.44 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.134 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.7 tt -94.94 145.81 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HA ' HG23 ' A' ' 111' ' ' VAL . 58.6 ttp180 -58.22 129.7 43.23 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.227 1.011 . . . . 0.0 112.222 -170.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.4 -6.1 31.79 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.873 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.81 132.69 36.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.102 0.561 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -77.07 151.03 35.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.112 0.565 . . . . 0.0 109.698 -178.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 3.8 tt -149.12 156.32 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.971 1.309 . . . . 0.0 108.166 -172.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 57.1 mtt180 -115.85 133.05 56.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.0 p -119.38 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.244 1.018 . . . . 0.0 109.571 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -62.84 -19.8 64.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.114 0.566 . . . . 0.0 111.301 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -77.14 -70.75 0.45 Allowed 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.623 0.769 . . . . 0.0 110.278 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.76 -159.96 11.25 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.3 tp -70.58 128.08 34.89 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 165.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -128.93 162.36 27.74 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.973 0.909 . . . . 0.0 109.613 173.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.04 128.22 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.922 0.889 . . . . 0.0 108.744 170.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 98' ' ' ARG . 33.3 m -65.75 111.58 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-O 121.506 0.67 . . . . 0.0 110.31 -178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.1 p -106.62 8.55 31.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.877 0.871 . . . . 0.0 111.664 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 50.6 m -148.2 172.86 13.66 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 109.257 174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -72.58 154.73 91.47 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 172.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 121' ' ' ILE . 18.9 Cg_endo -59.83 125.55 18.03 Favored 'Trans proline' 0 C--N 1.367 1.5 0 C-N-CA 123.065 2.51 . . . . 0.0 111.938 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.64 160.31 51.81 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.857 170.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -68.69 -21.05 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.363 0.665 . . . . 0.0 111.507 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 -0.41 15.92 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.652 0.781 . . . . 0.0 111.792 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.88 44.79 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.08 0.371 . . . . 0.0 112.274 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.2 p -129.03 122.3 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.589 0.755 . . . . 0.0 110.198 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 115' ' ' PRO . 1.6 mp -105.01 118.44 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.65 0.78 . . . . 0.0 109.371 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 42.3 m-80 -66.39 126.34 28.49 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.828 0.346 . . . . 0.0 110.758 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -132.84 169.42 16.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 0.0 110.839 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -121.87 125.31 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.481 0.712 . . . . 0.0 109.876 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 109' ' ' ALA . 90.0 mt -64.66 116.93 6.73 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.16 -50.88 68.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.544 0.338 . . . . 0.0 110.34 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 127' ' ' LYS . 14.9 ptpt 46.2 23.02 0.17 Allowed 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 126.03 1.732 . . . . 0.0 114.565 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -127.47 94.78 4.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.02 112.56 1.23 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.266 0.979 . . . . 0.0 109.884 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -105.55 97.24 7.1 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -69.91 161.53 29.77 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.256 0.622 . . . . 0.0 110.842 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -88.67 -13.29 40.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.918 0.487 . . . . 0.0 111.811 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.203 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.8 63.36 0.01 OUTLIER Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -75.1 86.96 2.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.308 0.575 . . . . 0.0 109.812 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -84.31 111.33 19.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -56.71 147.97 21.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.004 0.922 . . . . 0.0 111.564 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 111.49 3.76 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.89 -0.95 . . . . 0.0 111.837 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.06 129.15 14.8 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.442 2.095 . . . . 0.0 111.11 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -74.97 83.94 2.24 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -110.68 133.86 52.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.89 0.876 . . . . 0.0 109.622 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -154.03 135.55 14.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.748 0.819 . . . . 0.0 109.25 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -88.57 97.87 11.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.487 0.715 . . . . 0.0 109.274 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 tt -69.53 118.33 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 t -75.65 153.31 37.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 0.0 110.926 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.48 -125.42 0.14 Allowed Glycine 0 C--N 1.352 1.465 0 O-C-N 123.464 0.477 . . . . 0.0 112.978 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.36 159.69 32.62 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 116.991 0.396 . . . . 0.0 112.424 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.9 tp -161.12 127.28 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -145.3 144.6 30.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.56 0.744 . . . . 0.0 110.323 -173.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.21 173.88 52.11 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.171 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -139.08 134.81 33.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.113 0.565 . . . . 0.0 110.251 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -91.88 151.98 20.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -87.49 -176.19 5.5 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -71.64 169.13 16.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.143 0.977 . . . . 0.0 111.155 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.02 157.26 21.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -113.77 94.05 4.66 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.4 0.68 . . . . 0.0 110.405 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -91.92 126.59 37.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.654 0.782 . . . . 0.0 109.652 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -84.47 151.19 24.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.453 0.701 . . . . 0.0 109.734 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.34 143.95 44.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.075 0.55 . . . . 0.0 110.071 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.65 134.42 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.12 -136.56 0.8 Allowed Glycine 0 CA--C 1.537 1.407 0 O-C-N 123.497 0.498 . . . . 0.0 113.573 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.4 142.61 46.93 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.702 0.801 . . . . 0.0 111.196 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -72.48 172.98 13.96 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.174 2.583 . . . . 0.0 112.589 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.69 178.01 0.81 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.908 2.405 . . . . 0.0 113.244 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.1 p -72.81 169.69 16.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.385 0.674 . . . . 0.0 112.279 -175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -69.52 170.01 11.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.206 1.002 . . . . 0.0 112.269 -176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 p -75.15 161.27 29.53 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.177 0.991 . . . . 0.0 112.597 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.2 p -87.17 172.68 9.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.724 0.81 . . . . 0.0 110.828 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -123.08 170.89 9.73 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.667 0.787 . . . . 0.0 110.962 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.4 m -127.16 39.78 3.84 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.183 0.993 . . . . 0.0 109.464 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' H ' HD23 ' A' ' 37' ' ' LEU . . . -69.93 -26.76 64.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.446 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.68 -40.34 96.79 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.43 -33.12 73.64 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.918 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.61 -47.41 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.887 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 46' ' ' ASP . 44.3 mmm-85 -74.12 -21.92 59.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 47' ' ' ARG . 9.6 tp -78.17 -35.81 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-N 118.491 0.587 . . . . 0.0 109.989 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -75.61 -12.23 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 122.127 -0.358 . . . . 0.0 110.387 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 43' ' ' ARG . 31.6 t70 -90.09 -32.94 16.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.15 0.98 . . . . 0.0 111.28 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -67.8 -29.18 68.29 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 m -57.53 -39.87 77.57 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.502 171.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.77 124.9 24.59 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.153 0.581 . . . . 0.0 110.803 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.73 -103.02 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 74.79 1.27 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -121.19 107.37 12.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.833 0.853 . . . . 0.0 109.685 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -73.34 152.67 40.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.432 0.293 . . . . 0.0 110.334 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -83.13 164.38 20.27 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.375 0.67 . . . . 0.0 111.444 -174.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -67.37 156.57 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.788 0.835 . . . . 0.0 111.989 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.26 132.88 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.042 0.537 . . . . 0.0 110.305 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.4 174.96 10.97 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.57 0.7 . . . . 0.0 111.665 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.93 175.13 10.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.614 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -121.37 162.92 19.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.356 1.062 . . . . 0.0 109.759 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -97.76 146.48 25.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.324 0.649 . . . . 0.0 110.232 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 78' ' ' ILE . 9.0 t -67.96 141.66 56.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.059 0.457 . . . . 0.0 110.587 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.3 m -134.11 144.81 48.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.376 0.67 . . . . 0.0 110.188 -168.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.71 161.37 18.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.716 1.207 . . . . 0.0 110.116 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 0.2 OUTLIER -124.58 95.09 4.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.667 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.2 t -82.64 149.07 4.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.3 tm? -106.63 136.43 46.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 109.906 -3.316 . . . . 0.0 104.144 155.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.31 123.91 81.02 Favored Pre-proline 0 N--CA 1.472 0.672 0 C-N-CA 123.451 0.7 . . . . 0.0 109.667 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.01 -17.07 46.06 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.586 2.191 . . . . 0.0 112.066 173.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.34 -67.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.745 0.818 . . . . 0.0 110.985 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 p -84.57 -9.4 58.35 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 64.65 24.96 13.04 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.465 1.106 . . . . 0.0 111.991 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -112.43 143.72 43.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.218 1.007 . . . . 0.0 109.488 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -102.68 118.71 37.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.119 0.418 . . . . 0.0 109.888 -174.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 106' ' ' ALA . 13.0 ptpt -108.25 151.23 26.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 109.125 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -116.17 108.93 16.77 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.65 155.93 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.396 1.478 . . . . 0.0 110.537 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -66.7 144.81 56.14 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 124.765 1.226 . . . . 0.0 110.015 -173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 61' ' ' THR . 43.5 mt -88.32 125.24 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 103' ' ' ARG . 26.9 mt -84.05 -74.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -162.66 150.76 14.13 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.32 137.36 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 122.823 0.449 . . . . 0.0 109.965 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' HG3' ' A' ' 103' ' ' ARG . 1.6 mm? -98.49 -62.11 1.28 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 6.7 tp10 -72.43 106.01 4.37 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 t -78.82 124.51 84.98 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.42 167.26 17.43 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.575 2.183 . . . . 0.0 111.791 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.96 67.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.601 0.761 . . . . 0.0 110.326 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.84 47.53 1.43 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.741 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.76 -36.69 67.58 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -48.48 -39.56 23.45 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.122 0.969 . . . . 0.0 112.642 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.38 -46.13 18.19 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.695 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.91 -22.59 59.92 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 71.9 mtp180 -69.22 -40.74 77.79 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.482 172.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -72.41 -11.17 60.57 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.508 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.34 -4.2 60.15 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.584 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.494 ' HA ' HD11 ' A' ' 121' ' ' ILE . 43.7 mm -81.36 86.35 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.239 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.477 ' H ' HG12 ' A' ' 121' ' ' ILE . 2.5 mt -95.38 148.98 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.733 -172.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.1 tt -100.5 151.62 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.163 0.585 . . . . 0.0 109.937 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -45.24 130.45 8.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.486 1.114 . . . . 0.0 112.128 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.66 3.83 52.53 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.553 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.06 171.11 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.548 0.739 . . . . 0.0 110.795 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 64.5 mttp -117.12 155.18 29.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.052 0.541 . . . . 0.0 110.479 -175.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 78' ' ' ILE . 3.5 tt -145.54 159.95 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.864 1.266 . . . . 0.0 108.903 -175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HG3' HD21 ' A' ' 82' ' ' LEU . 93.1 mtt-85 -114.88 132.09 56.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 p -118.79 177.93 4.67 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.637 0.775 . . . . 0.0 109.851 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.29 -15.63 63.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.083 0.553 . . . . 0.0 111.852 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . . . -82.99 -64.9 1.08 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.464 0.706 . . . . 0.0 110.517 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.07 -159.97 11.42 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.869 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.0 tp -72.23 136.6 46.4 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.516 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -141.4 157.29 45.37 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.28 0.562 . . . . 0.0 110.311 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.3 p -110.15 127.38 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.408 1.083 . . . . 0.0 108.738 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.2 m -73.26 110.9 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.8 t -106.54 12.13 29.84 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.554 -170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . 69.6 m -140.98 166.64 24.25 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 173.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.19 158.72 87.08 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.047 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HA ' HG13 ' A' ' 121' ' ' ILE . 34.2 Cg_endo -64.3 120.49 7.83 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.502 2.135 . . . . 0.0 112.121 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.01 165.35 54.79 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 112.949 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -66.73 -18.83 65.57 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.139 0.576 . . . . 0.0 111.138 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.1 -12.6 61.82 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.345 1.058 . . . . 0.0 111.169 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.72 -2.24 87.66 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.042 0.353 . . . . 0.0 112.559 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 72.5 t -106.66 134.14 49.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.763 1.225 . . . . 0.0 108.973 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.2 mp -110.36 132.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 15.5 m120 -83.66 133.99 34.8 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 111.568 -174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.49 168.13 18.16 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.888 1.275 . . . . 0.0 111.124 -173.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.65 131.45 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 124.088 0.955 . . . . 0.0 109.469 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.667 ' HG ' HG11 ' A' ' 65' ' ' VAL . 62.8 mt -63.25 117.24 6.31 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 112.088 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 110' ' ' VAL . 54.3 mt -75.11 -27.49 59.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.639 165.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp 68.09 -66.93 0.21 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 126.637 1.975 . . . . 0.0 111.582 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -51.59 128.96 24.65 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.133 1.373 . . . . 0.0 111.276 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -62.51 138.34 58.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 110.42 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.8 t -66.77 87.51 0.13 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 110.163 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.05 89.96 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.918 0.887 . . . . 0.0 109.537 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -157.34 -44.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.815 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.456 0.703 . . . . 0.0 110.115 179.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.67 -94.97 0.62 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.1 t80 78.67 -41.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.604 1.562 . . . . 0.0 112.746 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -72.83 162.04 29.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.416 0.687 . . . . 0.0 111.196 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -77.39 177.89 7.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.384 0.673 . . . . 0.0 111.687 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 -143.31 14.32 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 173.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.23 -173.63 1.92 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.046 2.498 . . . . 0.0 111.521 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.81 143.19 57.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.758 0.423 . . . . 0.0 109.979 173.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -57.42 111.31 1.06 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.718 0.807 . . . . 0.0 110.399 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -61.34 116.28 4.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.208 0.603 . . . . 0.0 111.054 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -85.1 98.25 10.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.016 0.926 . . . . 0.0 109.566 -168.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.13 135.31 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.991 0.916 . . . . 0.0 109.958 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -85.64 168.57 14.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.807 0.843 . . . . 0.0 110.474 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -135.21 -33.01 0.28 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 116.551 -0.295 . . . . 0.0 112.575 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 138.86 21.51 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 120.286 -0.175 . . . . 0.0 112.932 -173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.01 147.76 21.58 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 108.1 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -167.52 146.07 4.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.61 0.364 . . . . 0.0 110.656 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.91 148.27 19.76 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -90.6 124.17 34.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.684 0.794 . . . . 0.0 110.53 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -98.84 121.01 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -82.17 164.45 21.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.79 173.38 12.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.79 0.836 . . . . 0.0 112.293 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 138.38 31.68 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.75 0.82 . . . . 0.0 110.114 -171.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -91.37 141.2 29.01 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.536 0.735 . . . . 0.0 110.562 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.12 160.67 24.36 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -120.07 109.58 15.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.469 0.708 . . . . 0.0 109.305 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.34 109.24 3.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.384 0.673 . . . . 0.0 109.903 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -104.41 117.21 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.173 0.989 . . . . 0.0 108.927 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.84 69.15 0.18 Allowed Glycine 0 C--N 1.343 0.953 0 O-C-N 123.366 0.416 . . . . 0.0 112.875 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -102.83 114.18 65.43 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.99 132.33 9.45 Favored 'Trans proline' 0 CA--C 1.563 1.93 0 C-N-CA 122.87 2.38 . . . . 0.0 112.787 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.98 112.1 3.21 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.583 2.189 . . . . 0.0 111.283 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.7 p -67.67 146.5 53.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.605 0.762 . . . . 0.0 111.96 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -88.42 129.03 35.52 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.991 0.916 . . . . 0.0 110.506 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 m -77.68 120.53 22.73 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.654 0.782 . . . . 0.0 109.767 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.4 p -75.52 -89.27 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.251 0.62 . . . . 0.0 111.399 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.9 172.3 5.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.001 0.92 . . . . 0.0 110.995 -175.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 p -126.08 37.94 4.24 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.269 1.028 . . . . 0.0 108.26 169.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 43' ' ' ARG . . . -65.71 -41.71 91.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.696 -175.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.81 -31.58 64.85 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.487 0.715 . . . . 0.0 111.49 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.65 -36.93 85.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.319 1.048 . . . . 0.0 111.107 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.63 -39.06 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.283 0.633 . . . . 0.0 110.553 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.509 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.8 mpt_? -72.14 -25.6 61.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.356 0.663 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.66 -30.83 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -66.09 -29.89 70.3 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.552 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.37 -36.39 58.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.988 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -66.44 -38.2 86.85 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 117.964 0.347 . . . . 0.0 110.52 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 t -80.52 -2.65 47.0 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.431 0.692 . . . . 0.0 112.717 -173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.55 137.54 57.99 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.52 78.93 0.57 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.565 0.541 . . . . 0.0 113.822 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.95 -4.16 61.69 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.142 0.401 . . . . 0.0 112.614 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.02 150.77 28.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.821 0.848 . . . . 0.0 110.164 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.54 157.29 15.96 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.779 0.831 . . . . 0.0 109.734 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -94.55 175.04 6.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.422 0.689 . . . . 0.0 110.722 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.16 136.89 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.852 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -76.58 154.41 34.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.941 0.896 . . . . 0.0 110.951 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.4 126.1 24.9 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.993 0.917 . . . . 0.0 111.9 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -68.16 130.91 44.35 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.244 1.018 . . . . 0.0 110.635 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -74.38 111.17 9.3 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.821 0.849 . . . . 0.0 110.345 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.7 m -80.25 134.47 36.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -69.69 142.49 53.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.975 0.51 . . . . 0.0 110.069 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.491 ' HB ' HG22 ' A' ' 120' ' ' VAL . 19.7 m -124.34 152.09 43.54 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.466 0.706 . . . . 0.0 109.626 -172.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.98 129.59 55.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.988 0.915 . . . . 0.0 109.709 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.16 87.52 2.92 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -175.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.574 HG11 ' HG ' ' A' ' 125' ' ' LEU . 2.1 t -77.37 134.34 28.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.01 136.95 33.05 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.881 152.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.98 116.12 64.01 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.463 1.105 . . . . 0.0 109.415 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.8 -23.55 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.638 2.225 . . . . 0.0 112.862 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.01 -68.28 0.69 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.346 0.658 . . . . 0.0 111.3 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.7 p -87.28 -22.36 25.21 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.436 0.694 . . . . 0.0 112.001 -172.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 64.26 58.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 122.883 1.325 . . . . 0.0 110.73 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.2 p -130.51 159.37 37.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.164 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.72 159.56 19.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.594 0.634 . . . . 0.0 109.832 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -159.1 95.08 1.24 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -96.95 104.31 16.31 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 105' ' ' GLU . 1.7 m -132.37 153.63 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.348 -168.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -62.71 151.38 38.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.044 0.938 . . . . 0.0 111.563 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 HD13 ' A' ' 121' ' ' ILE . 40.0 mt -87.01 130.9 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.29 -78.08 0.5 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.82 151.25 26.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -167.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -88.66 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.129 0.572 . . . . 0.0 109.925 172.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.3 mm? -105.04 -59.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.18 120.45 19.77 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.1 p -71.26 113.93 23.44 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.954 0.783 . . . . 0.0 110.392 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.18 168.83 19.68 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.523 2.148 . . . . 0.0 112.253 171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.17 84.94 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.723 172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 90' ' ' LEU . 3.4 p-10 -99.91 56.54 0.96 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.867 0.867 . . . . 0.0 109.892 173.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -77.83 -18.75 55.97 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.436 1.494 . . . . 0.0 113.301 178.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.54 -18.71 54.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 87' ' ' ASN . 68.9 mt -94.68 -32.15 13.5 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.772 0.429 . . . . 0.0 112.064 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.04 -16.65 62.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.129 0.972 . . . . 0.0 113.498 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -73.05 -23.26 60.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.905 0.482 . . . . 0.0 110.465 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.4 0.37 54.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.744 0.817 . . . . 0.0 110.52 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.14 6.64 84.35 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 123.565 0.602 . . . . 0.0 112.863 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.27 84.0 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.5 mt -107.28 138.26 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.938 -169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.57 142.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.873 0.869 . . . . 0.0 110.252 -172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -48.8 114.04 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.045 1.338 . . . . 0.0 112.505 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -7.31 13.01 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.689 0.662 . . . . 0.0 113.019 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -94.24 145.13 24.94 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.269 0.556 . . . . 0.0 110.915 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.34 135.91 33.7 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.767 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.8 tt -133.25 155.26 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 109.371 -173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.562 ' HG3' HD21 ' A' ' 82' ' ' LEU . 72.9 mtt180 -114.31 129.93 56.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.9 p -112.64 -177.77 3.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.885 0.874 . . . . 0.0 109.019 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 7.7 mm-40 -62.65 -32.0 72.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.125 0.488 . . . . 0.0 110.034 170.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.09 -69.26 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.305 1.042 . . . . 0.0 111.428 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.67 -158.72 10.15 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -75.16 128.87 36.49 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 165.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -134.66 166.81 22.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.214 1.006 . . . . 0.0 110.005 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.5 p -112.26 130.16 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.442 1.097 . . . . 0.0 108.695 166.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.9 m -66.55 120.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.549 0.613 . . . . 0.0 109.477 174.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -110.03 10.14 24.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.521 0.728 . . . . 0.0 112.003 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 41.5 t -138.72 169.79 17.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 0.0 110.58 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -83.33 143.15 44.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.265 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.627 ' HA ' HG13 ' A' ' 121' ' ' ILE . 97.8 Cg_exo -46.38 119.55 3.18 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 123.581 2.854 . . . . 0.0 113.694 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.53 166.0 54.7 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.702 0.626 . . . . 0.0 112.682 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.98 -21.25 60.88 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.248 0.619 . . . . 0.0 110.551 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.16 -12.67 60.65 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.175 0.59 . . . . 0.0 110.819 173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.46 33.02 17.88 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 62' ' ' THR . 60.2 t -127.18 129.9 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.402 0.681 . . . . 0.0 110.004 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.627 HG13 ' HA ' ' A' ' 115' ' ' PRO . 2.1 mp -114.42 120.13 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.856 0.862 . . . . 0.0 108.934 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -65.82 134.45 53.12 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.516 0.326 . . . . 0.0 110.665 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.11 165.12 23.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.103 0.961 . . . . 0.0 111.581 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -127.74 128.95 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 124.073 0.949 . . . . 0.0 109.603 170.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' HG11 ' A' ' 65' ' ' VAL . 87.8 mt -62.8 119.24 8.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.23 0.331 . . . . 0.0 111.283 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.463 HD11 ' HB ' ' A' ' 110' ' ' VAL . 89.0 mt -82.11 -24.62 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.565 0.746 . . . . 0.0 110.585 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.89 109.53 2.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -126.26 140.73 52.3 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.599 0.76 . . . . 0.0 109.398 -168.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -93.58 -15.42 25.43 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.835 0.854 . . . . 0.0 111.378 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.5 t 64.46 173.08 0.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.905 1.282 . . . . 0.0 111.092 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -158.8 102.11 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.875 -0.516 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -94.81 -52.33 4.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 169.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.258 1.529 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.827 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.81 86.09 1.07 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -58.85 114.62 2.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.096 0.958 . . . . 0.0 111.192 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -61.04 117.54 5.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.491 1.116 . . . . 0.0 109.615 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -53.63 -52.76 58.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.608 1.163 . . . . 0.0 112.546 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.15 141.9 3.42 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.273 -0.737 . . . . 0.0 112.282 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.61 140.65 21.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.78 2.32 . . . . 0.0 112.039 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.82 142.06 46.15 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.164 0.585 . . . . 0.0 110.399 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -94.12 142.5 27.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.882 0.873 . . . . 0.0 109.932 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.9 144.23 54.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 0.0 110.292 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.1 136.3 34.51 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.653 0.781 . . . . 0.0 110.576 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.7 tt -141.32 150.44 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.104 0.962 . . . . 0.0 108.865 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 t -74.79 161.97 29.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.078 0.551 . . . . 0.0 111.792 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.32 -32.52 0.02 OUTLIER Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.08 75.04 2.39 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 123.037 0.351 . . . . 0.0 112.846 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.55 144.93 24.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 108.384 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -168.77 125.25 0.97 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.292 0.637 . . . . 0.0 109.457 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.84 137.82 14.38 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -95.98 157.96 15.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.759 0.824 . . . . 0.0 110.466 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -76.14 160.89 29.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.554 0.742 . . . . 0.0 111.048 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -102.3 172.04 7.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.656 0.782 . . . . 0.0 110.991 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.6 142.49 29.92 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.796 0.839 . . . . 0.0 110.807 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -90.99 141.26 29.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.69 0.796 . . . . 0.0 109.774 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -67.06 116.39 7.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.871 0.869 . . . . 0.0 110.943 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -73.7 124.04 25.24 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.439 0.695 . . . . 0.0 109.917 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -75.54 154.46 36.81 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.537 0.735 . . . . 0.0 110.286 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.71 166.52 23.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.314 0.646 . . . . 0.0 111.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.0 136.42 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.074 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.64 -162.32 27.16 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.292 0.37 . . . . 0.0 112.782 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.9 OUTLIER -98.26 130.84 27.46 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.015 0.526 . . . . 0.0 109.7 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.4 168.02 23.54 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.978 2.452 . . . . 0.0 112.008 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -49.65 145.62 17.0 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.299 2.666 . . . . 0.0 113.123 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.6 p -76.22 -83.15 0.07 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.68 168.67 26.05 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.81 0.444 . . . . 0.0 111.594 -171.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 p -107.6 158.61 17.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.838 1.255 . . . . 0.0 109.927 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.0 p -69.32 147.1 51.59 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.823 0.449 . . . . 0.0 111.417 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 39' ' ' ALA . 1.8 pt? -65.15 169.86 5.13 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.115 0.966 . . . . 0.0 112.029 175.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -101.39 27.65 6.09 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.374 0.67 . . . . 0.0 111.909 -176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.438 ' H ' ' HG ' ' A' ' 37' ' ' LEU . . . -71.75 -44.67 63.67 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.62 0.368 . . . . 0.0 111.615 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.08 -8.01 53.85 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.82 -27.51 62.0 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.454 0.702 . . . . 0.0 110.505 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.1 mt -77.89 -32.33 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.614 0.766 . . . . 0.0 109.589 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 39' ' ' ALA . 10.4 mpt_? -70.11 -39.29 75.59 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.355 0.662 . . . . 0.0 111.562 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 47' ' ' ARG . 3.8 tp -67.01 -44.38 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -55.78 -35.47 66.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.092 0.557 . . . . 0.0 111.322 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.44 -49.75 45.43 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.373 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.455 ' HG2' HD12 ' A' ' 44' ' ' ILE . 19.9 ptt180 -70.43 -34.82 72.92 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.598 0.359 . . . . 0.0 111.826 -169.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 44' ' ' ILE . 13.1 t -82.0 -19.19 41.02 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.518 0.327 . . . . 0.0 110.451 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -63.65 117.62 7.09 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -71.58 0.76 Allowed Glycine 0 C--N 1.342 0.916 0 O-C-N 124.242 0.964 . . . . 0.0 114.7 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.23 61.1 4.73 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -80.51 155.94 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.465 0.706 . . . . 0.0 111.719 -174.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.5 151.13 30.94 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.681 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 2.9 mptp? -84.27 122.39 28.82 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.566 0.747 . . . . 0.0 109.621 -175.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.38 135.24 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.439 0.696 . . . . 0.0 109.911 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 120.42 38.99 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.106 0.963 . . . . 0.0 109.055 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.18 146.91 43.04 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.68 0.792 . . . . 0.0 109.694 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.34 158.43 26.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.179 0.591 . . . . 0.0 111.603 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -67.35 146.62 53.9 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.39 0.676 . . . . 0.0 111.392 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -63.95 137.02 57.82 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.852 0.861 . . . . 0.0 110.632 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 t -67.86 135.0 51.84 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.543 0.527 . . . . 0.0 109.595 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HG2' ' A' ' 75' ' ' LYS . 2.7 m -135.62 158.53 44.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -169.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.09 132.73 56.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.584 0.753 . . . . 0.0 109.21 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.95 94.36 5.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' HG ' ' A' ' 125' ' ' LEU . 1.4 t -81.47 142.43 13.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 N-CA-C 101.349 -3.575 . . . . 0.0 101.349 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 3.4 tm? -94.6 132.97 38.75 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 110.887 -2.87 . . . . 0.0 104.01 150.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.7 112.96 44.05 Favored Pre-proline 0 N--CA 1.471 0.592 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.3 -13.02 37.6 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.288 2.658 . . . . 0.0 113.76 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.91 -61.05 1.81 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.297 0.639 . . . . 0.0 111.387 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.0 p -91.06 -14.64 30.93 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.569 0.748 . . . . 0.0 112.536 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 61.38 44.41 9.55 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.535 1.159 . . . . 0.0 110.664 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.7 p -127.22 129.16 47.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.662 1.185 . . . . 0.0 108.488 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . . . -86.36 129.32 34.89 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.627 0.648 . . . . 0.0 111.392 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.24 155.68 20.82 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HG2' HG21 ' A' ' 62' ' ' THR . 5.5 ttpm? -121.75 108.98 14.14 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.13 151.23 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.506 1.523 . . . . 0.0 108.434 -175.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -72.6 159.45 33.85 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.504 0.722 . . . . 0.0 110.655 -168.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 121' ' ' ILE . 61.2 mt -86.11 130.7 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -175.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.35 -82.0 0.43 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 169.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -148.56 150.19 32.9 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.98 0.809 . . . . 0.0 112.82 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -91.54 142.19 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.1 mm? -102.06 -55.25 2.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.106 0.962 . . . . 0.0 108.878 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.7 tt0 -81.46 112.26 18.55 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.2 p -69.33 117.53 53.36 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.76 0.824 . . . . 0.0 110.983 -175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.55 160.73 25.29 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.17 1.913 . . . . 0.0 110.853 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.36 64.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.531 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' HD12 ' A' ' 90' ' ' LEU . 5.1 p-10 -87.16 60.47 6.18 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.708 0.803 . . . . 0.0 110.074 173.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -54.19 -51.38 64.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.35 0.66 . . . . 0.0 110.093 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -28.47 69.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 0.0 112.279 -170.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 87' ' ' ASN . 42.5 mt -79.8 -51.06 9.64 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.331 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.88 -26.01 45.23 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 88' ' ' LYS . 95.6 mtt180 -63.14 -40.82 98.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.631 0.729 . . . . 0.0 110.796 173.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -74.75 -21.43 59.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.447 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.07 -1.94 33.41 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.73 0.644 . . . . 0.0 112.698 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 115' ' ' PRO . 48.6 mm -80.2 84.89 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-O 122.245 1.022 . . . . 0.0 109.091 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mt -98.52 147.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.763 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -94.82 146.94 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.33 122.31 10.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.212 1.005 . . . . 0.0 111.1 -175.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.19 -19.39 11.83 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.317 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -85.76 139.72 31.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.92 0.488 . . . . 0.0 110.78 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.7 mptt -80.86 139.26 36.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.966 0.506 . . . . 0.0 110.669 -173.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.3 tt -130.77 157.35 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 125.365 1.466 . . . . 0.0 108.914 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HG3' HD21 ' A' ' 82' ' ' LEU . 73.2 mtt180 -114.23 129.52 56.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 168.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 p -110.2 179.23 4.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.61 -18.42 65.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.769 0.427 . . . . 0.0 111.616 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.95 -70.89 0.52 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.341 0.656 . . . . 0.0 110.474 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.82 -160.62 10.1 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.044 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.5 137.07 46.09 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 166.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -139.72 167.3 22.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.229 1.012 . . . . 0.0 109.539 171.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 126' ' ' LEU . 7.2 p -115.35 132.73 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.311 1.044 . . . . 0.0 108.511 168.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 100' ' ' ALA . 35.1 m -69.35 115.14 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-O 121.676 0.751 . . . . 0.0 109.755 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 p -105.26 14.54 28.82 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.927 0.891 . . . . 0.0 111.274 -176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 44.4 t -154.2 160.43 41.85 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.576 0.75 . . . . 0.0 109.396 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.47 162.78 72.71 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.853 171.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.571 ' HG2' HG23 ' A' ' 95' ' ' ILE . 77.4 Cg_exo -54.6 122.42 11.55 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.319 2.679 . . . . 0.0 113.85 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.72 166.8 54.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.268 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -65.7 -22.13 66.59 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.645 0.778 . . . . 0.0 112.048 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.76 -7.41 53.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.578 0.751 . . . . 0.0 112.132 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.69 21.8 65.6 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -173.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' THR . 43.1 t -113.26 123.99 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 0.0 109.394 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 78' ' ' ILE . 2.1 mp -106.45 116.63 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 35.3 m-80 -71.96 133.98 45.68 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.579 0.352 . . . . 0.0 111.579 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -131.09 168.77 16.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.162 0.985 . . . . 0.0 111.793 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.4 t -127.97 129.09 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.64 1.176 . . . . 0.0 109.499 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.691 ' HG ' HG11 ' A' ' 65' ' ' VAL . 81.2 mt -62.26 123.74 19.01 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.182 0.515 . . . . 0.0 111.64 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.505 HD11 ' HB ' ' A' ' 110' ' ' VAL . 91.7 mt -86.17 29.64 0.73 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.005 0.922 . . . . 0.0 111.39 174.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 125' ' ' LEU . 56.1 mtpt -57.06 -26.81 60.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 110.717 169.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -63.51 111.9 2.54 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.88 154.03 39.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -69.83 -35.48 74.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.396 0.678 . . . . 0.0 111.271 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -149.12 149.17 30.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.217 0.607 . . . . 0.0 110.716 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -156.56 108.63 2.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.769 0.827 . . . . 0.0 109.863 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.678 1.191 . . . . 0.0 108.413 177.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.99 126.42 1.15 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.509 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.29 175.76 5.8 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.208 1.003 . . . . 0.0 108.919 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -119.32 138.09 53.27 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.02 0.528 . . . . 0.0 109.966 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -150.07 178.01 9.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.732 0.813 . . . . 0.0 110.116 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.66 -111.59 0.5 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-O 118.895 -0.947 . . . . 0.0 112.177 174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.22 122.58 11.34 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.358 2.706 . . . . 0.0 113.429 -177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -115.21 -175.03 2.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.042 0.937 . . . . 0.0 109.292 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.41 82.66 2.08 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -130.25 116.66 18.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.404 1.082 . . . . 0.0 108.272 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -100.16 114.23 27.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.491 0.716 . . . . 0.0 109.988 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.84 132.94 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.327 0.651 . . . . 0.0 109.451 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -156.88 101.2 1.94 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.334 1.054 . . . . 0.0 108.558 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.5 -30.48 27.2 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.016 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.48 -163.88 37.48 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -93.09 -45.96 7.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.771 0.828 . . . . 0.0 109.59 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.3 tptm 61.8 103.43 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.286 1.434 . . . . 0.0 111.1 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.36 139.8 11.24 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.445 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -114.21 100.41 8.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.111 0.964 . . . . 0.0 108.417 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -68.94 106.59 2.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.519 0.728 . . . . 0.0 111.323 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -78.05 98.26 5.69 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 -169.55 2.64 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.162 0.585 . . . . 0.0 109.892 174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -130.77 154.41 48.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 0.0 110.439 -174.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -114.07 136.94 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 109.195 173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -76.4 144.74 39.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.94 0.496 . . . . 0.0 109.996 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -80.51 165.29 22.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.42 0.688 . . . . 0.0 111.319 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.46 147.96 26.81 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.433 0.693 . . . . 0.0 111.156 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.58 147.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.794 0.837 . . . . 0.0 109.974 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.3 179.78 14.5 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -99.09 151.47 37.4 Favored Pre-proline 0 N--CA 1.486 1.371 0 C-N-CA 123.904 0.882 . . . . 0.0 111.209 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.27 140.3 76.5 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.248 2.632 . . . . 0.0 113.191 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.45 174.17 13.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.968 2.445 . . . . 0.0 113.392 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 m -86.46 148.77 25.4 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.649 0.779 . . . . 0.0 110.545 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.42 158.28 20.26 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.527 0.731 . . . . 0.0 109.529 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.2 p -80.98 159.17 24.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.219 0.608 . . . . 0.0 112.109 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -97.76 178.98 4.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.952 0.901 . . . . 0.0 110.032 173.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -136.35 152.21 50.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.961 0.504 . . . . 0.0 111.159 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.0 m -119.78 21.34 12.01 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.251 1.02 . . . . 0.0 110.463 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -61.43 -34.34 75.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.256 0.623 . . . . 0.0 111.088 176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.02 -31.58 72.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.76 0.824 . . . . 0.0 111.64 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.44 -35.71 80.97 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.243 0.617 . . . . 0.0 110.165 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 mm -64.43 -40.24 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.789 173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 25.4 mmt180 -70.55 -31.6 68.71 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.316 0.646 . . . . 0.0 112.571 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 7.0 tp -78.28 -23.48 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-O 121.97 0.89 . . . . 0.0 109.392 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' HG22 ' A' ' 48' ' ' THR . 23.8 tptm -79.75 -25.65 40.97 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.096 171.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -74.28 -29.85 61.84 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 9.4 ttp180 -54.59 -61.2 2.46 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.887 0.875 . . . . 0.0 110.184 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 45' ' ' LYS . 11.4 t -71.97 -6.16 40.05 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.978 -165.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 tp -73.0 111.83 8.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.28 -157.71 26.03 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.766 -0.197 . . . . 0.0 113.09 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.23 -170.7 12.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.078 0.37 . . . . 0.0 112.408 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -109.4 171.77 7.24 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.834 0.854 . . . . 0.0 110.842 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -89.98 164.41 14.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.173 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -114.51 157.58 22.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.267 0.627 . . . . 0.0 109.351 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.94 137.67 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.042 0.537 . . . . 0.0 111.246 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 140.26 30.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.046 0.938 . . . . 0.0 108.634 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.78 147.42 26.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.449 0.699 . . . . 0.0 110.399 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -100.1 -178.35 3.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.411 0.684 . . . . 0.0 110.782 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -104.84 175.68 5.41 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.277 1.031 . . . . 0.0 110.057 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 t -136.73 151.92 49.77 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.347 0.594 . . . . 0.0 111.003 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 78' ' ' ILE . 90.8 m -115.33 100.6 8.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.707 1.203 . . . . 0.0 108.343 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 120' ' ' VAL . 28.5 m -135.57 153.1 51.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 109.249 -170.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -120.38 132.7 55.38 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.437 HD21 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -105.43 95.83 6.09 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 21.4 m -81.41 129.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.47 126.48 30.84 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 146.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -93.42 113.4 60.04 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.0 -28.42 59.66 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.766 2.977 . . . . 0.0 114.273 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.1 -60.37 2.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.728 0.411 . . . . 0.0 111.426 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 p -87.57 -16.6 34.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.21 0.604 . . . . 0.0 111.576 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 59.97 45.12 12.59 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.3 1.44 . . . . 0.0 110.574 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 75.2 p -129.32 145.23 51.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.981 0.912 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB1' HD21 ' A' ' 64' ' ' ASN . . . -85.41 149.66 25.27 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB3' HG23 ' A' ' 65' ' ' VAL . 18.5 ttmm -147.68 116.22 6.67 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HG2' HG21 ' A' ' 62' ' ' THR . 32.2 ttpt -102.08 103.38 13.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.34 154.8 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.463 1.505 . . . . 0.0 109.895 -171.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -65.86 151.79 45.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 111.525 -173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 121' ' ' ILE . 25.7 mt -85.81 130.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 103' ' ' ARG . 55.6 mt -91.07 -77.48 0.41 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 169.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -162.25 162.82 28.33 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.202 0.91 . . . . 0.0 113.315 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -92.08 131.21 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.542 0.737 . . . . 0.0 109.993 174.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD21 ' HG3' ' A' ' 103' ' ' ARG . 2.4 mm? -93.48 -66.57 0.91 Allowed 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 39.5 tt0 -72.49 107.04 4.82 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.5 m -79.36 118.05 70.38 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.39 -169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.63 165.14 33.09 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.559 2.173 . . . . 0.0 111.682 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.1 -22.71 67.04 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.406 0.682 . . . . 0.0 110.857 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.456 ' HB2' HD12 ' A' ' 90' ' ' LEU . 6.5 p-10 -98.25 43.22 1.07 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.369 1.067 . . . . 0.0 109.876 173.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -48.18 -47.92 34.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.234 1.013 . . . . 0.0 111.373 177.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.01 -33.17 72.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.288 0.566 . . . . 0.0 111.799 -173.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 26.3 mt -76.4 -47.57 22.76 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.621 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.65 -24.65 34.91 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.882 1.273 . . . . 0.0 114.392 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -68.02 -38.14 82.23 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.077 0.465 . . . . 0.0 110.441 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' NH1' HD23 ' A' ' 90' ' ' LEU . 47.9 mtt180 -76.14 -16.85 59.8 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.182 0.993 . . . . 0.0 109.788 173.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.98 -1.79 31.61 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.405 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 48.3 mm -80.07 83.73 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 CA-C-O 121.787 0.803 . . . . 0.0 108.927 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 19.4 mt -102.44 142.25 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.004 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.6 tt -94.97 149.28 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 112' ' ' THR . 35.7 ttt180 -56.82 131.26 48.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.735 0.814 . . . . 0.0 111.605 -176.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.3 -26.95 8.36 Favored Glycine 0 C--N 1.346 1.133 0 O-C-N 123.763 0.665 . . . . 0.0 112.684 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -81.8 133.52 35.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.037 0.535 . . . . 0.0 111.598 -173.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 83' ' ' GLU . 12.8 mptt -78.7 136.73 37.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.089 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.4 tt -133.25 151.54 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.019 1.327 . . . . 0.0 108.655 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG3' HD21 ' A' ' 82' ' ' LEU . 37.2 mtt180 -109.55 136.18 49.35 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.8 p -122.9 179.28 4.7 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 109.8 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -60.27 -28.8 68.36 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.35 0.66 . . . . 0.0 111.482 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.42 -69.98 0.48 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.539 0.735 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.4 -164.55 17.63 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 129' ' ' GLU . 42.6 tp -71.6 134.86 46.68 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 167.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -132.66 164.81 25.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.71 1.204 . . . . 0.0 109.885 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.76 129.0 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.166 0.986 . . . . 0.0 108.366 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 100' ' ' ALA . 27.6 m -65.76 121.78 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 124' ' ' VAL . 5.7 t -117.42 16.77 14.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.939 0.896 . . . . 0.0 110.545 -175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.4 p -144.57 172.51 12.87 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.924 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.43 152.66 52.62 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HG3' HG23 ' A' ' 95' ' ' ILE . 23.4 Cg_endo -58.85 126.82 22.25 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.534 2.823 . . . . 0.0 113.639 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.81 167.74 47.8 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.369 169.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -68.01 -20.71 65.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 111.116 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.16 -7.37 51.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.76 0.824 . . . . 0.0 111.865 173.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.98 20.45 79.97 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -172.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 62' ' ' THR . 96.1 t -105.62 118.75 53.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 108.657 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.7 mp -108.54 117.87 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -69.03 128.62 37.32 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . . . -129.03 166.42 19.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.441 1.096 . . . . 0.0 110.166 -176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 112' ' ' THR . 14.9 t -119.93 126.3 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.742 0.817 . . . . 0.0 108.868 169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.3 mt -63.14 117.84 7.08 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.558 0.536 . . . . 0.0 109.761 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.36 -35.51 79.52 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.102 0.561 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 71.03 -61.88 0.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.428 1.491 . . . . 0.0 110.535 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.652 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -114.77 133.79 55.64 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 163.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -110.11 142.87 41.01 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.1 m -80.54 68.1 6.63 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.267 0.627 . . . . 0.0 109.544 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.94 110.4 11.53 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.207 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -77.07 99.26 5.27 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 123.543 0.737 . . . . 0.0 109.169 176.391 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.82 6.55 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 62.61 23.02 13.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.232 1.013 . . . . 0.0 112.165 -178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -97.98 108.3 20.98 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.804 0.842 . . . . 0.0 109.528 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -88.36 152.57 21.83 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.201 1.001 . . . . 0.0 110.765 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.48 149.75 19.44 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.253 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.87 132.41 15.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.802 2.334 . . . . 0.0 112.581 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.52 125.02 26.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.771 0.429 . . . . 0.0 109.959 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -75.37 130.88 39.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.1 0.56 . . . . 0.0 109.978 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.8 119.0 23.8 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.123 0.569 . . . . 0.0 110.172 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.8 mt -56.7 124.79 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.883 0.873 . . . . 0.0 110.2 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 t -122.72 164.89 17.46 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.138 0.975 . . . . 0.0 109.764 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.9 146.32 11.64 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.75 -160.9 36.03 Favored Glycine 0 C--N 1.343 0.945 0 O-C-N 123.674 0.279 . . . . 0.0 112.439 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.6 tp -173.12 90.87 0.09 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HA ' ' HE3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -84.48 103.11 13.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.438 179.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.52 117.07 4.33 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -86.93 174.28 8.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.5 0.72 . . . . 0.0 110.307 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -138.64 161.22 37.68 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.81 0.844 . . . . 0.0 109.634 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -132.01 148.04 52.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.984 0.914 . . . . 0.0 109.561 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.0 169.09 18.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.177 0.591 . . . . 0.0 110.294 172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 157.26 43.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.783 0.833 . . . . 0.0 109.399 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.23 114.58 8.51 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.113 -176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -76.38 164.05 26.39 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.735 0.814 . . . . 0.0 110.974 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -58.55 153.88 15.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.542 1.137 . . . . 0.0 113.448 -173.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.91 161.27 39.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.478 1.111 . . . . 0.0 109.078 170.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.94 146.75 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.2 0.6 . . . . 0.0 109.912 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.28 -145.52 5.43 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.325 0.391 . . . . 0.0 112.794 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -120.26 139.85 29.17 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.465 0.706 . . . . 0.0 110.467 -176.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.02 163.44 33.1 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.984 2.456 . . . . 0.0 111.962 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -50.74 139.27 40.06 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.352 2.701 . . . . 0.0 113.169 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.0 p -86.53 -90.46 0.11 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.206 0.602 . . . . 0.0 112.291 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.21 159.64 37.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.472 0.709 . . . . 0.0 110.335 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.8 m -150.03 123.94 9.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 108.966 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.5 p -72.73 -179.72 3.23 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.617 0.767 . . . . 0.0 111.864 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -126.91 163.55 23.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.177 0.991 . . . . 0.0 109.834 175.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.5 m -125.71 20.25 7.84 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.105 0.562 . . . . 0.0 110.757 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 43' ' ' ARG . . . -58.37 -42.58 87.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.734 0.814 . . . . 0.0 110.854 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.31 -41.14 71.97 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 112.107 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 28.6 t70 -72.13 -35.54 69.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.505 0.722 . . . . 0.0 110.595 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.1 -36.41 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.497 0.719 . . . . 0.0 110.251 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 18.4 mmm180 -67.33 -32.12 72.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.209 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -75.27 -35.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 120.598 0.237 . . . . 0.0 111.055 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 61.0 mttm -61.95 -36.9 82.79 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.452 0.644 . . . . 0.0 109.318 171.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -70.52 -38.42 74.27 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.384 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -67.43 -37.33 82.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -82.6 -1.6 51.34 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 45' ' ' LYS . 4.4 mm? -111.71 121.55 45.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -105.32 -81.68 1.49 Allowed Glycine 0 C--N 1.353 1.495 0 O-C-N 123.388 0.43 . . . . 0.0 112.415 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.54 179.32 42.68 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -88.98 141.43 28.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.197 0.599 . . . . 0.0 110.446 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.43 117.46 34.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.065 0.946 . . . . 0.0 108.584 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 168.29 20.3 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -82.39 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.235 0.614 . . . . 0.0 110.911 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -90.27 153.7 20.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.543 0.737 . . . . 0.0 111.35 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.91 167.82 1.48 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.011 1.325 . . . . 0.0 113.333 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -86.83 160.01 18.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.226 -175.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.62 128.74 35.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.497 0.719 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.2 p -78.97 122.14 25.79 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.399 0.679 . . . . 0.0 110.54 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 78' ' ' ILE . 14.0 m -69.9 123.45 21.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.644 0.778 . . . . 0.0 109.922 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 75' ' ' LYS . 3.0 m -142.14 163.63 32.35 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.628 0.771 . . . . 0.0 108.934 -171.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.82 135.27 54.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.812 0.845 . . . . 0.0 108.771 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -105.78 89.42 3.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 18.2 m -78.79 115.98 21.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.24 126.31 29.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 103.887 -2.634 . . . . 0.0 103.887 144.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -93.15 115.37 64.88 Favored Pre-proline 0 C--O 1.218 -0.584 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.47 -24.31 74.28 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.185 2.59 . . . . 0.0 113.921 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 26.04 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.784 0.434 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -100.61 -13.61 18.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.053 0.541 . . . . 0.0 112.175 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 52.79 63.48 2.22 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.151 1.38 . . . . 0.0 111.236 -172.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 p -139.88 138.69 35.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.336 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.82 146.83 26.07 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 65' ' ' VAL . 26.4 ttmt -145.25 127.31 15.58 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.546 1.138 . . . . 0.0 108.231 -173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' HG21 ' A' ' 62' ' ' THR . 21.5 mtpp -100.71 108.91 20.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.105 0.955 . . . . 0.0 108.795 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.44 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 113.028 -1.896 . . . . 0.0 107.916 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -67.03 155.57 38.33 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.44 0.696 . . . . 0.0 110.823 -172.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 61' ' ' THR . 50.8 mt -86.88 123.44 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.74 -87.97 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.04 143.18 34.24 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -162.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -92.64 114.74 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.586 0.754 . . . . 0.0 109.814 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' A' ' 103' ' ' ARG . 3.0 mm? -75.96 -64.78 1.01 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.231 1.012 . . . . 0.0 109.224 -175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 101' ' ' LYS . 38.3 tt0 -78.4 108.19 11.58 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.7 m -71.1 121.04 83.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.761 0.663 . . . . 0.0 110.495 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HB3' HG22 ' A' ' 97' ' ' ILE . 51.3 Cg_exo -59.86 151.68 69.48 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.372 2.048 . . . . 0.0 112.27 168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.66 -30.54 68.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 109.763 170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.674 HD22 ' HB2' ' A' ' 90' ' ' LEU . 4.7 p-10 -91.01 58.93 3.91 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.814 0.846 . . . . 0.0 110.004 171.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -42.22 79.52 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.885 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HG2' HD22 ' A' ' 90' ' ' LEU . 1.6 pm0 -61.49 -26.9 68.2 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -172.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.674 ' HB2' HD22 ' A' ' 87' ' ' ASN . 4.1 mm? -80.64 -53.59 6.4 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.338 1.055 . . . . 0.0 110.076 172.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.23 -30.57 11.92 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -69.53 -36.86 76.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.543 0.737 . . . . 0.0 110.987 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -71.7 -17.99 62.19 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.044 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.69 -3.27 34.2 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.575 -177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.58 HG23 ' HG2' ' A' ' 115' ' ' PRO . 44.5 mm -83.55 85.05 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-O 121.909 0.861 . . . . 0.0 109.26 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mt -100.31 148.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.367 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 85' ' ' PRO . 18.0 tt -95.91 144.71 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 109.696 -177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -51.36 133.7 28.95 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.281 1.032 . . . . 0.0 111.973 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 105.36 -16.12 45.56 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.489 0.566 . . . . 0.0 113.194 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -90.13 140.59 29.51 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.86 0.464 . . . . 0.0 111.847 -173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 12.0 mptt -84.13 137.3 33.61 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 tt -134.43 152.33 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.398 1.479 . . . . 0.0 108.356 -175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG3' HD21 ' A' ' 82' ' ' LEU . 54.2 mtt180 -111.61 133.3 53.97 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.4 p -115.74 179.71 3.9 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.23 -15.48 62.45 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.376 0.27 . . . . 0.0 111.017 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.19 -66.48 0.88 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.866 0.866 . . . . 0.0 110.308 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.48 -161.66 13.97 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.886 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.62 133.19 43.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB2' HD23 ' A' ' 125' ' ' LEU . . . -135.26 166.44 23.11 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.339 1.056 . . . . 0.0 110.595 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.16 127.5 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 109.102 167.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 100' ' ' ALA . 28.3 m -67.0 126.77 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.4 p -119.05 7.46 11.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.688 0.795 . . . . 0.0 111.925 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 122' ' ' ASN . 33.4 t -147.95 161.93 40.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.034 0.533 . . . . 0.0 111.059 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -86.81 146.23 40.58 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.867 0.867 . . . . 0.0 109.286 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 95' ' ' ILE . 85.9 Cg_exo -46.46 125.51 9.24 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.57 3.513 . . . . 0.0 114.943 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.92 171.08 51.07 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.77 170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -23.35 66.09 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.746 0.819 . . . . 0.0 110.441 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' HB3' HG12 ' A' ' 120' ' ' VAL . 22.9 t70 -71.53 -14.47 62.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.822 0.849 . . . . 0.0 111.469 176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.09 25.91 46.76 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 118' ' ' ASP . 8.5 p -111.46 126.9 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 110.225 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 121' ' ' ILE . 2.5 mp -107.66 110.84 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 113' ' ' SER . 0.8 OUTLIER -69.73 136.59 51.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.916 -174.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -135.15 166.75 22.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.032 0.933 . . . . 0.0 111.196 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.17 123.47 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.259 1.024 . . . . 0.0 108.928 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 109' ' ' ALA . 83.3 mt -62.91 115.67 4.59 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.48 0.488 . . . . 0.0 110.584 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.06 -40.58 91.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.069 0.548 . . . . 0.0 110.82 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 58.32 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.895 1.372 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -73.06 112.79 9.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.556 0.742 . . . . 0.0 109.067 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.89 153.17 46.96 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.4 t -55.03 123.09 12.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.119 0.968 . . . . 0.0 110.912 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -71.57 87.3 0.91 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.683 0.754 . . . . 0.0 109.079 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -87.04 78.31 8.98 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.847 1.259 . . . . 0.0 110.103 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.43 1.092 . . . . 0.0 108.679 179.5 . . . . . . . . 0 0 . 1 stop_ save_